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Abstract
The mammalian central nervous system (CNS) develops from a thin layer of 
neuroepithelial stem cells that form the early neural tube. Initially neuroepithelial 
cells generate neurons, the identity of which depends on their position of origin 
along the embryonic axis. Glia are generated at the end of neuronogenesis and 
very little is known about their specification. One of the challenges of modern 
developmental biology is to understand the extent of the diversity of glial cell 
types found in the CNS and how this diversity is generated. In this thesis I 
describe work using Cre-loxP technology combined with PAC transgenesis that 
clarifies the origins of various glial cells in the CNS.
CNS glial cell generation was studied by fate-mapping restricted pools of neural 
precursors and identifying their glial progeny. Using PAC transgenesis 
technology I generated mice expressing Cre recombinase in the same patterns as 
the transcription factors Dbxl, Emxl and Msx3. The resulting transgenic mice 
were crossed with Oe-dependant reporter mouse strains to visualise the progeny 
of the various neuroepithelial regions. Using these techniques I was able to 
demonstrate that the all the neuroepithelial domains studied produce neurons as 
well as the major glial cell types; astrocytes and oligodendrocytes. Of particular 
interest was the demonstration of novel sources of oligodendrocytes in the dorsal 
spinal cord and cortex. This work helps to resolve much of the controversy 
surrounding the origins of cortical and spinal cord oligodendrocytes. 
Investigation of the mechanism of dorsal oligodendrocyte specification indicates 
that dorsally-derived oligodendrocytes may be specified by Sonic hedgehog 
(SHH) -independent pathways, unlike their ventrally derived counterparts. The 
implications of these results are discussed in the context of possible mechanisms 
of glial cell specification in the CNS.
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Chapter 1
Introduction
‘You start out as a single cell derived from the coupling o f a sperm and an egg; 
this divides in two, then four, then eight, and so on and at a certain stage there 
emerges a single cell which has as all its progeny the human brain. The mere 
existence o f such a cell should be one o f the great astonishments o f the earth. 
People ought to be walking around all day, all through their working hours 
calling to each other in endless wonderment, talking o f nothing except that cell. ’ 
Lewis Thomas (1979)
1.1 The study of animal development
Development of animals from fertilised egg through to fully formed adult has 
fascinated people for centuries. Aristotle is known to have examined the 
development of chick embryos in the fourth century BC. He tried to describe the 
progression of developmental processes that create a mature functioning adult 
chicken, and ever since then people have tried to understand how the complexity 
of the adult form is achieved. Before the advent of modem microscopy some 
interesting theories were put forward. 17th century preformationists claimed that 
with the help of the earliest microscopes they could visualise fully formed 
animals or people residing in sperm or ova. Each ‘homunculus’ was then said to 
develop merely by increasing in size in the protective environment of the egg or 
uterus. While at the time these ideas were entirely plausible, improvements in the 
world of microscopy discredited them and instead people observed that embryos 
start as tiny single cells, and progressively divide, grow and become more 
complex. These observations led to the idea of epigenesis, which is the process 
by which embryonic development occurs in successive steps, with each step 
representing a progression in the formation of an animal both in terms of
14
increases in the embryo’s size and also adding to its morphological complexity. 
Importantly each step is a direct progression along a path of increasing 
complexity and size that directly relies on the basis provided by the preceding 
step.
By the end of the 19th century, the work of many descriptive embryologists had 
mapped out the complex morphological and growth changes that convert the 
single cell into a complex organism. It was noted that, at least to begin with, the 
many animal species studied underwent a fairly similar set of processes. The 
fertilised egg undergoes division to produce two cells. These then divide again 
and again until a body of cells is produced, generally in the form of a hollow ball 
called a blastocyst (mouse), blastula (Xenopus laevis) or blastoderm (chicken, 
zebrafish). The cells that form the outer layers of this ball go on to form the 
extra-embryonic tissues needed to support the growing embryo, for example the 
placenta. Meanwhile inside the ball, a disc-shaped group of cells called the 
epiblast is destined to form the embryo proper. In order to do this the epiblast 
undergoes an incredibly complex and fascinating process called gastrulation. 
Gastrulation is a series of complex cellular movements, divisions and 
invaginations that transform the single layered disc of the epiblast into the three 
germ layers of the embryo; the ectoderm, the mesoderm and the endoderm. 
These germ layers are separate cellular lineages that will give rise to the tissues 
and organs of the fully formed adult. Their formation represents a major 
divergence in the developmental pathways that the various cells of the embryo 
can take. Generally, once a cell becomes endodermal for example, it will never 
revert and switch to become a cell of the ectodermal lineage. Once this major 
fate decision has been made to create the three lineages, their constituent cells 
begin the long process of becoming all the parts of an organism, through growth 
and generation of cellular complexity. The ectoderm gives rise to skin and the 
nervous system, while the mesoderm gives rise to tissues such as muscle, blood 
vessels and blood, connective tissue, bone, the kidneys and the reproductive 
organs. The endoderm is responsible for producing the digestive tract and its 
appendages, such as the liver.
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Of particular interest for many embryologists has been the process by which the 
ectodermal layer gives rise to the nervous system. The reasons for this are 
understandable. From its humble beginnings as a strip of cells on the surface of 
the gastrula, the human brain is thought to eventually contain over 1011 neurons 
which are associated with 1012 glial cells (Gilbert, 2000). This means that the 
nervous system, particularly the human brain, may well be the most complex 
arrangement of matter in the universe. ‘Is the brain powerful enough to solve the 
problem of its own creation?’ (Eichele, 1992) may well sound like some sort of 
faux philosophical question posed during middle class dinner parties, but the fact 
is that a fascination with this concept has acted like a red rag to a bull for many 
developmental biologists, causing them to devote their lives in an attempt to 
work out how the nervous system could possibly come about. Away from these 
more esoteric concepts there are important practical considerations that have 
previously influenced and continue to influence many embryologists in their 
choice of which part of the embryo to study. Firstly the nervous system is simply 
more obvious than many other tissues during development. It derives from the 
surface ectoderm and as such its formation can be relatively easily observed 
occurring on the surface of the gastrula. This rather spectacular process called 
neurulation will have captured the imagination of many people. Secondly, the 
desire to understand the formation of the nervous system has become even more 
pressing due to the possibility that this knowledge could be used in conjunction 
with modem medical techniques in order to treat the numerous disorders, 
diseases and injuries that affect the nervous system. In its simplest terms, if we 
know how the nervous system was constructed in the first place, we may be able 
to mimic part or all of the processes involved and therefore repair damage that 
has occurred to the system. This idea is now the driving force behind the bulk of 
the work that goes into the study of nervous system development.
1.2 Neurulation
Neurulation, or the formation of the nervous system from the ectoderm, occurs in 
response to the migration of mesodermal cells into the region directly underlying 
the ectoderm during gastmlation. Cells destined to become mesoderm (and 
endoderm) move from the outside of the epiblast through a groove that runs
16
along the surface of the embryo, called the primitive groove, to the underside of 
the epiblast. It is this movement of cells that creates the three layered form of the 
gastrula from the simple one layered epiblast. Moreover, as these cells migrate 
under the gastrula’s surface (now called the ectoderm) they are differentiating 
and activating genes specific to their particular, mesodermal, lineage. Those 
mesodermal cells that maintain contact with the ectoderm are called the 
chordamesoderm and they are important for nervous system formation. At the 
anterior (‘head’) end of the primitive groove lies the node. Migrating 
chordamesoderm cells pass underneath or through the node and then progress in 
an anterior direction underneath the ectoderm. When they do this they directly 
cause the start of neurulation in the ectodermal cells that lie above them. The 
mechanism for this is now partly understood, at least for Xenopus development. 
Within the ectodermal layer, signalling via proteins of the BMP (Brain 
Morphogenic Protein) family, particularly BMP-4, normally inhibits the start of 
neurulation and maintains the ectoderm in an epidermal (skin-forming) state 
(Graff et al., 1994). As the chordamesodermal cells pass under the ectoderm, 
they produce proteins such as chordin and noggin which bind and inactivate 
BMP-4 (Piccolo et al., 1996;Zimmerman et al., 1996). This ‘disinhibits’ the 
process of neurulation, removing the signalling which normally prevents it from 
happening. Neurulation can therefore be viewed as the default developmental 
pathway that ectoderm would take, but one that it is prevented from taking by the 
inhibitive effects of the BMP signalling. Once these are lifted by noggin and 
chordin, the cells that lie directly above the chordamesoderm begin neurulation.
The first change seen in neurulation is the formation of the neural plate. The 
ectodermal cells disinhibited by the chordamesoderm elongate along their basal 
(bottom) to apical (top) axis and become thinner. In effect they become 
columnar. They also move about, with the more lateral, outermost cells moving 
inwards towards the midline by intercalating with the cells already there. Some 
of the cells lying closer to the midline also move in the anterior direction to make 
room for the lateral cells that are moving in. The effect of all this is to produce a 
slightly raised region of ectoderm that forms a strip along the surface of the 
embryo. This is the neural plate (figure 1.1). As this movement and 
columnarisation is occurring, a depression forms along the midline of the neural
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plate, which is called the neural groove. Additionally, ridges of cells form along 
the lateral boundaries between the neural plate and the epidermal ectoderm, 
which is now fated to become skin. Elongation of the neural plate along the 
midline and a contraction laterally, particularly in the posterior (tail-forming) 
region, cause the plate to assume a keyhole shape when viewed from above.
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Figure 1.1 Schematic representation of neurulation in a section of the 
developing embryo. Neurulation begins with the induction of the neural plate by 
underlying mesoderm. Folding of the neural plate is caused by hinge points 
located at the base of the neural groove and in the lateral neural plate regions. 
The neural crests move together as the epidermal ectoderm grows towards the 
midline. When the neural crests meet they connect the neural tube to the 
overlying epidermis but as the neural crest cells disperse the neural tube 
becomes separated from the epidermis. (Adapted from (Gilbert, 2000) and from 
http://laxmi.nuc.ucla.edu:8888/Teachers/pphelps//Published_Trays/PS107- 
Fall98-Lec2/Pindex.html)
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Once this is achieved the neural plate curls up at the edges with the 2 neural 
ridges on each side curving over to meet each other. The cells at the crests of 
these ridges are now called the neural crest cells and are fated to give rise to, 
amongst other things, the peripheral nervous system. The curling of the neural 
plate is achieved by ‘hinges’ that are formed by cells at the base of the neural 
groove and also in two lateral strips along the plate. Essentially, the hinge cells 
become wedge-shaped with their apical surfaces constricting in diameter and 
their basal surfaces expanding. The plate is therefore made to curve around at 
these points. When the neural crests meet, they fuse together by expressing 
particular cell adhesion molecules. They also lose adhesion with the surrounding 
epidermal ectoderm. This results in the neural plate forming a tube. The 
epidermal ectoderm on either side of the plate now comes into contact and fuses 
over the top of the tube so that an internalised neural tube forms covered by 
surface epidermis. The cells of this neural tube are now fated to become the 
whole of the central nervous system. For a review of neurulation see Smith and 
Schoenwolf, (1997).
1.3 The neuroepithelium
The neural tube expands along its anterior-posterior axis following its formation. 
Towards the anterior end it folds and parts of it swell around internal vesicles. 
This folding and expansion forms the brain. The more posterior neural tube 
remains relatively tube-like, forming the spinal cord. The neural tube, as the 
name suggests, has a central lumen or cavity running all the way through it. The 
cells that directly line this lumen are called neuroepithelial cells and throughout 
the process of development they divide at a furious pace to give rise to all the 
precursors and cellular sub-types that form the CNS. It has been proposed that 
the neuroepithelium persists into adulthood, where it takes the form of 
ependymal cells and that these ependymal cells have a reduced mitotic activity 
but still retain the ability to generate neurons throughout life (Johansson et al.,
1999). However other results indicate that the ependymal cells are not the source 
of adult neurogenesis (Spassky et al., 2005) and that this ability is actually 
retained by sub-ependymal astrocytes in the sub-ventricular zone (SVZ)
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(Doetsch et al., 1999). Therefore it appears that the maintenance of a stem cell 
phenotype in the adult CNS is achieved by the sub-ependymal astrocytes.
At the beginning of CNS development, the neuroepithelial cells span the entire 
width of the neural tube, contacting both the central lumen and the outer surface 
of the neural tube, the pia. While maintaining contact with both surfaces, the cell 
bodies of the neuroepithelial cells move inwards and outwards depending on 
their stage of the cell cycle. S-phase cell bodies tend to be found further from the 
ventricular zone nearer the pia, while mitotic cell bodies are found directly next 
to the lumen. The initial phase of CNS expansion is characterised by the 
symmetrical division of neuroepithelial cells that increases their number and 
therefore the size of the neuroepithelium. Interestingly the length of this period 
of symmetrical division is thought to go some way to specifying the properties of 
a particular CNS region. For example, a longer period of symmetrical division 
will lead to the production of a larger neuroepithelial cell pool, able to give rise 
to larger structures in the adult. This is thought to underlie the huge differences 
in the sizes of various CNS structures. The telencephalon, which gives rise to the 
cortex, one of the largest brain regions, has one of the longest periods of 
symmetrical division, presumably to provide a larger pool of precursors from 
which to derive the adult structure (Rakic, 1995). Neurogenesis begins after the 
symmetrical division phase. At the beginning of this process many of the 
neuroepithelial cells begin to become more glial, expressing glial markers such 
as GLAST and GFAP and becoming more bipolar (Campbell and Gotz, 2002). 
They are thus termed radial glia and represent the majority of the CNS precursors 
at this time. Some of them at least alter their mode of division, giving rise to 
asymmetric progeny consisting of one neuron and one precursor. These are the 
so-called transit amplifying precursors and their asymmetric division helps 
maintain a precursor population while producing the many neurons required by 
the CNS. Other neurons are produced from symmetric divisions. Glial cells, 
astrocytes and oligodendrocytes, are generated at the end of neurogenesis and 
appear to be mostly produced by symmetric division (for review see Gotz, 
(2003)).
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1.4 Generation of cell diversity in the CNS
A wide variety of neuronal cell types are produced in different areas along the 
CNS. Their identity is initially dependant on their position, and the signalling 
molecules they are exposed to which are produced by a variety of signalling 
centres. One of these signalling centres is the notochord (figure 1.1) which runs 
ventrally along the entire length of the neural tube. The notochord is the source 
of a glycoprotein called Sonic Hedgehog (SHH). SHH is secreted along the 
ventral neural tube and has a large number of effects mediated by a complex 
signal transduction pathway (see below). One of its earliest effects is on the 
medial hinge cells located at the ventral midline of the neural tube. Upon 
exposure to SHH these cells become specialised to form a structure called the 
floor plate. The floor plate cells then also secrete SHH, setting up a gradient of 
SHH concentration along the dorso-ventral axis of the ventral neural tube 
(highest concentration in the ventral areas) (Briscoe et al., 1999;Roelink et al., 
1995;Wijgerde et al., 2002) . At the same time the epidermal cells above the 
dorsal part of the neural tube are still expressing BMPs such as BMP-4, which 
originally inhibited neurulation. These now induce the dorsal-most cells of the 
neural tube to form the roof plate (analogous to the floor plate) and cause the 
roof plate cells to produce their own BMPs along with WNT proteins and other 
signalling molecules of the Transforming Growth Factor p (TGF-P) superfamily 
(Caspary and Anderson, 2003;Liem, Jr. et al., 1995;Liem, Jr. et al., 1997). These 
proteins again form a gradient of signalling molecules with the highest 
concentrations existing in the more dorsal regions. Therefore a signalling grid is 
set up by SHH, BMPs and Wnt proteins as well as other unidentified molecules, 
and it is this mix of signalling molecules that provides the positional information 
which governs a cell’s fate.
The process by which cell signalling gradients actually determine neural cell fate 
is best understood in the context of SHH signalling in the ventral neural tube. 
SHH signals by binding to a protein on the surface of cells called Patched (PTC). 
This binding interferes with the normal action of PTC, which is to inhibit the 
action of another cell surface protein called Smoothened (SMO). It is quite likely 
that PTC and SMO exist as a complex on the cell surface which could then be
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regarded as the SHH receptor (Murone et al., 1999). SMO acts as the signal 
transducer for SHH signalling into the cell, possibly by the action of G proteins, 
(Marti and Bovolenta, 2002) and this SMO signalling causes the activation of 
proteins of the GLI family. GLI proteins are transcription factors that when 
inactive are sequestered by cytoskeletal proteins in the cytoplasm of the cell. 
This sequestration appears to be mediated by a protein called Suppressor of 
Fused (SUFU) and involves the phosphorylation of GLI proteins. SHH signalling 
via SMO causes suppression of SUFU, probably by the protein Fused and also 
the dephosphorylation of GLIs. The upshot of this is that GLIs are released from 
their cytoskeletal anchors and are transported into the nucleus where they are 
able to activate the transcription of their target genes (Ruiz, 1999). There are 
actually three GLI proteins, GLI1, GLI2 and GLI3 expressed in the neural tube 
in partially overlapping domains and when the actions of these separate GLI 
proteins are considered, the situation becomes quite complex and is not 
completely understood. It is thought for example that in the ventral neural tube at 
least, SHH signalling induces the transcriptional activation activities of GLI1 and 
2, but actually causes GLI3 to assume a transcriptional repressor role. Depending 
on the context however, the GLI proteins can probably all act as repressors and 
activators. Knockout experiments indicate a relatively high level of redundancy 
between them and there are also indications that interactions occur between GLI 
proteins and the BMP and WNT signalling pathways (see Altaba et al., (2003). 
The results of these complex interactions are various groups of cells in the neural 
tube will express certain combinations of transcription factors, typically of the 
homeodomain (HD) transcription factor family, depending on their location. 
These differing transcription factor expression profiles will then determine which 
cell type(s) a particular region of the neural tube gives rise to. The neural tube 
can thus be divided into domains of neuroepithelial cells on the basis of the cells’ 
transcription factor expression, and the cell types they give rise to.
The transcription factors expressed in neuroepithelial cells of the ventral neural 
tube have been classified as either Class I or Class II depending on whether they 
are repressed or activated by SHH respectively. Class I HD proteins such as 
PAX6 and IRX3 are repressed by SHH and are therefore expressed in more 
dorsal regions of the ventral neuroepithelium, while class II proteins such as
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NKX2.2 and NKX6.1 are induced by SHH and are expressed more ventrally. 
Once expression of the HD proteins is initiated or repressed in various areas of 
the neuroepithelium via SHH signalling, pairs of HD proteins can form co­
repressing partners that act to antagonise each others’ expression. This mutual 
antagonism acts to set up sharp boundaries between domains of differential HD 
expression. For example Nkx2.2 (a class II HD) is repressed by, and in turn 
represses Pax6 (a class I HD). This means that a sharp boundary is set up where 
Nkx2.2 expression stops and Pax6 expression starts. This boundary marks the 
transition from the Nkx2.2-expressing p3 domain to the Paxd-expressing pMN 
domain (Ericson et al., 1997). Figure 1.2 illustrates the neuroepithelial domains 
of the ventral spinal cord and shows which co-repressing HD protein partners are 
responsible for setting up the boundaries between them. This model shows us 
how the ventral spinal cord becomes patterned into a series of domains, each 
defined by its unique pattern of HD transcription factor expression. The 
differential expression of HD proteins in different domains is thought to help 
determine the cell type that is produced from each (Briscoe and Ericson, 
2001;Kessaris et al., 2001).
How do the different HD expression profiles of the 5 ventral spinal cord 
neuroepithelium domains specify the production of different cell types? The p3, 
pMN and p2 domains generate V3, motor and V2 neurons respectively. Nkx6.1 is 
expressed in these three domains and studies by Briscoe et al. (Briscoe et al.,
2000) showed that ectopic expression of this HD protein in the absence of 
another HD protein, Irx3, leads neuroepithelial cells to apparently enter the 
motomeuron (MN) lineage, as occurs normally in the pMN domain. When Irx3 
is present however, the combinatorial expression of both HDs leads to the 
production of V2 intemeurons and not MNs, This is what normally occurs in the 
p2 domain. Therefore the MN-promoting activity of Nkx6.1 can be altered to a 
V2-promoting activity in the presence of Irx3. In a similar way, Nkx2.2 
expression in the p3 domain means that here, Nhc6.7-induced production of MNs 
is prevented, instead leading to the production of p3 intemeurons. What the HDs 
actually do is to induce the expression of other transcription factors that are 
specific to a particular neuronal lineage. Lim3 is a HD sufficient to promote the 
V2 intemeuron phenotype. In the p2 domain, Lim3 expression is induced by
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Nkx6.J. In the pMN, Nkx6.1 still induces Lim3 expression, but also induces 
MNR2, Hb9 and Is ll  and it is these four transcription factors that are sufficient to 
induce MN differentiation. In the p2 domain, Irx3 specifically represses the 
expression of these 3 other MN-determining genes meaning only Lim3 is 
expressed, and the cells become V2 interneurons, not MNs. Similar control 
mechanisms exist in the other ventral neuroepithelial domains (Briscoe et al., 
1999;Briscoe et al., 2000;Briscoe and Ericson, 2001;Pierani et al., 2001c). 
Further differentiation along a lineage, for example the specialisation of a 
particular type of MN to a particular motor column in the spinal cord, is further 
mediated by even more lineage restricted proteins, such as other members o f the 
LIM family (Briscoe and Ericson, 2001).
Class fl genes
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Figure 1.2 The ventral spinal cord neuroepithelium showing the 5 neuroepithelial 
domains and the floor plate. Class I genes are repressed by SHH and so only 
appear more dorsally while class II genes are activated by SHH and appear more 
ventrally. Once expressed they mutually repress each other as shown forming 
sharply defined boundaries of HD protein expression and therefore delineating the 
domains of the ventral spinal cord. Note Olig2 is actually a basic helix-loop-helix 
transcription factor not a HD protein (from Kessaris et al., (2001).
24
1.5 Oligodendrocyte specification and development in the CNS
Oligodendrocytes in the spinal cord are generated from the pMN domain 
neuroepithelium at the end of MN production. This process is therefore closely 
associated with mechanisms that underlie MN specification. Patterning via SHH 
and Nkx6.1, is responsible for the induction of 2 genes recently found to be vital 
for the establishment of the pMN domain, the Olig genes (Liu et al., 2003). Oligl 
and Olig2 are basic helix-loop-helix transcription factors that are essential for 
formation of the pMN domain. Double knockout of these two transcription 
factors (Zhou and Anderson, 2002) leads to the expansion of the p2 domain in a 
ventral direction and subsequent production of V2 intemeurons from this area. 
This occurs because Olig2 is actually a repressor of Irx3 (Novitch et al., 2001) 
and therefore in the absence of Olig2, Irx3 expression occurs in the pMN, 
essentially converting it to another p2 domain. One of the results of this is a loss 
of MNs but in addition, the differentiation of oligodendrocytes is abolished 
indicating that the Olig genes are also involved in oligodendrocyte production 
and that the pMN gives rise to oligodendrocytes as well as MNs. MN production 
begins around E l0.5 with oligodendrocyte production taking over at around 
E l2.5 but Olig genes function throughout these processes. This indicates that 
other factors must be involved to cause a switch from production of neurons to 
production of oligodendrocytes. Pro-neural genes such as Ngn2 are expressed 
during MN production in 0/(g2-expressing cells, but are then down-regulated 
when the pMN domain switches to oligodendrocyte production (Zhou et al., 
2001). This indicates that they may be involved in a switch. The situation is not 
simple however given that knocking out Ngnl and 2 does not speed up 
production of oligodendrocytes (Rowitch, 2004). The switch may also involve 
signalling via the Delta-Notch pathway, at least in zebrafish. Dismption of Delta- 
Notch signalling by removing certain Delta ligands or by preventing Delta 
ligands from activating their receptor, Notch, leads to an absence of 
oligodendrocytes, with only neurons being produced from 0//g2-expressing 
cells. Conversely, forced expression of an active Notch receptor blocks neuron 
production and causes an overproduction of oligodendrocytes (Park and Appel, 
2003). Other important genes in the production of oligodendrocytes may include 
Sox9 (Stolt et al., 2003) as shown by disrupted oligodendrocyte production and
25
increased MN production in Sox9 knockouts. The timing of the switch is also still 
unclear. For example, it is not known yet whether at the time of pMN 
specification, the domain contains a homogenous pool of precursors that produce 
MNs then oligodendrocytes, or whether the two lineages are distinct at this point 
and that the MN precursors merely activate MN production first before the 
oligodendrocyte precursors (OLPs) produce their progeny a few days later. 
Additionally, at whatever point the OLP and MN precursor lineages diverge, 
does their common precursor divide to produce one MN committed cell and one 
oligodendrocyte committed cell? Or is the segregation of the lineages a more 
random process, perhaps with one daughter cell stochastically adopting a 
particular fate and then some form of lateral inhibition process meaning that it 
inhibits neighbouring cells from adopting that same fate? These would therefore 
enter the other lineage. Obviously more work is required to determine the nature 
of the switch.
Once the switch has occurred, oligodendrocyte differentiation begins in earnest. 
In the spinal cord pMN, an expansion of the Nkx2.2-expressing domain into the 
pMN is observed around E12.5. This appears to be ‘allowed’ due to the down- 
regulation of Ngnl in the pMN and it has been shown that coexpression of 
Nkx2.2 and Olig2 is sufficient to produce oligodendrocytes (Zhou et al., 2001). 
The Nkx2.2/Olig2 cells may therefore represent the first restricted OLP of the 
spinal cord, although there is controversy. Work in vitro by Rao et al. has 
identified a ‘Glial-Restricted Progenitor’ (GRP) (Rao et al., 1998), which may 
represent an alternative route to OLP production that does not involve the MN 
lineage. Or perhaps this GRP is merely an intermediate between the MN 
precursor and the Nbc2.2/0//g2-expressing OLP. Either way, once specified, the 
OLPs begin to show massive proliferative capacity and they migrate widely, 
progressing through several developmental stages before maturing.
Each developmental stage in the life of the oligodendrocyte is characterised by 
the expression of different overlapping markers. The cell surface antigens 
recognised by the monoclonal antibody A2B5 appear first (Raff et al., 1984). 
Cells expressing this marker are known to be able to give rise to 
oligodendrocytes and so called type-2 astrocytes in vitro and for this reason they
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are known as 0-2A progenitors. It is unclear whether this ability is manifested in 
vivo however. Further maturation of OLPs leads to expression of galactosulfatide 
and a novel proligodendroblast antigen (POA), which are recognised by the 04 
monoclonal antibody. Soon the proligodendrocyte stage is reached, characterised 
by low motility, and a multiprocessed morphology. The final stage in the 
development of oligodendrocytes is characterised by the upregulation of the 
major myelin components such as myelin basic protein (MBP) and proteolipid 
protein (PLP) (Miller, 2002).
OLPs are highly proliferative and this behaviour begins in the ventricular zone 
and sub-ventricular zone before differentiation is very advanced. However, the 
majority of proliferation takes place after migration to the white matter (Miller et 
al., 1997). Immature OLPs express the Platelet Derived Growth Factor Receptor 
a (PDGFRa) (Pringle et al., 1992;Pringle and Richardson, 1993) and can 
therefore respond to the mitogen and survival factor PDGF. Over-expression of 
PDGF dramatically increases OLP numbers (Calver et al., 1998) while knocking 
it out reduces OLP numbers (Fruttiger et al., 1999). It further appears that PDGF 
acts as a rate-limiting factor in OLP proliferation in vivo (van Heyningen et al.,
2001). OLPs also proliferate in response to fibroblast growth factor (FGF) 
although the effects of various FGF subtypes appear to be dependant on the stage 
of oligodendrocyte development. Basic FGF (bFGF) applied in combination with 
PDGF promotes extended OLP proliferation (Bogler et al., 1990;McKinnon et 
al., 1990). FGF2 however appears to affect mature oligodendrocytes by 
converting them to an altered phenotype (Bansal and Pfeiffer, 1997). Various 
FGF receptors are found to be expressed on oligodendrocytes at different stages 
(Bansal et al., 1996) and it now appears that various FGF ligands interact with 
these FGF receptors to direct a large number of processes during oligodendrocyte 
development (Fortin et al., 2005). Additional factors found to increase OLP 
proliferation in vitro include insulin-like growth factor 1 (IGF-1), neuregulin 
(NRG) and neurotrophin 3 (NT3) (Baron et al., 2005), although their influence 
on proliferation remains to be demonstrated in vivo.
While proliferating, OLPs migrate to populate the entire CNS. Migration can be 
influenced by PDGF in a concentration dependant manner, indicating that PDGF
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may act as a chemoattractant (Armstrong et al., 1990). This may not be the case 
in vivo however, as PDGF is widely expressed in the CNS and is therefore 
unlikely to exist in the kind of concentration gradients that could widely 
influence OLP migration. Specific cues guiding OLP migration have been 
identified in the optic nerve where netrin-1 (and possibly semaphorin-3a) has 
been identified as a chemorepellant for OLPs (Sugimoto et al., 2001) These 
guidance molecules are expressed by the optic chiasm causing cells to migrate 
away from the chiasm towards the retina. Results from the spinal cord also 
indicate that netrin-1 is expressed by the ventral ventricular zone and acts as a 
chemorepellant driving migration of OLPs away from the pMN (Tsai et al., 
2003). Migration may also be guided by axons and the cues provided by them, 
although this is not certain (Cohen, 2005;Miller, 2002).
The end of oligodendrogenesis is marked by the cessation of OLP proliferation 
and the myelination of axons. The final number of OLPs appears to be partly 
mediated by the availability of mitogens, particularly PDGF (van Heyningen et 
al., 2001). Interestingly the final number of mature oligodendrocytes is not 
directly related to the number of OLPs as shown by the presence of normal 
numbers of myelinating oligodendrocytes even when OLPs over-proliferate due 
to PDGF over-expression (Calver et al., 1998). Control of normal OLP number 
probably involves local signalling processes, possibly including TGFp. Some 
sort of density dependant feedback mechanism is thought to operate to prevent 
OLP proliferation when OLP density reaches a certain threshold. The exact 
nature of this feedback mechanism is unknown (Miller, 2002) but the simplest 
model is that proliferating OLPs deplete mitogens, particularly PDGF, in 
proportion to their number (Calver et al., 1998;van Heyningen et al., 2001). The 
mechanism definitely involves exit from the cell cycle, mediated by cell cycle 
regulatory proteins like p27kip'1 (Casaccia-Bonnefil et al., 1997). There is also a 
role for cell death with up to 50% of newly formed oligodendrocytes dying 
during development (Barres et al., 1992). This appears again to be mediated by 
competition for cell survival factors such as PDGF and also the presence of 
axons. Increase in axon number directly increases the number of 
oligodendrocytes present in the rat optic nerve (Bume et al., 1996). This is 
probably mediated, at least in part, by axons proving neuregulin, which has been
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shown to prevent oligodendrocyte cell death (Fernandez et al., 2000). Neuregulin 
signalling via ErbB2 receptors also plays a role in inducing myelination, as does 
IGF-1 which was found to affect myelination as shown by transgenic mice that 
over-express IGF-1 showing increased myelination (Carson et al., 1993). This 
effect could be indirect however, mediated by altering axon-derived factors that 
in turn induce myelination.
Oligodendrocytes are required to myelinate the CNS in a strictly controlled 
manner. There is no point in all OLPs differentiating and myelinating a restricted 
ventral portion of the neural tube before any of them have migrated to the rest of 
the developing CNS. Therefore the spatial and temporal controls on OLP 
development and differentiation must be very precise. Temporal control could be 
mediated by the differential expression of different repertoires of soluble growth 
factor receptors such as those discussed above. For example it is known that IGF 
and NT3 are able to potentiate OLP proliferation in response to PDGF, while 
TGFp signalling prevents PDGF induced proliferation, leading instead to 
differentiation. These various findings indicate a mechanism to explain how 
responses at certain times could be moderated by altering which receptors are 
expressed at a particular time (Baron et al., 2005). This idea is supported by the 
changing FGF receptor expression profiles exhibited by OLPs during their 
development (Bansal et al., 1996). Soluble factors are unlikely to mediate 
differing spatial responses however, given that they are free to diffuse over wide 
distances, unless their diffusion is somehow limited via sequestration by the 
extra-cellular matrix or receptor-bearing cells. Spatial control is thus more likely 
to rely upon insoluble, localised signalling molecules such as cadherins, Notch 
receptors and extra-cellular matrix (ECM) proteins. Interesting work on the 
integrin ECM receptor family indicates that specific subtypes are expressed 
differentially during OLP maturation and in different CNS areas, as are certain of 
their ligands. Additionally, specific knock-out of various integrin receptor 
subunits in transgenic mice has shown effects upon oligodendrocyte survival and 
myelination. PDGF signalling appears to mediate both cell proliferation and 
survival. It also appears that PDGFRa requires association with integrins to be 
able to respond to physiological levels of PDGF. The choice of whether cell 
survival or proliferation occurs in response to PDGF signalling may therefore
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depend on the integrin receptor subtype that the PDGFRa associates with. A 
model has been proposed in which association of PDGFRa with the av03 
integrin receptor results in a proliferative response by the oligodendrocyte 
(provided both PDGF and the integrin receptors ligands are present) while 
association of PDGFRa with the a6pl subtype promotes survival (in the 
presence of both ligands). The differential expression patterns of the different 
ligands for these two integrins therefore provides a mechanism for controlling 
how an oligodendrocyte responds to PDGF signalling depending on its 
immediate surroundings (Baron et al., 2005). These speculations require 
demonstration in vivo however.
As mentioned previously, OLPs appear to derive from specific foci in the CNS. 
The role of the pMN in OLP specification is well established, but given the 
degree to which spinal cord oligodendrocyte generation is now understood, it is 
slightly surprising that the location of forebrain oligodendrogenesis is still quite 
controversial. There is evidence that indicates a ventral source of 
oligodendrocytes in the forebrain which would be analogous to the situation in 
the spinal cord. The neuroepithelium of the medial ganglionic eminence, a region 
responsible for producing GABAergic intemeurons, is known to express Shh, Ptc 
and Olig2 in a similar way to the pMN domain, and could therefore represent a 
source of oligodendrocytes (Spassky et al., 2001;Tekki-Kessaris et al., 2001). In 
fact from around E l2.5, cells that label with PDGFRa, can be found in the 
ventral telencephalon and they appear to stream away from this area in all 
directions as development progresses (Tekki-Kessaris et al., 2001). Many of 
these appear to enter the cerebral cortex (dorsal forebrain) indicating that the 
ventral source may populate more dorsal regions. Using expression of the Dlx 
HD protein family to identify cells with a ventral origin, He et al. (He et al., 
2001) showed the presence of ventrally derived oligodendrocytes in the cortex 
indicating dorsal migration from a ventral source. Work with chick-quail 
chimeras also indicates the origin of forebrain oligodendrocytes is in the ventral 
telencephalon (Olivier et al., 2001). However there is evidence that there are 
dorsal sources of oligodendrocytes too. Fate-mapping using an Emxl-Cre 
transgenic line indicated that many dorsal oligodendrocytes are dorsally derived 
(Gorski et al., 2002) and cultures of cortical progenitors can give rise to
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oligodendrocytes (Kessaris et al., 2004;Spassky et al., 2001) though with a delay 
relative to ventral progenitors. As there is evidence for both sources it is 
important to determine if both are active in the normal embryonic brain. The 
existence of two (or more) sources of oligodendrocytes could indicate the 
existence of functionally distinct populations of oligodendrocytes, or could 
indicate the existence of different signalling mechanisms that trigger 
oligodendrogenesis. The results therefore have implications for the study of a 
variety of diseases, notably multiple sclerosis.
1.6 Astrocyte specification in the CNS
The field of CNS astrocyte biology lags some way behind the study of neurons 
and oligodendrocytes, not least due to the fact that the term astrocyte covers what 
appears to be a highly heterogeneous group of glial cells that are classed together 
due to their multiprocessed stellate appearance and their (mostly) mutual 
expression of the intermediate filament glial fibrillary acidic protein (GFAP) 
(Eng et al., 1971). The level of astrocyte diversity is unclear, although two 
morphologically distinct subtypes can be distinguished. The ‘fibrous’ astrocyte is 
characterised by a relatively small cell body surrounded by large, branching 
processes that are immunoreactive to antibodies specific for GFAP. They tend to 
be concentrated in the white matter of the CNS although they are also found in 
the grey matter. Distinct from this type of astrocyte is the smaller ‘protoplasmic’ 
astrocyte which again has a small cell body, this time surrounded by a dense 
mesh of very fine fibres giving them a bushier appearance. Examples can be 
found that are immunoreactive for GFAP, although it is possible to find 
morphologically identical cells that show no GFAP immunoreactivity. This may 
represent either a problem with the threshold of detection provided by 
immunohistochemistry, or it may be that these cells do not express GFAP at all. 
This does create a problem though as most investigators now use GFAP 
expression as a defining characteristic of an astrocyte. Investigations placing the 
reporter gene EGFP under the control of the human GFAP promoter in 
transgenic mice have found populations of EGFP-expressing cells that show no 
GFAP immunoreactivity indicating that GFAP may be transcribed in these cells, 
but not expressed (at least at levels detectable by GFAP immunohistochemistry)
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(Nolte et al., 2001). This immediately creates problems for the definition and 
identification of astrocytes as being GFAP-expressing cells, but does mean that 
protoplasmic astrocytes (defined morphologically) that appear GFAP-negative 
could still be classed as astrocytes, (albeit examples in which GFAP is 
undetectable by immunohistochemistry). Another marker that aids in the 
identification of astrocytes is SlOOp (Matus and Mughal, 1975) as most cells that 
express it appear astrocytic in morphology or via GFAP staining. Use of this 
marker to define astrocytes must be treated with some caution however due to its 
expression in some neurons (Kimelberg, 2004) and some oligodendrocytes 
(Hachem et al., 2005). Additional markers such as Aquaporin-4 (Nielsen et al., 
1997) GLAST (Shibata et al., 1997) and FGFR3 (Pringle et al., 2003) can also be 
used in conjunction with GFAP and S100P to further characterise cells as 
astrocytes, but these have their own drawbacks, such as possible expression in 
ependymal cells (Aqu-4, (Badaut et al., 2002)), radial glial cells (GLAST, 
(Shibata et al., 1997)), and MNs and OLPs (FGFR3, (Bansal et al., 2003;Philippe 
et al., 1998)). So for now, morphological and antigenic criteria should be 
considered in combination when defining astrocytes.
Classification of astrocytes using their biological functions is in some ways even 
more confusing than using their appearance. They have been assigned roles as 
diverse as providing metabolic functions such as water homeostasis and ion 
transport, synaptic support (such as removal of excess neurotransmitter), 
signalling via calcium waves, acting as barriers to delineate various brains 
regions and even as stem cells for neural cell renewal (Kimelberg, 2004). 
Perhaps the best studied role of astrocytes is in reactive gliosis in which 
astrocytes proliferate, upregulate GFAP and produce even more complex 
branching processes (Norton et al., 1992). Clearly, cells that perform all these 
functions in various combinations, or in isolation, are very hard to classify as one 
cell type. It may be more useful then to think of astrocytes as a group of cells that 
fulfil various functions to support and maintain the CNS and that are united by 
their common GFAP protein, or at least mRNA, expression and stellate 
appearance. Their functional heterogeneity may be a function of their high levels 
of plasticity, but could also be the result of them being a grouping of completely 
distinct cell types. Work in culture whereby single lineages of astrocyte cells
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were characterised seems to imply that heterogeneous populations can derive 
from a single precursor, indicating that indeed the astrocyte may well be an 
inherently plastic cell that regulates its own fate depending on surrounding cues, 
as opposed to having its fate restricted at an earlier precursor stage (Miller and 
Szigeti, 1991). Ultimately though, characterisation of the various astrocytic 
phenotypes and functions needs to continue, until hopefully it will become clear 
if it is appropriate to talk of the astrocytes as a single type of cell or if it will 
become necessary to define new classes of astrocytic cells.
At this point it is appropriate to highlight another glial subtype identified in the 
rat that has received attention recently. Cells expressing the chondroitin sulphate 
proteoglycan NG2, which are found throughout the postnatal CNS, have been 
assigned as OLPs or 0-2A cells. This was because at least a subset of them co­
express markers found on oligodendrocytes and their precursors such as GD3 
ganglioside, RIP, GalC, 04 and PDGFRa (Levine et al., 1993;Nishiyama et al., 
1996;Reynolds and Hardy, 1997). In addition these cells were found not to co­
express normal astrocyte markers such as GFAP or vimentin (Levine et al., 
1993). NG2-expressing cells are also able to give rise to oligodendrocytes in the 
same way as 0-2A cells in culture (Levine et al., 1993). However, their 
designation as OLPs has become uncertain due to various findings. The 
morphology of most NG2-expressing cells is not that of the bipolar 0-2A 
progenitor but rather is one of a stellate, multi-processed astrocyte. They appear 
to make intimate contacts with axons at their nodes of Ranvier (Butt et al., 1999) 
and have been demonstrated to establish direct synaptic contacts with neurons in 
the hippocampus (Bergles et al., 2000) and cerebellum (Lin et al., 2005). This 
shows that at least a sub-population of NG2-expressing cells is directly 
responsive to neuronal activity. Most NG2-expressing cells (>95%) appear to be 
post-mitotic and thus are unlikely to act as postnatal oligodendrocyte precursors 
(Dawson et al., 2003;Levine et al., 1993). At least some of them are uncoupled 
from any dependence upon axons for their survival (Greenwood and Butt, 2003) 
which is in marked contrast to the axonal dependence of typical oligodendrocyte 
precursors (Barres and Raff, 1993;David et al., 1984). There are reports that at 
least some NG2-expressing cells in the cerebellum do not express the OLP 
marker OLIG2 (D. Atwell, personal communication). They also appear to play a
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major role in reactive gliosis showing hypertrophy, proliferation and migration in 
response to CNS injury (Butt et al., 2002;Butt et al., 2004). Because of these 
findings it has been proposed that the NG2-expressing cells of the CNS actually 
comprise at least 2 distinct populations, the less numerous of which can act as 
OLPs and the rest as a sort of non-GFAP-expressing astroglial cell involved in 
monitoring axonal activity and reacting to CNS insult. Additionally the presence 
of two distinct NG2-expressing populations is supported by work on 
oligodendrocyte development using a PLP-EGFP mouse to trace cells expressing 
the myelin proteolipid protein PLP (Mallon et al., 2002). This demonstrated both 
an EGFP-positive NG2-expressing cell population, presumably of the 
oligodendrocyte lineage, but also an EGFP-negative NG2-expressing population. 
These apparently non-OLP NG2-expressing glial cells have thus been proposed 
to represent a separate glial cell type, tentatively termed synantocytes (Butt et al., 
2002;Butt et al., 2004), which could also be considered as a protoplasmic 
astrocyte-like cell. This is controversial, however. The fact that so-called 
synantocytes are non-mitotic, stellate and reactive glial cells does not preclude 
them from being a ‘branch’ of the oligodendrocyte lineage. Merely because most 
of them do not incorporate markers of mitotic cells (BrdU, 3H-thymidine) does 
not mean they have permanently lost this ability, and they could still give rise to 
differentiated oligodendrocytes at later times under certain conditions. Their 
stellate appearance certainly does not preclude them from being OLPs. In fact it 
can be argued that possessing many branched processes will enable more 
comprehensive monitoring of the CNS and thus an increased ability to respond to 
signals requiring differentiation into oligodendrocytes. It appears that in order to 
resolve the controversy surrounding the nature of the ‘synantocyte’, experiments 
are needed to directly establish the lineage of these cells, thereby demonstrating 
the relationship these cells have with OLPs and/or astrocytic cells.
Due to the uncertainty surrounding classification of astrocyte identity it is 
dangerous, and possibly wrong, to view the process of astrocyte specification 
simply as a single lineage. It can be argued however that commitment to at least 
the traditional GFAP-expressing astrocytic lineage represents a choice to not 
enter either the neuronal or oligodendroglial lineages. It may therefore be 
possible to find common themes. As discussed earlier, neuroepithelial cells give
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rise to all CNS cell types via divisions that create progressively more specialised, 
antigenically distinct and lineage-restricted precursors. It might therefore be 
possible to identify types of astrocyte precursors by their marker expression and 
lineage restriction. The best characterised glial precursor is the already- 
mentioned 0-2A precursor which has been isolated in culture. In rats it is 
immunoreactive to the A2B5 monoclonal antibody, and also expresses PDGFRa. 
0-2A cells can be isolated from a variety of CNS regions and are able in vitro to 
give rise to oligodendrocytes (as discussed above) and the ‘Type 2’ astrocytes 
which specifically express A2B5 but do not express Ran-2 or FGFRs (unlike the 
‘Type 1’ astrocyte) (Liu and Rao, 2004). The 0-2A cells’ in vivo relevance is not 
clear however and there are even indications that 0-2A cells will not produce 
astrocytes in vivo (Espinosa de los et al., 1993). In addition, the in vivo relevance 
of the distinction between the so-called Type 1 and Type 2 astrocytes has been 
called into question (Butt et al., 1994). For these reasons data about the 0-2A 
cell still leave us with no clear idea of the identity of the astrocyte precursor.
A similar glial precursor is the A2B5-expressing Glial Restricted Precursor 
(GRP) described by Rao et al. (Rao et al., 1998) that appears between E l2 and 
E14 in the rat neural tube. Isolated in vitro via A2B5 antibody-mediated 
immunopanning, these cells differ from 0-2As in that they do not express 
PDGFRa. In addition they could be influenced by various culture conditions to 
give rise to oligodendrocytes and both type-1 and type-2 astrocytes (not only 
type-2 as with the 0-2A cells) as defined by GFAP and differential FGFR3 and 
Ran-2 expression (Rao et al., 1998). GRPs do not generate neurons. An A2B5+ 
population of cells can be seen in a broad, mostly ventral domain of the rat 
caudal neural tube between E12 and E14. This corresponds to the age at which 
GRPs can be isolated. This A2B5 antigen-expressing population has therefore 
been assigned as possibly representing the earliest point along a glial restricted 
lineage. However A2B5 immunoreactivity alone does not differentiate the GRP 
from the 0-2A population and it remains to be seen whether or not the GRP is 
even functionally relevant in vivo, as it could represent a culture artefact. 
Clarification is also needed into how this GRP fits in with the differentiation of 
OLPs from the pMN domain.
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Another marker of astrocyte precursors was tentatively identified as CD44 in the 
chick embryonic spinal cord. CD44-expressing cell clusters were found lining 
the central canal from where they apparently dispersed to populate the dorsal 
lateral and ventral funiculi (Alfei et al., 1999). CD44 expression in the dorsal 
spinal cord covers a fairly wide domain indicating that astrocyte generation may 
occur from multiple origins in the neural tube (Liu et al., 2002) although a direct 
lineage relationship between CD44 and astrocytes remains to be confirmed in the 
rodent. Intriguingly though, CD44 over expression apparently leads to a GFAP 
over expression phenotype (Tuohy et al., 2004) indicating a role for CD44 in 
astrocyte differentiation.
Using the available data, a model has been proposed (Liu and Rao, 2004) in 
which Rao et al.’s glial restricted precursors (Rao et al., 1998) derive from 
dividing neuroepithelial stem cells and may be distinguishable via their A2B5 
immunoreactivity. These are able to produce oligodendrocytes and astrocytes. 
Further differentiation towards an astrocyte-restricted precursor is apparently 
indicated by the appearance of CD44 (Liu and Rao, 2004). The data used to 
construct this model is currently unpublished however, and it definitely appears 
that while both A2B5 and CD44 are expressed in ventricular zone domains of the 
rodent spinal cord, their expression domains show only minimal overlap (see Liu 
et al., (2002)) undermining the idea that one population gives rise to the other. 
There are other, more restricted glial precursors that can be isolated in vitro, but 
again a linear relationship with earlier progenitors has never been demonstrated 
(Liu et al., 2002) and their in vivo roles are unproven. For these reasons the role 
of the A2B5-expressing GRP is still unclear at best. More fundamental to the 
problem of astrocyte specification is the fact that there is still no definitive 
information about the actual molecular triggers that might cause differentiation 
along a GRP/astrocyte restricted lineage.
A glimmer of hope into defining the mode of astrocyte specification comes from 
work on oligodendrocyte specification. As mentioned previously, the absence of 
the Olig gene expression in the pMN domain leads to the ventral expansion of 
IrxS expression and the conversion of the pMN domain to a ‘p2’-like phenotype 
(see section 1.5). One consequence of this is that this altered pMN now produces
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astrocytes instead of oligodendrocytes (Zhou and Anderson, 2002). This suggests 
that the p2 domain of the neuroepithelium normally produces astrocytes. Pringle 
et al. have shown that both the dorsal and ventral neural tube generates 
astrocytes, except for the pMN domain (Pringle et al., 1998;Pringle et al., 2003). 
This may provide an important insight that shows that in specialised regions of 
the neural tube (e.g. the pMN), particular cell types may be specified by 
particular gene expression programs (in this case the one driven by Olig genes). 
In other regions of the neural tube though, absence of any particular lineage 
promotion may lead to the ‘default’ astrocyte lineage operating. Perhaps then 
entry to the astrocyte lineage does not involve specific signalling such as in the 
oligodendrocyte lineage, but rather occurs in the absence of any signals 
specifying an alternative fate. This is rather speculative however.
A distinct and relatively well established mechanism in which astrocytes are 
produced from neuroepithelial cells is by differentiation from radial glia. Radial 
glia are a specific cell type derived directly from neuroepithelial cells that show a 
unique bipolar morphology and can express a variety of astrocyte-associated 
markers such as GFAP (in primates) and GLAST (see Gotz, (2003);Hartfuss et 
al., (2001)). They can give rise to neurons (Gotz, 2003) but they have also been 
shown, unambiguously, to give rise to astrocytic cells via direct differentiation 
(Malatesta et al., 2003;Voigt, 1989). This appears to represent a mode of 
astrocyte generation distinct from the GRP pathway discussed earlier given that 
Rao et al (Rao et al., 1998) make no mention of radial glia in their model and that 
radial glial differentiation occurs mainly around birth and in the postnatal period. 
The extent to which radial glia produce astrocytes (as opposed to, for example, 
neurons) appears to vary with the location and type of radial glia in question. It is 
thought that no matter what the timing of differentiation of radial glia into 
astrocyte, the specification of a radial glial cell along the astrocyte lineage occurs 
early in development (Gotz, 2003) and may actually represent a lack of 
instruction to enter a different lineage. This again brings us to the question of 
what are the fate determinants that control restriction to one lineage or another. 
Intriguing results using a constitutively active Notch signal showed that Notch 
signalling caused cells to become radial glia which later gave rise to astrocytes 
(Gaiano et al., 2000). This therefore suggests a possible role for Notch in
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inhibiting the acquisition of alternative cell fates, and promoting the maintenance 
of an astroglial lineage.
The mechanisms that determine specification of the astrocytic lineage are still 
unclear, not least due to the confusing origins of astrocytes and the subsequent 
problems in defining cells as astrocytes or astrocytic subtypes once they have 
differentiated. It appears that at least two modes of astrocytic generation can be 
identified; a fairly clear radial glia to astrocyte differentiation that appears quite 
widespread, and a less well established lineage arising from a glial restricted 
precursor, shown predominantly in more caudal neural tube regions. Efforts must 
now be made to define the cell fate determinants that control entry into the 
astrocyte lineage(s) and subsequently whether it is even correct to think in terms 
of a single lineage with a variety of relatively ‘plastic’ outcomes, or whether 
there are specific determinants that control the production of the various 
astrocyte types, perhaps for example determinants that define a protoplasmic 
astrocyte as opposed to a fibrous astrocyte. One of the first steps in answering 
these questions must be to determine the contributions of various neural tube 
regions to astrocyte production. The pMN domain provides an interesting model 
that can be used to ask questions of these other neuroepithelial domains. Given 
the pMN’s switch from neuron to oligodendrocyte production, do all 
neuroepithelial domains initially give rise to neurons before switching to the 
production of glial cells? Many of the intemeuron cell types that populate the 
spinal cord have had their origins mapped to distinct neuroepithelial domains 
(Caspary and Anderson, 2003;Gowan et al., 2001;Pierani et al., 2001). So is it 
possible that all the intemeuron-producing domains give rise to an intemeuron 
subtype before switching to the production of a particular class (or classes) of 
astrocyte? Or are there distinct domains that produce neurons then astrocytes 
while others give rise to only neurons? Mapping of astrocyte origins and fates 
will help to answer some of these questions.
1.7 Fate-mapping the CNS
The idea of fate-mapping goes back to one of the earliest questions asked by 
experimental embryologists. Does a particular cell have a predetermined fate? If
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you were to take a particular cell from the same position in embryos of several 
animals of a single species, would those cells all produce the same offspring, or 
would they produce a variety of different progeny? This question led to the 
principle of lineage tracing and the production of fate-maps. Fate-mapping 
involves following a cell and all of its progeny through the process of 
development in order to define what that cell is responsible for producing in the 
later versions of the same organism. It is not easy however. The earliest attempts 
relied upon using animals that were transparent in order to be able to follow their 
cell divisions, for example Edwin Conklin’s study of the sea squirt Styela partita 
(Conklin, 1905). More modem studies have also used organisms that are 
amenable to direct observation, albeit with the aid of some modern inventions. 
Uwe Deppe and co-workers (Deppe et al., 1978) used the transparent worm 
Caenorhabditis elegans to produce a map of the lineages of the first 182 cells of 
the developing worm using Nomarski interference microscopy and video 
recording.
Obviously, few organisms of interest can be studied by observation alone, not 
least because they are simply not transparent which especially hampers the 
mapping of the CNS. Therefore various techniques have been developed to mark 
individual cells or groups of cells and their progeny in order to study cell lineage. 
Vogt pioneered the use of dyes in 1929 when he followed the fates of different 
areas of newt eggs by inserting shards of dye-containing agar into various 
positions on the eggs. The dye was passed into successive cellular generations 
when the cells divided and thus he was able to produce a fate map for various 
areas of the newt egg (Vogt, 1929). Alternative methods use radioactive 
thymidine which becomes incorporated into the DNA of newly bom cells as their 
DNA is replicated. Radioactive thymidine can therefore be injected into 
developing embryos or animals and then either sections of labelled embryo can 
be transplanted into recipient embryos or the fates of newly bom cells can be 
followed directly in the treated animal. Radioactive cells are detected via the 
electrons discharged from the thymidine reducing silver ions in the photographic 
emulsion which causes silver to precipitate over regions of the tissue that are 
radioactive. These can be visualised microscopically and in this way the 
contribution of various embryonic regions to later tissues can be shown.
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Transplantation of radiolabelled tissue was used in the cerebellum of the rat to 
demonstrate the migration of cells from the external granule layer to the 
cerebellar cortex (Das and Altman, 1971) while direct tracing of proliferative 
cells was used to demonstrate the contribution of ventricular zone precursors to 
the hippocampus of Rhesus monkeys (Nowakowski and Rakic, 1981). Many 
other examples of this technique can be found, but both the radioactivity and dye 
methods are hampered by the fact that every time a cell containing the marker 
substance divides, the marker is diluted and eventually its concentration falls 
below the threshold of detection. These problems can be somewhat ameliorated 
with the use of fluorescent dyes such as fluorescein, DAPI and dil which can be 
injected into single cells and visualised in subsequent cellular generations by 
exciting them with UV light. For example, DAPI was used along with 
radioactive thymidine to study the fates of visual cortex neurons in ferrets 
(McConnell, 1988). Many other examples of the use of fluorescent dyes can be 
found, but while their fluorescence makes them easier to visualise than normal 
dyes, they still become diluted. Ideally permanent labelling is desired and this 
can be achieved by genetic marking of cells.
In 1969, Nicole le Douarin discovered that quail cells that are undergoing 
interphase contain condensed nucleolar-associated heterochromatin that is not 
found in chick cell interphase nuclei (Le Douarin, 1969). She subsequently 
showed that grafts from quail embryos could be inserted into chick embryos 
where they would participate in the formation of various organs. Because the 
quail cells could be distinguished from the chick cells on the basis of their 
interphase nuclei after Feulgen staining (which stains DNA), these grafts could 
aid the study of lineage analysis (Le Douarin and Barq, 1969). Subsequently, Le 
Douarin used the techniques she developed to transplant quail neural tube and 
notochord into chick embryos and demonstrated amongst other things how the 
neural crest cells give rise to the peripheral nervous system (Le Douarin et al., 
1975). It also became possible with the advent of immunocytological techniques 
to differentiate the quail and chick derived cells on the basis of their different 
antigenic profiles. Thus the use of chick quail chimeras revolutionised the 
understanding of the origins of the peripheral nervous system, cranial bones, 
pigment cells and the haematopoietic system to name but a few.
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Chick-quail chimeras are not without their problems however. Not only are they 
technically difficult, the resulting chimeras face severe disease before reaching 
adulthood due to their immune systems rejecting whatever grafted tissue they 
contain. For example grafts containing neural tube and notochord are rejected 
leading to neurological syndromes including limb paralysis. There is also the 
fairly obvious constraint that you have to study the development of birds, which 
does differ in many ways from that of mammals. As already mentioned, genetic 
marking of cell lineages provides a permanent label for a cell lineage. Chick- 
quail chimeras harnessed a natural phenomenon to enable permanent labelling, 
but the advent of molecular biology has enabled us to modify organisms 
genetically, in particular mice, to drive expression of marker molecules in a 
targeted way.
There are typically two ways to modify mice genetically. Exogenous DNA can 
be inserted randomly into the genome along with a specific promoter sequence 
that will drive expression in a lineage of interest. Alternatively DNA can be 
targeted to the locus of a lineage-restricted endogenous gene via homologous 
recombination in embryonic stem cells. This so-called ‘knock-in’ approach will 
then result in the expression of the gene of interest in the same pattern as the 
lineage-restricted gene. These strategies have their own advantages and 
disadvantages. Random insertion of a gene downstream of a promoter sequence 
relies heavily on the suitability of the promoter used. Promoter regions that will 
drive gene expression in one particular cell lineage are generally not known. 
Many genes with restricted expression patterns are known but the elements that 
control their expression are mostly unidentified. This means that use of random 
insertion transgenesis is limited. In addition, expression from a transgenic 
construct randomly inserted into the genome is subject to influences by 
surrounding genomic regions into which the transgenic construct has integrated. 
These so-called ‘positional effects’ often cause misexpression and even silencing 
of the transgene. The ‘knock-in’ approach avoids these problems because 
expression of the transgene is controlled by endogenous elements. This technique 
therefore by-passes the need to isolate the individual regulatory elements 
involved in lineage-restricted expression. Unfortunately this strategy is
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technically complex and time-consuming and carries with it the possibility of 
causing phenotypic abnormalities due to haploinsufficiency after disruption of 
one allele of a gene (Nutt and Busslinger, (1999) and others). In addition many 
lineage-restricted genes show down-regulation over time. A reporter gene 
‘knocked-in’ to one of their loci would therefore only function for a brief period, 
and not throughout the entire lineage as desired.
One of the tools that has recently revolutionised the science of fate-mapping in 
vivo is Cre recombinase. Cre was isolated from PI bacteriophage where it plays a 
vital role in the phage’s life cycle, helping to produce monomeric molecules of 
the PI genome. The enzyme itself causes a recombination event to take place 
between specific sites that Cre recognises, known as loxP sites. The loxP site is 
a 34bp sequence that can be bound by the Cre enzyme. Binding of two loxP sites 
by Cre results in recombination between the two loxP sequences. If both loxP 
sequences are located on the same strand of DNA and orientated in the same 
direction relative to each other, this recombination causes the excision of the 
stretch of DNA that lies between them, leaving only one loxP site remaining 
(figure 1.3). If the loxP sites have opposing orientations, any intervening DNA 
will be inverted instead.
The phenomenon of Cre-mediated excision is now widely used as a method to 
label cell lineages via permanent activation of a reporter gene. The strategy for 
this is summarised in figure 1.4 (for a review see Nagy, (2000)). Firstly a 
transgenic mouse is created that shows expression of Cre in a desired pattern. A 
second transgenic mouse is then used that contains a ubiquitously expressed 
promoter separated from a reporter gene by an intervening stretch of spacer 
DNA. This spacer DNA prevents the ubiquitous promoter from driving 
expression of the reporter gene. Importantly, the spacer DNA is flanked on either 
side by loxP sites oriented in the same direction. The Cre-expressing animal and 
the reporter animal are then mated. In the offspring of this mating, in cells 
expressing Cre, recombination will occur between the loxP sites flanking the 
spacer DNA. This will excise the spacer DNA, bringing the reporter gene closer 
to, and therefore under the influence of, the promoter. The reporter gene will then 
be transcribed. Importantly while the recombination event will only occur in cells
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that express Cre, the recombined DNA will be passed on through successive 
cellular generations as the cells’ DNA is copied during mitosis. Thus the 
ubiquitous reporter will continue to drive expression of the reporter gene in all 
the cells descended from the original Oe-expressing cells, even when the 
endogenous lineage-restricted gene and Cre are down-regulated. In this way 
specific, permanent expression of a reporter gene in a lineage of interest is 
achieved.
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Figure 1.3 Cre mediated recombination. Cre recombinase recognises loxP 
(yellow) sites located on stretches of DNA. When two loxP sites are 
recognised, Cre mediates recombination between them to form two new loxP 
sites from the original ones, each consisting of one half of the original pair. If 
both loxP sites are located on the same stretch of DNA as above, this 
recombination event will cause the intervening stretch of DNA to be excised 
and a new, shorter stretch of DNA to be produced.
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Figure 1.4 Schematic representation of the use of Cre recombinase in lineage tracing. A Cre mouse containing the Cre gene 
(turquoise) whose transcription is controlled by the regulatory elements of a lineage specific endogenous gene (purple) is mated 
with a reporter mouse containing a silenced reporter gene (green) downstream of a ubiquitous promoter (blue). In the offspring of 
this mating, those cells that express Cre undergo a DNA recombination event between loxP sites (yellow) that excises the spacer 
DNA (red) that was silencing the reporter gene. The ubiquitous promoter can now drive the expression of the reporter gene but 
only in those cells that express Cre and their progeny.
Previous studies have been successful in using this system for lineage analysis 
either via the ‘knock-in’ approach to express Cre as desired (for example Chai et 
al., (2000);Gorski et al., (2002)) or via the random insertion of transgenic 
constructs where Cre expression is driven by a lineage specific promoter (Miniou 
et al., (1999);Yamauchi et al., (1999) and many others). But as discussed above, 
both these methods have drawbacks. A new approach is provided by PAC 
transgenesis.
PACs, or PI bacteriophage-derived Artificial Chromosomes, are circular DNA 
plasmid vectors which are able to contain large DNA inserts up to 250kb in 
length (Ioannou et al., 1994). Their usefulness in lineage tracing experiments is 
directly related to this ability to contain large inserts of genomic DNA. The large 
insert size means that a PAC clone containing a gene of interest is very likely to 
also contain all the surrounding regulatory elements that control the expression 
of that particular gene. Cre can thus be inserted within the coding region of a 
lineage-restricted gene carried by a PAC and this recombined PAC introduced 
into mouse embryos by microinjection, thus causing Cre expression in the same 
pattern as the lineage-restricted gene. Given the large size of PACs there is very 
little chance that positional effects will be able to influence Cre expression. 
HaploinsufFiciency problems are avoided as the transgenic mouse still contains 
two functional copies of the lineage-restricted gene. PACs are also fairly easy to 
propagate and manipulate as they are carried by bacterial hosts. Recent advances 
have developed specialised E. coli cells able to facilitate PAC homologous 
recombination via a defective \  prophage system that protects and recombines 
linear DNA targeting cassettes with their target sequence (Yu et al., 2000). One 
of the problems associated with this is that normally, targeting vectors must 
include a selectable marker gene that increases the likelihood of the investigator 
isolating a clone that has undergone the desired recombination event. These 
selectable markers can interfere with the subsequent function of a targeted locus. 
A specialised E. coli strain was therefore further modified to include an 
arabinose-inducible Flpe gene (Buchholz et al., 1998) that could be used to direct 
the excision of an fr t site-flanked selectable marker after recombination (Lee et 
al., 2001). These advances now mean that recombination can be efficiently 
carried out and selected for in a bacterial system, making production of large
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amounts of recombinant PAC DNA relatively simple compared with 
homologous recombination in ES cells. Once the correct clone is isolated, 
recombinant PAC DNA is simply extracted, linearised and inserted into the 
mouse genome by pronuclear injection of fertilised ova. Therefore the 
combination of PAC transgenesis and Oe-mediated reporter gene activation 
provides a powerful new approach to fate-mapping the mammalian CNS.
1.8 The aims of the project
The origins of many neurons have been mapped to specific neuroepithelial 
domains, particularly in the spinal cord. However, many areas of uncertainty 
remain concerning the origins of cell types such as astrocytes in the spinal cord 
and brain, and oligodendrocytes in the forebrain. The aim of this project is to 
clarify the origin of glial cells from spinal cord and forebrain neuroepithelial 
cells. To do this, three genes that show spatially and temporally restricted 
expression profiles were identified. Dbxl is expressed during embryogenesis in a 
small region of the spinal cord neuroepithelium between the alar and basal plates. 
Msx3 is expressed in the dorsal third of the developing spinal cord. Emxl is 
expressed in the dorsal telencephalon during embryogenesis in a region already 
known to be fated to become the cerebral cortex. A PAC library was screened to 
identify PAC clones containing genomic inserts that include these three genes. 
These PAC inserts were then targeted by homologous recombination to introduce 
Cre into the loci of these genes. Recombinant PAC DNA was used to create 
transgenic mice that express Cre in the desired regions of the neuroepithelium. 
These mice were crossed to reporter mice to activate reporter genes in the cell 
lineages of interest. The results of these experiments are split into 3 chapters. 
Chapter 3 deals with the DbxliCre mouse and reports the discovery that cells 
derived from this region of the neuroepithelium give rise to the three major cell 
types of the CNS including, surprisingly, oligodendrocytes. Chapter 4 reports the 
creation of the Msx3iCre mouse and shows that the dorsal spinal cord also gives 
rise to neurons, glia and oligodendrocytes. Chapter 5 deals with the creation of 2 
transgenic lines, the EmxIiCre line and a similar transgenic that expresses an 
inducible Cre enzyme, CreER12 in the Emxl lineage. These results form part of a 
larger study that maps the origins of oligodendrocytes in the forebrain. The
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implications of this study for forebrain oligodendrogenesis and the nature of 
forebrain oligodendrocytes are discussed. Chapter 6 summarises the findings of 
this project and discusses the results found with particular focus on the 
implications that the results have on what we know about generation of glial cells 
in the CNS.
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Chapter 2 
Materials and Methods
2.1 PAC transgenesis
2.1.1 Nucleic Acid Isolation
Small scale plasmid preparation
Small quantities of plasmid DNA (l-2pg) were prepared following the method of 
Sambrook and Russell 2001. Briefly, 2ml of LB containing the appropriate 
antibiotic was inoculated with a single colony of transformed bacteria and 
incubated shaking overnight (16hrs) at 37°C. 1.5ml of this culture were 
transferred to a microfuge tube and centrifuged at maximum speed (13200 rpm) 
in a microfuge. The supernatant was removed and the pellet resuspended in 
100pi of Solution I (50mM glucose, 25mM Tris-HCL, pH 8.0 and lOmM EDTA, 
pH 8.0) by vortexing. 200pl of fresh Solution II (1% w/v SDS and 0.2N sodium 
hydroxide) were added and the tube inverted around 10 times to lyse the cells.
150(a.l of Solution III (3M potassium acetate and 11.5% w/v glacial acetic acid) 
were then added and again inverted around 10 times. The tube was then 
centrifuged at maximum speed for 5 minutes at 4°C. The supernatant was 
transferred to a fresh tube containing 900pl of absolute ethanol (2x the volume) 
to precipitate the plasmid DNA. The microfuge tube was then spun at maximum 
speed in a microfuge at 4°C for 10 minutes. The supernatant was removed and 
the pellet washed with 70% ethanol. The tube was spun again and the supernatant 
removed and the pellet allowed to air dry. The DNA was then resuspended in 
40pl TE buffer (5mM Tris, pH 7.5, 0.5mM EDTA, pH 8.0).
Large Scale plasmid preparation
Large quantities of plasmid DNA (< lmg) were prepared as follows. 50ml of 
terrific broth containing the appropriate antibiotic were inoculated with around
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lOOpl of overnight culture from the small scale preparation and incubated at 
37°C overnight while shaking. 850pl were then removed and added to 150pl 
glycerol to make a glycerol stock for storage at -80°C. Each 50ml suspension was 
then centrifuged at 3750rpm for 10 minutes at 4°C. The supernatant was 
discarded and the pellets resuspended in 4ml of Solution I. 8ml of Solution II 
were added to each and the mixture gently inverted 10 times to mix. Next 6ml of 
Solution III were added and the mixture again inverted 10 times to mix and then 
left on ice for 5 minutes. The mixture was then centrifuged at 3750rpm for 10 
minutes at 4°C. The supernatant was collected in a fresh 50ml Falcon tube after 
passing through two sheets of autoclaved muslin cloth. 17ml of isopropanol were 
added and the DNA allowed to precipitate for 15 minutes on ice. The suspension 
was then centrifuged for 10 minutes at 3750rpm at 4°C. The supernatant was 
removed and the pellet air dried. It was then resuspended in 2ml of TE and 2.5ml 
of 4.4M LiCl added. The mixture was left on ice for 30 minutes. The tube was 
then centrifuged again at 3750rpm for 15 minutes at 4°C. The supernatant was 
removed to another 50ml falcon tube and 9ml absolute ethanol added. This was 
then centrifuged at 3750rpm for 10 minutes at 4°C. The supernatant was 
removed, washed with 70% ethanol and resuspended in 400pl TE. This was then 
tranferred to a fresh microfuge tube and 5 pi of 4mg/ml DNase-free RNaseA 
added. This mixture was incubated at 37°C for 15 minutes. After this lOpl of 
20% SDS were added and the mixture incubated for 10 minutes at 70°C. 415pl of 
phenol-chloroform were added, the mixture vortexed and then spun at 13200 rpm 
for 5 minutes. The supernatant was removed to a fresh tube and 400pl of 
chloroform:IAA (24:1) added. Again the tube was vortexed, centrifuged at 
13200rpm and the supernatant removed to a fresh tube. The DNA was 
precipitated by adding 2 volumes of absolute ethanol and 1/10* volume 3M 
sodium acetate and then spinning for 10 minutes at 13200rpm at 4°C. The pellet 
was then air dried and resuspended in 200pl TE.
Large Scale PACpreparation
Two methods were used for this. The first is a modification of the standard 
alkaline lysis method. Briefly 400ml of LB containing 15pg/ml kanamycin were 
inoculated with 500pl of EL250 cell starter culture and grown at 32°C overnight 
(16-24hrs). The cell suspension was then centrifuged at 3750rpm for 15 minutes
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at 4°C in 8 50ml Falcon tubes. The supernatant was discarded and the pellets 
each resuspended in 8ml of solution PI plus RNase A (50mM Tris-HCL, pH8.0, 
lOmM EDTA, pH 8.0, lOOpg/ml RNase A) by pipetting up and down. 8ml of 
fresh P2 were added (0.2N sodium hydroxide, 1% SDS) and the tubes gently 
inverted several times before being left at room temperature for no longer than 5 
minutes. 8ml of P3 were then added to each tube (3.0M potassium acetate, 11.5% 
w/v glacial acetic acid) and each tube immediately gently inverted until the 
suspension was completely white. The tubes were then incubated on ice for one 
hour before centrifuging at 3750 rpm for 15 minutes at 4°C. Each supernatant 
was then transferred to a fresh falcon tube passing through a double sheet of 
autoclaved muslin cloth. The supernatants were then centrifuged again as before. 
The clear supernatants were transferred to a new falcon tube and 24ml of ice- 
cold isopropanol added. Each tube was inverted a few times and left at room 
temperature for 5 minutes before centrifuging at 3750 rpm for 15 minutes at 4°C. 
All the supernatants were removed and 250pl of TE added to each tube. The 
resuspended pellets were then all pooled into 4 x 1.5ml microfuge tubes using 
wide bore tips to prevent DNA shearing. These were used for all PAC DNA 
pipetting from this point on. These microfuge tubes of pooled DNA were briefly 
spun at 13200 rpm to remove any undissolved matter, and the clear supernatants 
transferred to 4 fresh microfuge tubes. 500pl of phenol-chloroform (pH 7.9) were 
added to each tube. These were carefully inverted 8 times and spun for 5 minutes 
at 13200 rpm. The supernatants were removed to fresh tubes and the phenol- 
chloroform extraction repeated. 500pl of choloform:IAA were added to each 
supernatant, the tubes carefully inverted 8 times and the tubes spun again at 
13200 rpm for 5 minutes. All the supernatants were then pooled into one 2ml 
microfuge tube to pool the DNA. This DNA was then split into 4 x 1.5ml 
microfuge tubes again. 1ml ice cold 100% ethanol was added to each tube and 
the tubes inverted 4 times. 2 of the tubes could then be stored at -20°C for future 
use. All remaining tubes were spun for 10 minutes at 13200 rpm and the 
supernatants discarded. The pellets were washed in 1ml room temperature 70% 
ethanol by inverting gently and spinning again before aspirating all the ethanol. 
The pellets were air dried at room temperature until they began to become 
translucent and the each was resuspended in lOOpl MilliQ water. The DNA
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solutions were then pooled for further use. Throughout, care was taken to avoid 
shearing of the DNA by excessive pipetting or use of narrow bore pipettes.
The second method of PAC DNA maxipreparation was to use the Nucleobond® 
BAC Maxi Kit from BD Biosciences (Cat # 635941). See user manual for 
details.
Extraction o f Genomic DNA from mouse tissue/tails
Mouse genomic DNA was extracted from either small biopsies (3-4mm) of 
mouse tail tips, or from embryonic tissue (3-4mm2). Each sample of tissue was 
placed in a 1.5ml microfuge tube and mixed with 500pl DNA extraction buffer 
(lOOmM Tris-HCl, pH 8.5, 5mM EDTA, pH 8.0, 200mM NaCl, 0.2% SDS) 
containing 0.48mg/ml Proteinase K. This was incubated at 55°C overnight. 200pl 
of 6M amonium acetate were added to each tube and the mixture vortexed before 
leaving on ice for 10 minutes. The tubes were then centrifuged at 13200 rpm for 
10 minutes at 4°C. The supernatants were transferred to fresh tubes and 500pl of 
room temperature isopropanol were added. The tubes were again vortexed and 
centrifuged for 3 minutes at 13200 rpm. The supernatants were quickly poured 
off and 500pi of 70% ethanol added. The tubes were centrifuged again for 3 
minutes at 13200 rpm and the supernatants completely removed. The pellets 
were air-dried and then resuspended in 40pl of TE.
Quantitation o f double stranded DNA.
DNA was quantified using one of two methods. Estimates of DNA concentration 
could be made by comparing DNA solutions of interest to known quantities of a 
standard on an agarose gel. Briefly this was done by diluting lpl of the DNA 
solution to be quantified in lOpl of water containing DNA loading buffer. This 
was then run on a 1% agarose gel alongside 5pi of Hyperladder 1 (Bioline Cat # 
HYPL1500), which is a mixture of a variety of DNA fragment of known sizes 
(200bp -  lOkb) and known amounts (15ng -  lOOng). Staining with ethidium 
bromide allowed visualisation of the DNA in the gel when illuminated by UV 
light. The intensity of the fluorescence emitted by the sample and the standard 
could be used to estimate the DNA concentration.
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More precise calculation of DNA concentration could be achieved by measuring 
the absorbance of UV light by a DNA solution at a wavelength of 260nm. At this 
wavelength 50pg of DNA has an absorbance of 1.0 and so the value obtained 
could be used to calculate the DNA concentration, so long as the solution was 
free from RNA and protein contaminants. This was done using a UV Mini 1240 
uv-vis spectrophotometer from Simadzu.
2.1.2 Analysis of DNA
Restriction Enzyme Digestion o f DNA
Restriction enzymes were obtained from New England Biolabs. Digestions were 
carried out using the appropriate buffer systems supplied with the enzymes. For 
analytical purposes, around 50ng of plasmid DNA were digested in 10-20pl 
volumes for at least one hour at 37°C. For cloning purposes, greater 
concentrations were used (up to lpg) to allow for recovery of practical amounts 
of DNA. Reaction volumes and times were scaled up accordingly (see New 
England Biolabs Catalogue and Technical Reference).
Blunting of overhanging ends from restriction digests was carried out by mixing 
the DNA to be blunted with 2pi of lOx buffer #1 (NEB), lpl mixed dNTPs 
(NEB), 1 unit of the Klenow fragment of DNA Polymerase 1 from E. coli (NEB) 
per microgram of DNA in 20pl of water. This reaction mix was incubated at 
room temperature for 15 minutes before heat killing the enzyme at 75 °C for 20 
minutes. The DNA could then be used for blunt ended ligations.
Agarose Gel Electrophoresis
Agarose gel electrophoresis was performed in a Horizon 11.14 horizontal gel 
tank from Gibco BRL, powered by a BioRad Power Pac 300. Electrophoresis 
was carried out in 1% agarose and lx TAE buffer (0.04 M Tris, 0.001 M EDTA, 
0.35% glacial acetic acid). For plasmid DNA, ethidium bromide was included in 
the gel at a final concentration of 0.5pg/ml and the gels were run at 150V. DNA 
was loaded into the wells of the gel mixed with loading buffer (lOx stock, 50% 
v/v glycerol, 1 mM EDTA pH8.0, 0.25% v/v bromophenol blue, 0.25% w/v 
xylene cyanol in DEPC treated milliQ water). For genomic DNA, gels were run 
at around 100V and stained with ethidium bromide subsequent to running.
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Southern Blotting
The DNA to be analysed was run on an agarose gel, stained with ethidium 
bromide and the gel then photographed alongside a ruler to provide a record of 
the relative distances that the various marker DNA species had migrated. The gel 
was then treated for 30 minutes in a depurinating solution (0.8% hydrochloric 
acid in water). It was washed in distilled water and then denatured for 30 minutes 
in denaturing solution (0.4 M sodium hydroxide, 1.5 M sodium chloride). After 
another wash in distilled water the gel was treated for 30 minutes in neutralising 
solution (1.0 M Tris, 1.5 M sodium chloride, 0.5 M EDTA pH 8.0, adjusted to 
pH 7.5 with hydrochloric acid). The gel was then capillary blotted overnight in 
lOx SSC (1.5 M NaCl, 0.15 M sodium citrate) as described in Sambrook and 
Russell, 2001, to transfer the DNA to a Hybond XL nucleic acid transfer 
membrane (Amersham Biosciences). After the transfer the DNA was cross- 
linked to the membrane by UV irradiation (254nm, 0.15J/cm2) in a Stratagene 
UV Stratalinker. Prior to hybridisation to the radiolabelled probe, the southern 
blots were prehybridised with salmon sperm DNA. Salmon sperm DNA was 
denatured by heating for 5 minutes at 95 °C and cooling in ice water for 2 
minutes. It was then mixed with MIB (0.225 M NaCl, 15 mM NaH2P0 4 , 1.5 mM 
EDTA, 10% PEG 8000, 7% SDS) to make prehybridisation solution with a 
salmon sperm concentration of 100pg/ml. The southern blots were pre-wetted in 
2x SSC (0.3 M NaCl, 0.03 M sodium citrate) and placed in a hybridisation bottle 
with the side hybridised to the DNA facing the inside of the bottle. Then 15ml of 
the prehybridisation solution was added, and the membrane prehybridised at 
65 °C for one hour while being rotated constantly.
Preparing Radiolabelled probes for Southern analysis and PAC library 
screening
The template DNA, used to make the radiolabelled probe was made by digesting 
the relevant plasmid with restriction enzymes and gel purifying the resulting 
template DNA fragment (see below). Once purified, the template was quantified 
and diluted to a concentration of 25ng in a total volume of 45(4.1 of MilliQ water. 
The template fragment was denatured for 5 minutes at 95°C, rapidly chilled in ice 
for 2 minutes then briefly centrifuged. Radiolabelling was achieved using the
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itedSrprime™ II kit from Amersham Pharmacia Biotech (Cat # RPN1633). This 
kit used extension of random oligonucleotides. Briefly, the purified denatured 
template DNA was added to a reaction tube containing the reaction components 
(DNA polymerase enzyme, random primers, dATP, dTTP and dGTP). 5pi of 
[32P] dCTP was then added to the reaction tube and the mixture was incubated 
for an hour at 37°C. Following probe synthesis the radiolabelled probe was 
purified from the unincorporated dNTPs by spin-column chromatography (Micro 
Bio-Spin® P-30 Tris chromatography columns, Bio-Rad laboratories). The 
purified probe was denatured at 95 °C and rapidly cooled. It was then added to the 
hybridisation bottle containing the southern blot membrane in prehybridisation 
solution and the bottle was placed at 65 °C overnight rotating constantly
Washing Southern blots and autoradiography
After hybridisation, the membranes were rinsed in Wash I solution (2xSSC, 0.1% 
SDS) at 65 °C for 15 minutes with constant agitation, then in Wash II solution 
(O.lx SSC, 0.1% SDS) at 65°C for 5 minutes or until radioactivity levels had 
depleted to an appropriate level. Excess liquid was blotted off the membranes 
and they were wrapped in Saran Wrap. They were then exposed to Hyperfilm 
MP (Amersham, Cat # RPN1675H) in a sealed light cassette with an intensifying 
screen at -80°C. The exposure time varied with the type of southern blot, for 
example a blot of plasmid DNA was only exposed for a few hours whereas 
genomic DNA was exposed for up to 2 weeks depending on the strength of the 
signal.
DNA sequencing
DNA sequencing was carried out by WIBR Scientific Support Services. Plasmid 
DNA prepared by miniprep was washed once with 100% ethanol, then twice 
with 70% ethanol. It was then sequenced using Beckman Coulter DTCS quick 
start kits (Cat No 608120) along with the appropriate primer. All sequencing was 
carried out on a Beckman Coulter CEQ 8000 Genetic Analysis System. Primer 
sequences specific to promoter regions of the plasmids used were as follows 
(from 5’ to 3’); M13 Reverse, GGA AAC AGC TAT GAC CAT G; M13-20, 
GTA AAA CGA CGG CCA GT; T3, AAT TAA CCC TCA CTA AAG GG; T7,
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GTA ATA CGA CTC ACT ATA GGG C; Sp6, ATT TAG GTG ACA CTA 
TAG
2.1.3 PAC Library Screening and PAC characterisation
Screening o f mouse PAC library RCPI21
Initially, a variety of radiolabelled DNA probes were constructed based on 
known genomic sequence templates, constituting, generally, the 3’ untranslated 
regions of genes of interest. The specificity and suitability of these probes was 
confirmed by using them to probe southern blots of BamHI and EcoRI digests of 
mouse genomic DNA. Probe sequences were therefore selected on their ability to 
bind specifically and efficiently to sequences contained within a gene of interest.
The mouse genomic phage artificial chromosome (PAC) library RCPI 21 
(Osoegawa et. al. 2000) was obtained from the UK HGMP resource centre. This 
consists of a genomic DNA library from female 129/SvevTACfBr mouse spleen 
ligated into the pPAC4 vector. The library contains 128 000 clones which were 
grown in LB broth and plated out, then gridded in a 4 x 4 array on 22.2 x 22.2 cm 
Hybond N nylon membranes (Amersham) using a Genetix Qbot robot. Each 
clone was spotted twice to give 36 864 spots on each membrane. 7 filters cover 
the whole library. Clones spotted on the filters had been processed by SDS 
treatment, denaturation and neutralisation, then dried and UV cross linked. 
Screening was carried out in the same manner as the Southern blots described 
above, although larger hybridisation bottles were required due to the size of the 
filters and nylon mesh was placed between each filter to prevent overlapping 
sections of filter from interfering with the hybridisation process. Once Hyperfilm 
MP had been exposed to the hybridised filters, putative clones of interest were 
identified via the positions of any points of hybridisation. The gridded layout of 
the spotted colonies allows the correct identification and purchasing of the 
clones. The method for doing this can be found in the Mouse PAC library; 
RPCI21 Product Information Sheet from the UK HGMP Resource Centre 
(http://www.hgmp.mrc.ac.ukA.
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Pulsed Field Gel Electrophoresis o f PAC DNA
Pulsed field gel electrophoresis (PFGE) was used to separate DNA fragments 
longer than lOkb. PFGE was carried out in a Bio-Rad contour-clamped 
homogenous electric field electrophoresis cell connected to a CHEF DR II 
control module and CHEF DR II drive module (Bio-Rad). 1% agarose gels were 
made up in 0.5x TBE buffer (45 mM Tris-borate, 1 mM EDTA, pH 8.0). These 
had a 2mm plug of Pulse Marker™ (Sigma, 0.1-200kb) placed in one of the 
wells as a size standard. PAC DNA was loaded in a standard loading buffer (see 
above). Gels were run in approximately 2 litres of 0.5x TBE which was kept 
constantly recirculating through a peristaltic pump, at 4°C. The gel was subjected 
to a 6V/cm field, with an initial switch time of 2.1 seconds and a final switch 
time of 10 seconds, for 12 hours. Gels were stained after running with ethidium 
bromide and the DNA visualised on a UV transilluminator.
Inverse PCR o f PAC DNA insert ends
To fully characterise the region of the mouse genome contained in each PAC, 
inverse PCR was carried out followed by sequencing of the resulting amplicons. 
The inverse PCR protocol involved the digestion of each PAC using sites known 
to exist in the regions of the pPAC4 vector that immediately flank the insert (for 
example Psil in figure 2.1). It was hoped that equivalent sites also exist in the 
ends of the PAC insert proximal to the boundary with the vector sequence. A 
variety of restriction enzymes (PstI, Pvull, Smal, Sphl and Hindlll) were used as 
it was unknown which restriction sites exist in the ends of the insert. It was 
hoped at least one of the digestions would result in a fragment of less than 4kb. 
After digestion, the fragments containing a portion of the insert plus a flanking 
portion of vector were subjected to intramolecular ligation (see below) to form 
small circular fragments. Primers specific to the regions of the pPAC4 vector 
flanking the insert (e.g. FI and R1 in figure 2.1) were then used to PCR amplify 
the circularised fragments. The two regions of the vector flanking the insert have 
different sequences and as such had to be digested and amplified using unique 
combinations of restriction enzymes and primers. For this purpose the two insert- 
flanking vector regions of pPAC4 were arbitrarily designated ‘5 prime’ and ‘3 
prime’. The ‘5 prime’ flanking region was digested with Pstl or Pvull and Smal. 
After ligation the Pstl digests were amplified using primers 5’FORI and 5’REV1
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or 5’FOR2 and 5’REV2 or 5’FOR2 and 5’REV1. The Pvull and Smal digestion 
allowed amplification with the same 3 combinations of primers. The ‘3 prime’ 
flanking sequence was digested with either Pstl or Sphl or HindQl. All 3 digests 
could then be amplified with primer combinations of 3’FORI and 3’REV2 or 
3’FOR2 and 3’REV1 or 3’FOR2 and 3’REV2. The sequences of the primers 
were as follows (from 5’ to 3’); 5’FORl -  ACA GTT CTG ACT TTT ACG AC; 
5’FOR2 -  TAT TAC ACG CCA TGA TAT GC; 5’REV1 -  TTG ACT AGT 
GGG TAG GCC TG; 5’REV2 -  TGA GTC GCT CCT CCT GCC AG; 3’FORl 
-  CGA CTC ACT ATA GGG AGA GG; 3’FOR2 -  CGA GCT TGA CAT TGT 
AGG AC; 3’REV1 -  GGC ATG ACT ATT GGC GCG CC; 3’REV2 -  CCT 
TGA GAG CCT TCA ACC CA. The resulting amplicons were then TOPO 
cloned (see figure 2.1) and sequenced via the Ml 3-20 and Ml 3-Rev sequencing 
primers (see above). The sequence results were then used in conjunction with the 
published mouse genome (www.ensembl.org) to precisely define the genomic 
location that the PAC inserts correspond to. To ensure that the amplified 
fragments corresponded to the ends of a PAC and were not non-specific 
contaminants, nested PCR was carried out using two further primer combinations 
specific to the PAC vector sequence (e.g. F2 and R2 in fig.l). Specifically, these 
extra nested PCRs used, for the ‘5 prime’ Pstl digests, 5’FOR2 and 5’REV1. For 
the ‘5 prime’ PvwII and Smal digests, nested PCR was carried out using 5’ FOR3 
and 5’REV1. The sequence of 5’FOR3 was GCA AAA GGA CTT GAT GTG 
TG. For all 3 of the ‘3 prime’ digests, nested PCR was carried out with the 
primer combination 3’FORI and 3’REV1.
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Figure 2.1 Schematic of the Inverse PCR protocol including nested PCR 
confirmation. At the top is a flanking region of a theoretical PAC clone insert 
and its adjoining vector sequence, both of which contain Pstl sites. Digestion 
of this PAC with Pstl results in a variety of fragments containing genomic 
and/or vector DNA that can be ligated to form circular fragments. PCR 
amplification with the FI and R1 primers can only occur from circular DNA 
fragments that contain the portion of the vector that FI and R1 are specific to, 
and that are circular these plus the flanking region of inserted genomic DNA. 
The amplified fragment contains a Pstl site that derives half from the vector 
Pstl site, and half from the genomic Pstl site. Cloning this fragment into the 
TOPO vector allows it to be sequenced, and this sequence can be used to 
characterise the end of the PAC insert. The specificity of the process can be 
checked via nested PCR using the F2 and R2 primers.
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2.1.4 Polymerase Chain Reaction
Polymerase Chain Reaction (PCR) was used for a variety of purposes, such as 
inverse PCR (see above), genotyping animals via PCR from genomic DNA, and 
for amplifying fragments of plasmid and genomic DNA for cloning and use as 
probes. The PCR conditions used were standard unless otherwise indicated.
PCR Conditions
Reactions were carried out in 0.2ml PCR tubes, each reaction containing 18pi of 
water with 2.5pl of 10X PCR buffer (Promega), 2.0pl of 25 mM magnesium 
chloride (Promega), 0.25pl of DNA polymerisation mix (containing 20mM each 
of dATP, dCTP, dGTP and dTTP, Amersham Biosciences), 0.5pi of forward and 
reverse primers at 100 pM (from MWG or TAGN), l.Opl template DNA (varying 
concentrations depending on the PCR reaction) and 0.25pl Taq DNA Polymerase 
(5u/pl, Promega). Magnesium chloride was sometimes increased to 2.5 or 3.0pl. 
7% DMSO was also used in the reaction to amplify the 5’ homology of EmxJ 
due to technical difficulties with this amplification. When increasing the volumes 
of reaction components used, the volume of water added was decreased 
accordingly.
Tubes were placed in a PCR machine (either an Eppendorf Mastercycler 
Gradient or an MWG-Biotech Primus 96) and run on a PCR programme based 
around the following: Reactions were initially denatured at 94°C for 4 minutes. 
They were then cycled 35 times through a programme of denaturing for 45 
seconds at 94°C, then annealing for 45 seconds at 66°C, then an extension of 1 
minute 30 seconds at 72°C. After 35 cycles like this there was a final extension 
step of 10 minutes at 72°C and the reaction was stopped by a rapid cooling to 
4°C. Major variations generally occurred to the annealing temperature which 
could be made less stringent for difficult reactions. Optimum annealing 
temperatures were determined by employing a gradient of annealing 
temperatures across a number of reaction tubes, a feature allowed by the 
Eppendorf Mastercycler Gradient PCR machine.
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Specific primer sequences and PCR conditions for genotyping, inverse PCR, 
targeting vector construction etc. are discussed in the relevant section of the 
thesis.
2.1.5 Construction of targeting vectors
Isolation o f DNA fragments for cloning
DNA fragments for cloning were obtained by either restriction digest of plasmid 
DNA, or through PCR amplification (see above). Fragments of interest were then 
isolated by agarose gel electrophoresis followed by band purification. This 
required bands to be illuminated by UV excitation and excised from the agarose 
gel with a clean scalpel. Dialysis tubing was cut to approximately 3x the length 
of each agarose fragment and rinsed with distilled water. One end was sealed 
with a clip and the tubing filled with lx TAE. Each agarose fragment containing 
a DNA species of interest was placed in the dialysis tubing and most of the TAE 
removed, leaving only enough to ensure the agarose was surrounded by TAE. 
The other end of the tubing was sealed and then the band, plus tubing, was 
subjected to electrophoresis for 30 -  60 minutes at around 100 V. The DNA 
would migrate from the gel into the TAE solution which was then aspirated and 
placed in a fresh microfuge tube. It was subjected to one phenol/chloroform 
extraction and one chloroform extraction followed by ethanol precipitation with 
2x volumes of 100% ethanol and O.lx volumes of 3M sodium acetate ph 5.2 at - 
20°C for 10 minutes. The precipitation was pelleted by centrifuging for 10 
minutes at 4°C, 13200rpm and the pellet washed with 70% ethanol. The pellet 
was air dried and resuspended in either TE or MilliQ water.
Ligation o f DNA fragments
Ligations were carried out using band purified fragments of DNA that had been 
digested with restriction enzymes to generate overhanging ends. All DNA to be 
ligated was quantified first. Reactions were carried out using 50ng of vector. The 
amount of insert added was determined by ensuring that there was an insert : 
vector molar ratio of 3:1. This could be calculated by applying the equation X = 
((50/V) x I) x3 where X is the amount of insert in ng, V is the length of the 
vector in base pairs and I is the length of the insert in base pairs. The reaction 
mixture was made using the calculated amounts of vector and insert, plus 1 pi
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lOx T4 DNA ligase buffer, 1 \x\ T4 DNA ligase (New England Biolabs) 0.5 jxl 10 
nM ATP and MilliQ water up to 10 pi. The reaction mixture was then incubated 
either at 16°C overnight or at room temperature for 1 hour. For blunt ended 
ligations the reaction was always carried out at 16°C overnight.
TOPO® cloning
For rapid cloning of PCR products, a cloning kit was used. TOPO TA cloning® 
containing pCR®II-TOPO® from Invitrogen (Cat no. K4600-01) uses a 
topoisomerase enzyme to rapidly clone any PCR fragment into its covalently 
bound vector. TOPO® cloning reactions were carried out according to the 
instruction manual.
Preparation o f Electrocompetent Bacterial Cells
The XL 1-Blue E. coli bacterial strain was used for electroporating plasmid DNA 
while the EL250 strain was used for electroporating PAC DNA (for method see 
next section). Electrocompetent cells were prepared using the following method 
(Dower W, 1988;Dower et al., 1988); An overnight culture of cells was set up in 
10ml of SOC medium (with tetracycline selection at 35 pg/ml in the case of 
XL 1-Blue). 2 x 400ml of SOC were then inoculated with 4 ml of the overnight 
cultures and grown until the OD600 reached 0.6 -  0.8 (3 -  4 hours). 16 x 50ml 
centrifuge tubes were pre-cooled on ice and the cultures then decanted into these 
and cooled for 15 minutes. They were then spun for at 4°C for 15 minutes at 
1500g. In a cold room, the supernatants were discarded and the pellets gently 
resuspended in 25 ml of cold ultraclean water. The suspensions were then pooled 
into 8 50ml tubes. These were centrifuged again as before, and the pellets once 
more resuspended in 25ml of ultraclean water and then pooled, this time into 4 
50ml tubes. The tubes were spun a third time and the pellets resuspended in 10 
ml of ultraclean water and pooled into 1 50ml tube. After a final spin the pellets 
were resuspended in 250pl of cold 10% glycerol. These were then aliquoted into 
1.5ml screw-cap cryo-tubes and snap frozen in liquid nitrogen. They were stored 
at -80°C until required.
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Electroporation o f Competent cells
Cells were normally transformed with either 2 pi of a ligation reaction, or with a 
ligation reaction product that had been ethanol precipitated and resuspended in 
5pi of water. Competent cell were thawed on ice and 40pl mixed with the DNA 
to be electroporated. The mixture was transferred to a 0.2cm electroporation 
cuvette (Bio-Rad) on ice. Electroporation was carried out at 2.5kV (25pFD 
capacitance and 200Q resistance) in a Bio-Rad MicroPulser™. Immediately 
after, 500pl of warm SOC were added to the cuvette and the cells decanted into a 
warm 1.5ml microfuge tube. They were then incubated at 37°C for 30 minutes 
before plating on LB agar plates containing an appropriate antibiotic and 
incubating further overnight at 37°C. When possible, blue/white selection was 
used to distinguish recombinant bacteria. To allow this the inserted plasmid 
needed to contain a lacZ gene that would be disrupted by the ligation of the insert 
DNA. If this was the case, X-gal and IPTG were added to the LB agar plates 
(20pl of 50mg/ml X-gal in DMF and lOOpl of 0.1M IPTG per plate) to act as 
substrates for any remaining intact lacZ gene product.
2.1.6 PAC recombination.
Isolation o f targeting vectors
Once constructed, targeting vectors were excised from their plasmid vectors 
using the appropriate restriction enzymes. The resulting fragments were 
separated by agarose gel electrophoresis and the appropriate band purified by 
standard band purification. The linear targeting construct was then electroporated 
into EL250 cells containing the PAC DNA that was to be recombined.
Electroporation ofEL250 electrocompetent cells
The EL250 strain is a modified DH10B strain [Gibco] containing defective 
lambda prophage (Yu et al., 2000) and arabinose flpe gene (Lee et al., 2001). 
EL250 bacterial cells were transformed as normal, except that 0.1cm 
electroporation cuvettes were used at 1.8kV. After electroporation the cells were 
allowed to recover in warm SOC at 32°C for 2 hours. Prior to electroporation 
with the linear targeting vector the EL250 cells were first electroporated with the 
non-recombined PAC DNA. Correctly transformed cells were selected via 
antibiotic resistance (the pPAC4 vector contains a kanamycin resistance gene).
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Once this electroporation had been confirmed, recombination was induced as 
described below, followed by the electroporation with the targeting vector.
Induction o f recombination in EL250 cells
EL250 cells that contained PAC DNA were grown on LB agar plates 
supplemented by kanamycin (12.5pg/ml) at 32°C overnight. Single colonies were 
picked and used to inoculate 5ml starter cultures that were again grown 
overnight, shaking at 32°C (with kanamycin). 4ml of this overnight culture were 
used to inoculate 50ml of fresh LB broth (without kanamycin) which were grown 
until the OD600 reached 0.5-0.8. Recombination was induced by transferring 
10ml of this culture to a 42°C water bath for 15 minutes. This culture was then 
cooled rapidly in ice water for 5 minutes. At the same time a 10ml non-induced 
culture was rapidly cooled. This would act as a negative control for the 
recombination. Both induced and non-induced cultures were spun at llOOg at 
4°C for 8 minutes and the pellets resuspended in 1ml ice cold pure water. This 
was transferred to a 1.5ml microfuge tube and pulse spun at maximum speed for 
20 seconds. This wash process was repeated three times, and after the final wash 
the pellets were resuspended in lOOpl of sterile water. 50pl of the induced and 
non-induced cells were electroporated as described above with 100-300ng of the 
linear targeting vector DNA. After transformation 500pl of warm LB broth was 
added to the cells and they were incubated at 32°C for 90 minutes. Aliquots of 
the cells were then plated on LB agar either containing 20pg/ml ampicillin or 
15pg/ml chloramphenicol to select for recombination events (by virtue of the 
introduction of an ampicillin or chloramphenicol resistance cassette in the 
targeting vector) or containing 12.5pg/ml kanamycin as a control to demonstrate 
the presence of live cells in both the induced and non-induced cultures regardless 
of whether recombination had occurred properly. Colonies found growing on the 
ampicillin/chloramphenicol plates from the induced cultures were used to 
inoculate overnight cultures. PAC DNA could then be extracted and Southern 
analysis carried out to determine if recombination had occurred in the desired 
way.
In addition to the temperature-inducible recombination events, it was also 
necessary in some cases to remove the chloramphenicol resistance cassettes prior
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to inserting the recombinant DNA into the animals. To allow this the 
chloramphenicol resistance cassettes were flanked by fr t sites. The EL250 
bacteria contain an arabinose inducible flpe gene that could be used to excise the 
cassettes. To achieve this, 300pl of recombinant EL250 bacterial culture was 
used to inoculate 15ml of fresh LB broth. The bacteria were grown to an OD600 
of 0.5 -  0.8 and the sterile arabinose was added to a final concentration of 0.2%. 
The cultures were incubated like this for 1 hour at 32°C. 1ml of this culture was 
then used to inoculate 10ml of fresh LB broth and this was incubated for 2 hours 
at 32°C before plating on the appropriate selective LB agar. Ampicillin 
(20pg/ml) was used to select for recombinant bacteria. Chloramphenicol 
(15pg/ml) selection was used to indicate the efficiency of the recombination 
event. In theory, the recombination should be very efficient giving no colonies on 
the chloramphenicol-containing LB agar. Again recombination is verified by 
carrying out Southern blot analysis as described below.
Screening for desirable recombination events
Overnight cultures of putative recombinant colonies were set up from single 
clones and used to carry out minipreps of PAC DNA in much the same way as 
with plasmid DNA, except that wide bore tips were used (see Small scale 
plasmid preparation). Isolated PAC DNA was subjected to restriction enzyme 
digestion overnight with the appropriate enzyme(s) and the resulting fragments 
separated by PFGE. Southern blotting was carried out as before and the blots 
were hybridised with a radiolabelled probe specific to the fragment of PAC of 
interest. Recombination was confirmed by the appearance of a shift in fragment 
size corresponding to the removal/replacement of the appropriate DNA section. 
For example, removal of the chloramphenicol resistance cassette should result in 
a decrease in fragment size of around 1.3kb.
2.1.7 Creation of Transgenic Mice
Linearization and isolation o f linearised recombined PAC DNA 
Linear recombinant PAC DNA was used for in ovo injections. This was obtained 
by firstly carrying out a large scale PAC DNA preparation as described above. 
The resulting DNA (lOOpl) was digested overnight with the appropriate 
enzyme(s). The PAC fragments were subjected to PFGE as above, however in
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this case, 90% of the digested PAC DNA was run in a central wide lane on the 
gel, while two small ‘marker’ lanes on each side of the wide lane were loaded 
with 5% of the digest each. After PFGE the marker lanes were cut out of the gel 
and stained with ethidium bromide. These revealed the relative locations of the 
PAC fragments of interest without actually staining the majority of the DNA 
with ethidium bromide. Using the marker lanes as guides, the vector and PAC 
insert fragments were excised from the large lane and place in a mini gel tray. 
The relative arrangements of the excised bands in the min gel tray are shown in 
figure 2.2. 4% low melting point (LMP) agarose was poured over the bands into 
the tray, allowed to set and the mini gel run at 50V for 9 hours at 4°C. After 
running, the portion of the mini gel containing the vector band was excised and 
stained with ethidium bromide to check that the DNA had run into the 4% LMP 
agarose. The position of this migrated DNA was then used to guide the excision 
of the corresponding migrated PAC insert DNA, but without having to stain this 
DNA with ethidium (see figure 2.2).
The small block of LMP agarose containing the DNA of interest was equilibrated 
with TENPA buffer (1M Tris-HCl pH 7.5, 0.5M EDTA pH 8.0, 5M NaCl) 
containing 30pM spermine and 70pM spermidine while being agitated for at 
least 1.5 hours. The gel block was the placed in a microfuge tube and melted at 
68°C for 3 minutes in a water bath before being briefly spun in a microfuge and 
incubated for an additional 5 minutes at 68°C. The tube was then transferred to a 
42°C water bath for 5 minutes. Without removing the molten agarose from the 
water bath, 2 units of (3-Agarase (NEB) were added per 100pi of molten agarose 
and the solutions mixed by pipetting up and down with a wide bore pipette. 
Agarose digestion was allowed to carry on for 3 hours at 42°C before the mixture 
was placed at room temperature to ensure the agarose had been fully digested 
and the solution did not set. In a small Petri dish, 3 dialysis membranes 
(Millipore, pore size 0.025pm) were placed floating on a solution of 
microinjection buffer (1M Tris-HCl pH 7.5, 0.5M EDTA pH 8.0, 5M NaCl, filter 
sterilised) containing 30pM spermine and 70pM spermidine. The DNA solution 
was pipetted directly on top of the three filters in equal volumes and the solutions 
were allowed to dialyse for 1 hour at room temperature. The PAC DNA solution 
was recovered from the top of the filters and stored at 4°C until required. A small
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volume of the DNA was subjected to PFGE overnight along with some PAC 
DNA standard prepared previously in order to give a rough quantification of the 
DNA and to check its quality. The DNA was then microfuged and diluted 
appropriately with microinjection buffer before being used for microinjection.
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Figure 2.2 (A) The arrangement of the excised bands in the mini gel tray. 
Hashed area indicates the location of the DNA (B) After running the DNA 
becomes concentrated in a small region of the 4% LMP agarose immediately 
adjacent to the original excised PFGE band. The dashed line indicates where the 
vector DNA section of the mini gel should be cut away to allow it to be stained 
with ethidium bromide. (C) Visualisation of the vector band by UV illumination 
allows localisation and removal of the PAC DNA of interest. From M. Grist.
Transgene Forward Primer 5’ to 3’ direction
Reverse Primer 
5’ to 3’ direction
Annealing
temperature
Product
size
Emx1 iCre GCGGCCGCGACCAT GGT GCCCAAGAAGAAGAGGAA
GCCT GAATT CT CAGT CCCC 
ATCCTCGAGC
61-56°C
Step-down
1000bp
Emx1CreERT2 CAGT GGCCCAACT CGGT G TTAGG
CGGGT CACGAACACGGCA 
TGG 66°C 650bp
Dbx1 iCre GAAACCT GGACT CT GAGA CTGGG
GAGAGAAAT CGCTTCCTCC 
CG 66°C 700bp
Msx3iCre GAAACCT GGACT CT GAGA CTGGG
GGCT GT CCAAT AACCGAAG 
ACG 66°C 1000bp
Table 2.1 Table showing the primer sequences used to genotype the transgenic 
mice created and also the annealing temperatures required in the PCR reaction. 
Note, ‘step-down’ indicates that the reaction used a series of decreasing annealing 
temperatures, in this case 61°C for one reaction cycle, 60°C for 5 reaction cycles 
and then 56°C for 34 reaction cycles.
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In ovo injection o f PAC DNA and transplantation
Fertilised eggs were obtained from superovulated females. Superovulation was 
induced in 3-4 week old (B6 x CBA) FI mice by injecting with follicle 
stimulating hormone (Folligon, from Intervet) at around 5pm on day 1. They 
were then injected with human chorionic gonadotrophin (hCG, Chorulon, from 
Intervet) around 45 hours later. After hCG injection, females were mated with 
(B6 x CBA)F1 fertile males. 4-6 females typically yielded 100-200 fertilized 
ova.
Microinjection of DNA was carried out by U. Dennehy and P. Iannarelli 
(Richardson Lab, WIBR). Briefly, linear ~lng of linear PAC DNA in suspension 
in microinjection buffer was injected into the pronuclei of the fertilised mouse 
ova. Surviving 2 cell stage embryos were then transplanted into the oviducts of 
pseudopregnant foster mothers (18-22 embryos per mother). Pseudopregnant 
mothers were prepared 24 hours previously by mating 6-24 week old females in 
natural oestrous with vasectomised males.
2.2 Analysis of transgenic mice
2.2.1 Screening mice for transgenes
PCR Genotyping
Genomic DNA was extracted from tissue biopsy and used as template DNA for 
PCR amplification as described above. Reporter animals were genotyped by 
laboratory staff according to PCR conditions devised by their source laboratories 
and therefore the details of these protocols are not included here. Primers for 
genotyping the animals created in our laboratory were designed specifically to 
amplify only stretches of DNA containing a specific transgene. Primers and PCR 
conditions for genotyping are listed in table 2.1.
Southern Blot Genotyping
To confirm putative founder mice contained the transgene southern blot was 
carried out on the genomic DNA extractions. 20pl of genomic DNA was used in
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an appropriate restriction enzyme digest and the resulting fragments 
electrophoresed, blotted and analysed as described above.
Crossing mice with reporter strains
In order to visualise the cellular progeny of the neuroepithelial domains we were 
interested in, the mice expressing transgenic Cre were crossed with ‘reporter’ 
mouse strains that express a reporter gene only after the removal of 
transcriptional stop codons by Cre-mediated recombination. Three commercially 
available reporter strains were used; the Rosa26 strain containing the lacZ gene 
under the control of the ubiquitous Rosa26 promoter (Soriano, 1999); another 
Rosa26 strain expressing EGFP under the control of the same promoter (Mao et 
al., 2001); a third reporter strain called the Z/EG mouse also expressing EGFP, 
but this time under the control of the pCAGGS promoter (Novak et al., 2000). 
Correct recombination was assessed by looking for activation of the reporter 
gene, either enzymatically (for P-Gal), via immunohistochemistry (all reporters) 
or by direct visualisation under UV light (EGFP).
2.2.2 In situ hybridisation analysis
Tissue fixation and preparation
Tissue required for in situ hybridisation analysis was initially fixed overnight in 
4% paraformaldehyde (4% PFA, in phosphate buffered saline). In the case of 
postnatal tissue, animals were initially terminally anaesthetised with Domitor® 
(1 mg/ml solution of Medetomidine hydrochloride, inject at 1 ml/kg of animal, 
Pfizer) and Vetalar (lOOmg/ml ketamine hydrochloride solution, inject at 
0.75ml/kg of animal, Pharmacia). Once unconscious, animals were perfused with 
4% PFA via the right ventricle of the heart. The volume of PFA varied, but 
generally a 10 day old animal would receive around 30ml of PFA and volumes 
were adjusted accordingly with age. Once perfusion was complete, the tissue of 
interest was dissected out and then left in 4% PFA overnight. Once fixed the 
tissue was cryoprotected by overnight treatment with a 20% w/v sucrose solution 
in PBS. This 20% sucrose was made RNase free by DEPC treatment (diethyl 
pyrocarbonate, added to solution at 1/1000* volume and left for one hour, then 
autoclaved). After sucrose treatment, tissues were embedded in OCI™ 
compound (RA Lamb) and frozen. They could then be stored at -80°C.
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Embryonic tissue was treated in exactly the same way except that there was no 
perfusion step. Tissue was simply removed from the pregnant mother euthanised 
by a schedule 1 method, and placed in 4% PFA. All other steps were as those for 
postnatal animals.
Preparation o f digoxigenin (DIG) labelled RNA probes 
To make probes for in situ hybridisation, a plasmid template was required. 
Templates were obtained from collaborators, the IMAGE consortium, or by PCR 
amplifying genes of interest and cloning them into the TOPO® vector. The 
template was linearised at an appropriate point using restriction enzyme digestion 
and the resulting linear fragment purified using phenol-chloroform extraction and 
ethanol precipitation. It was vital to ensure that the template remained RNase 
free. RNA transcription was then carried out using either T3 or T7 RNA 
polymerase, depending on which gave the desired strand synthesis. The RNA 
transcription reaction required 5 pi linear template DNA at roughly lOOng/pl, 5 pi 
of 5x transcription buffer (Promega), 7.5pi dithiothreitol (DTT), 2.5pi RNA 
labelling mixture (DIG labelling, Roche), lpl RNasin (RNase inhibitor, 
Promega), 2pJ RNA polymerase (T3 or T7, Promega) and 2pl RNase free water. 
This mixture was incubated at 37°C for 2.5 hours. Once complete the reaction 
mixture was diluted with 75 pi DEPC treated water. The success of the 
transcription was checked by running lpl of the reaction mixture on a 1% 
agarose gel to ensure the presence of a transcript at the correct size. Once this 
was shown the reaction mixture was aliquoted in 5 pi aliquots and stored at - 
80°C.
RNA in situ hybridisation to tissue sections
Tissue blocks were sectioned in a Bright OTF5000 cryostat. Sections were 
typically cut to a width of 15pm. Sections were collected on SuperFrost® Plus 
slides (VWR International) and dried for 30 minutes. Probe aliquots were 
defrosted, and the probe diluted 1/1000 in hybridisation buffer containing 50% 
formamide, lOOmg/ml dextran sulphate, 1 mg/ml tRNA, lx Denhardt’s solution 
(50x stock, 1% Ficoll 400, 1% polyvinylpyrrolidone, 1% bovine serum albumin), 
and lx salt solution (lOx salt stock, 2M NaCl, 50mM EDTA, lOOmM Tris-HCl
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pH 7.5, 50mM NaH2P0 4 ,2 H2 0 , 50mM Na2HPC>4, DEPC treated). The diluted 
probe was denatured at 70°C for 5 minutes and then vortexed and centrifuged 
and immediately applied to the slides. The slides were placed in a hybridisation 
box, the base of which contained 2 sheets of Whatman paper wetted with a 50% 
formamide lx SSC solution. After application of the probe, each slide was 
covered with a coverslip and the hybridisation box was sealed closed with tape. 
Hybridisation was carried out at 65 °C overnight. After hybridisation, slides were 
placed in wash solution (50% formamide, lx SSC, 0.1% Tween-20) in a coplin 
jar for 15 minutes at 65 °C to remove the coverslips. The slides were then washed 
a further two times for 30 minutes each at 65°C. The slides were next washed in 
room temperature lx MABT (5x stock, 0.5M maleic acid, 0.75M NaCl, 1M 
NaOH, 0.5% Tween 20) twice for 30 minutes each. The sections were then 
blocked in blocking solution (8g blocking reagent, Roche cat no 1-096-176, 
100ml 5x MABT, 200ml distilled water, heated to 65°C to dissolve then 80ml 
heat treated sheep serum added and finally made up to 400ml with distilled 
water) for at least one hour at room temperature. Next, an anti-Digoxigenin 
alkaline phosphatase conjugated (Roche) antibody was diluted 1/1500 in 
blocking solution and applied to the sections overnight at 4°C. The sections were 
then washed 3 times for 20 minutes in lx MABT, followed by 2 ten minute 
washes in staining buffer (0.1M NaCl, 0.05M MgCb, 0.1M Tris pH 9.5, 0.01% 
Tween-20). The colour reaction was developed by placing the slides in a solution 
containing 20ml staining buffer, 0.025 MgCl2, 87pi NBT (lg 4-nitro blue 
tetrazolium chloride crystals, plus 7ml dimethyl formamide and 3 ml distilled 
water), 67pl BCIP (BCIP from Roche, lg plus 20ml dimethyl formamide), and 
20ml of a 10% polyvinyl alcohol solution. Reactions were incubated in the dark 
at 37°C and periodically checked for development of a blue precipitate on the 
sections. In cases of less abundant transcripts, reactions were allowed to proceed 
overnight. Once reactions had proceeded to a suitable point, they were quenched 
with excess water. After this, the sections were dehydrated through alcohols 
before being treated with xylene and mounted in DPX mountant (Fluka) under a 
coverslip.
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2.2.3 Immunohistochemistry
Tissue fixation and preparation
In most cases, tissue was prepared in exactly the same way as for in situ 
hybridisation. However for some of the antibodies used it was necessary to fix 
the tissue less severely in order to preserve the epitope structure of the antigen of 
interest. In particular antibodies such as anti-PDGFRa, anti-Pax7, anti-Pax6, 
anti-Mashl, anti-Panlsl, anti-Lbxl, anti-Lim2 and Lim3, anti-Enl and anti- 
Evxl/2 all require light fixation. In these cases, embryonic tissue was isolated as 
for in situ hybridisation, but was then only treated with 4% PFA for between 5 
minutes (E10.5) and 30 minutes (E18.5) before treating with sucrose overnight. 
For postnatal tissue, animals were perfused as described above, but the excised 
tissue was then only placed in 4% PFA for a maximum of 1 hour (adult brain) 
but usually only 30 minutes. This was followed by sucrose treatment and 
embedding as described above.
Using anti-SoxlO antibody to detect SoxlO in the postnatal brain presented a 
unique problem. The antigen was found to be particularly unstable and as a result 
perfusion and overnight 4% PFA treatment were not effective in preserving the 
epitope. To achieve more efficient preservation, the animals were perfused as 
before but once the brain had been removed, it was sectioned into 1mm thick 
sections using a vibroslice (NVSLM1, World Precision Instruments). These 
sections were then treated with 4% PFA overnight prior to sucrose treatment and 
embedding in OCT™. The slicing of the tissue allowed greater penetration of the 
tissue by the fixative.
Detection o f antigens on tissue sections
Frozen tissue embedded in OCT™ was sectioned as described for in situ 
hybridisation. Sections were collected on SuperFrost plus slides and allowed to 
dry. They were blocked for one hour (at least) in a blocking solution of 10% 
sheep serum, 0.1% Triton-X 100, lx PBS. In cases where the primary antibody 
used was a goat or sheep antibody, 10% foetal calf serum (FCS) was substituted 
for sheep serum in the blocking solution. After blocking, primary antibodies 
were diluted as appropriate in more blocking solution. Again in the case of 
primary antibodies derived from sheep or goat, the blocking solution contained
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FCS instead of sheep serum. Primary antibodies were applied overnight. After 
primary antibody binding, sections were washed three times in lxPBS 0.1% 
Triton-X 100 for 20 minutes each. Then the appropriate secondary antibody(s) 
was added. This was diluted appropriately in 10% serum lx PBS, 0.1% Triton-X 
100. After secondary antibody binding, the sections were washed three times in 
lx PBS, 0.1% Triton X 100. In the case of immunohistochemical reactions that 
did not use a blue fluorophore (AMCA or Alexa Fluor® 350) conjugated 
secondary antibody, sections were counterstained with Hoescht for 1 min 
(lOmg/ml stock, diluted 1:1000 in lx PBS, 0.1% Triton X 100) followed by a 5 
minute was in lx PBS 0.1% Triton X 100. The sections were fixed by a 5 minute 
treatment with 4% PFA and after one final 5 minute wash in lx PBS 0.1% Triton 
X 100, they were mounted under coverslips in Citifluor anti-fade reagent (City 
University, UK). All slides were stored in the dark at 4°C. For double labelling 
using two primary antibodies from the same species (eg anti-GFP and anti-01ig2) 
one of the primary antibodies was effectively converted to a different species. 
This was achieved in the case of 01ig2 and GFP by applying anti-01ig2 primary 
antibody alone and then using a goat anti-rabbit FAB fragment in excess to 
saturate all the rabbit specific epitopes on the anti-01ig2 antibody, leaving only 
goat epitopes available for secondary antibody binding. Subsequently a mouse 
anti-goat secondary antibody was used to visualise the location of the 01ig2 
antigen. Only after this step was the second rabbit primary antibody (rabbit anti- 
GFP) applied, and visualised in the normal way.
Tabe 2.2 lists the working dilutions of the antibodies used, the secondary 
antibodies used to detect them, and the sources of the antibodies.
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Primary
antibody Dilution Source Secondaries used
Secondary
dilution Source
Rabbit anti- 
GFP 1:8000 AbCam
FITC goat anti-rabbit 1:200 Pierce
Alexa Fluor® 488 goat 
anti-rabbit 1:300 Invitrogen
Rabbit anti- 
Olig2 1:2000
Gift from 
D.
Rowitch
FITC goat anti-rabbit 1:200 Pierce
Goat anti-rabbit FAB 
fragment
then a Rho mouse 
anti-goat
1.200 Jackson
1:200 Pierce
Mouse
monoclonal
anti-RC2
IgM
1:5 DSHB
AMCA or Rho goat 
anti-mouse IgM 1:200 Pierce
Alexa Fluor® 350 goat 
anti-mouse IgM 1:300 Invitrogen
Rat anti- 
PDGFRa 1:500
BD
Bioscienc
es
Rho goat anti-rat 1:200 Pierce
Alexa Fluor® 555 goat 
anti-rat 1:300 Invitrogen
Mouse
monoclonal
anti-GFAP
1:400 Sigma Rho goat anti-mouse IgG 1:200 Pierce
Guinea-pig
anti-Sox10 1:2000
Gift from 
M. 
Wegner
Rho goat anti-guinea- 
pig IgG 1:200 Pierce
Alexa Fluor® 555 goat 
anti-guinea-pig 1:300 Invitrogen
Mouse
monoclonal
anti-NeuN
1:400 Chemicon Rho goat anti-mouse IgG 1:200 Pierce
Mouse
monoclonal
anti-Pax7
1:10 DSHB Rho goat anti-mouse IgG 1:200 Pierce
Mouse 
nomoclonal 
anti-pan- 
Islet 4D5
1:20 DSHB Rho goat anti-mouse IgG 1:200 Pierce
Guinea-pig
anti-Evxl 1:8000
Gift from 
T. Jessel
Rho goat anti-mouse 
IgG 1:200 Pierce
Mouse
monoclonal
anti-APC
(CC1)
1:400
Merck
Bioscienc
es
Rho goat anti-mouse 
IgG 1:200 Pierce
Guinea-pig
anti-Lbxl 1:8000
Gift from 
T. Jessel
Rho goat anti-mouse 
IgG 1:200 Pierce
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Mouse
monoclonal
anti-Lim2
1:5 DSHB Rho goat anti-mouse IgG 1:200 Pierce
Mouse
monoclonal
anti-Lim3
1:20 DSHB Rho goat anti-mouse IgG 1:200 Pierce
Mouse 
mononclona 
1 anti S-100p
1:400 Sigma Rho goat anti-mouse IgG 1:200 Pierce
Mouse
monoclonal
anti-Mash1
1:20 Gift from T. Jessel
Rho goat anti-mouse 
IgG 1:200 Pierce
Mouse
monoclonal
anti-En1
1:5 DSHB Rho goat anti-mouse IgG 1:200 Pierce
Table 2.2 Table showing all the primary and secondary antibodies used for 
immunohistochemistry, their working dilutions and sources. Abbreviations used; 
DSHB, Developmental Studies Hybridoma Bank; FITC, Fluorescein; Rho, 
Rhodamine.
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2.3 Tissue culture
Extraction o f primary spinal cord cells
Spinal cords were removed from E12.5 mice embryos and the surrounding tissue 
was dissected away in Hepes-buffered minimal essential medium (MEM-H, 
Invitrogen). After coarse dissociation of the cord by dissecting into pieces, the 
cells were further dissociated by incubation in 0.0125% (w/v) trypsin in Earle’s 
balanced salt solution (EBSS, Invitrogen) for 30 minutes at 37°C in 5% CO2. The 
cells were then mechanically dissociated by pipetting in the presence of DNasel 
and they were seeded onto 13mm poly-D-lysine coated coverslips in a 50pi 
droplet of Delbecco’s modified Eagle’s medium (DMEM, Invitrogen) containing 
0.5% FCS at a density of 2.5xl05 cells per coverslip. The cells were allowed to 
adhere to the coverslip for 30 minutes, and then 350pl of defined medium 
(Bottenstein and Sato, 1979) was added and the incubation of cells was 
maintained in 5% CO2 at 37°C.
Cells were treated by using one of, or a combination of the Shh antagonist 
cyclopamine, added to a final concentration of 1 pM, and the FGFR inhibitor 
PD173074 at a final concentration of 100 nM.
Analysis o f cell cultures
Primary spinal cord cultures were allowed to develop with or without the 
inhibitor cyclopamine and/or PD173074. After 5 days in culture (DIV5) the 
cultures were fixed for 5 minutes in 4% PFA and then blocked with 10% FCS lx 
PBS 0.1% Triton X 100. Subsequently primary and secondary antibodies were 
added as described above (rabbit anti-GFP and guinea-pig anti-SoxlO). After 
mounting, the coverslips were examined under fluorescent light microscopy. 
Sox 10 positive, GFP positive and double positive (Sox 10 and GFP) cells were 
counted in each visible field using a xlO objective. For each coverslip at least 
1000 SoxlO positive cells were counted so that the proportion of GFP and SoxlO 
double positive cells could be expressed as a proportion of the total number of 
SoxlO positive cells.
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Chapter 3 
Dbxl transgenesis
3.1 Introduction to Dbxl
Dbxl (developing brain homeobox gene) was first identified as a homeobox gene 
with a highly restricted pattern of expression in the embryonic brain and spinal 
cord (Lu et al., 1992;Lu et al., 1994;Murtha et al., 1991). Within the 
homeodomain Dbxl shows 85% amino acid sequence similarity to Dbx2. The 
expression patterns of the two highly related genes are similar throughout the 
CNS although Dbx2 transcripts appear in slightly broader regions than Dbxl 
(Shoji et al., 1996). Dbxl is encoded by 4 exons spanning a region of 4.27 kb on 
chromosome 7, with exons 3 and 4 containing the homeobox coding region (for 
schematic see Figure 3.8B). Similarly, Dbx2 consists of four exons covering 
30.45kb on chromosome 15 (www.ensembl.orgT Promoter analysis of Dbxl has 
shown that a 5.7kb fragment around the transcription start site contains at least 
two separately-acting regulatory elements that are able to direct expression of 
Dbxl in distinct regions (Lu et al., 1996). However, ectopic expression of a p- 
Gal reporter driven by the 5.7kb enhancer/promoter indicates that other elements 
are also required for correct expression of the gene (Lu et al., 1996;Matise et al., 
1999).
Expression of Dbxl and Dbx2 along the dorso-ventral axis of the spinal cord 
starts off in four neuroepithelial domains. From E l0.5 onwards expression of 
Dbxl shrinks to occupy only dP6 and pO (see Figure 3.1) (Pierani et al., 2001). 
The combinatorial expression of Dbxl, Dbx2 and Pax7 at E l0.5 can be used to 
identify four distinct progenitor domains: two dorsal domains, dP5 {Dbxl-, 
Dbx2+, Pax7+) and dP6 (Dbxl+, Dbx2+, Pax7+), and two ventral domains, pO 
(Dbxl+, Dbx2+, Pax7-) and pi {Dbxl-, Dbx2+, Pax7-) (Pierani et al., 1999) (See 
figure 3.1). Dbxl is required specifically for the production of VO intemeurons
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from the pO domain and Dbx2 is required specifically for the production of VI 
interneurons from the pi domain
Pax7
Mashl
Dbx2
Dbxl
Nkx6.1
Figure 3.1 Progenitor domains in the mouse embryonic spinal cord 
neuroepithelium at E10.5. To the left of a Hoescht stained E10.5 spinal cord 
neuroepithelium is a schematic representation of the progenitor domains that are 
thought to exist in the neuroepithelium. Dorsal to ventral; RP, roof plate; dPl; 
dP2; dP3; dP4; dP5; dP6; pO; pi; p2; pMN; p3; FP, floor plate. Also shown are 
the expression domains of various transcription factors superimposed on the 
spinal cord neuroepithelium; Pax7; M ashl; D bxl, Dbx2; Msx3. Note it is 
thought that at E9.5, D bxl is briefly expressed in the same wide domain as Dbx2 
and then shrinks down to the narrower domain shown. Adapted from (Briscoe et 
al., 2000;Caspary and Anderson, 2003;Pierani et al., 2001).
Misexpression of Dbxl in the pi domain represses VI intemeuron generation 
and promotes VO intemeuron production, while loss of D bxl results in excess V 1 
interneurons due to pO progenitor cells acquiring a pi-like phenotype. It has also 
been shown that correct D bxl expression is required to allow VO interneurons to 
migrate correctly and project axons to the correct locations. Given that VO 
interneurons lose D bxl expression after leaving the ventricular zone, it is thought 
that Dbxl must be required to correctly prime these cells to receive the extrinsic 
factors that control migration and axonal projection (Pierani et al., 2001).
Initial work had suggested that induction of Dbx genes can be mediated by low 
levels of SHH or by a SHH-independent, retinoid-activated pathway (Pierani et
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al., 1999). More recent work, however, has shown an absolute requirement for 
Shh signalling in Dbxl expression. pO and pi neuroepithelial cells lacking smo 
function have no Dbx expression, while cells lacking smo in more ventral 
domains show ectopic expression of Dbx (Wijgerde et al., 2002). The precise 
effect that is seen is dependant on the position of cells along the dorso-ventral 
axis, and the presence or absence of other transcription factors within those 
regions. The discrepancy with previous results that showed no requirement for 
Shh (Pierani et al., 1999) has been explained by the suggestion that under 
conditions where Shh signalling is blocked (for example by a Shh specific 
antibody as in the earlier work), low levels of Indian hedgehog (Ihh) secreted 
from the gut endoderm underlying the notochord may compensate. This 
mechanism is unlikely however, to be significant under normal Shh signalling 
conditions (Wijgerde et al., 2002). It remains possible that retinoid and hedgehog 
pathways act either synergistically or independently to specify and induce 
development of Dbx progenitors and their intemeuron progeny.
The role of Dbxl in spinal cord development has been further elucidated using 
loss-of-fimction studies in mouse (Lanuza et al., 2004). In the absence of Dbxl 
mice show dismption in the alternation between the firing of the motor neuron 
pools in the left and right sides of the spinal cord. Whereas wild type P0 spinal 
cord slice preparations show precise phasing of the firing of left and right hand 
side flexor-extensor motomeurons, mutant spinal cords show frequent periods of 
synchronous firing of these cells. This deficiency is due to loss of a population of 
V0 commissural GABAergic interneurons. It is thus thought that these cells play 
an important role in the so-called ‘central pattern generator’ circuitry that 
underlies the alternate contraction of muscle groups important for movements 
such as swimming and walking.
The identity of neurons generated from the Z)£x-expressing neuroepithelial cells 
and the role of Dbxl in intemeuron specification are well established. However 
the identity of glial cells generated from this region is unknown. Previous work 
has suggested that astrocytes may be derived from Dbxl progenitors (Wijgerde et 
al., 2002). To fully characterize the glial progeny of the Dbx-expressing 
precursors we used Oe-LoxP technology to permanently label the Dbxl-lineage
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in the spinal cord. We demonstrate that the Dbx domain produces radial glia that 
give rise to at least two distinct types of astrocytes. We further show that, 
surprisingly, a subset of oligodendrocytes distinct from those produced by the 
pMN domain (Fogarty et al., 2005) are also generated from this region.
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3.2 Results
3.2.1 Screening for PAC clones containing the Dbxl gene
To identify a genomic PAC clone that contains the Dbxl gene we screened a 
Mouse PAC (RPC 121) library (from the UK HGMP Resource Centre) with a 
cDNA probe that is specific for Dbxl. The probe used was a 900bp BamHl -  
Notl cDNA fragment from IMAGE clone 426959 spanning the 3’UTR region of 
Dbxl (figure 3.2). When used as a probe on a Southern blot of mouse genomic 
DNA digested with EcoRl or HindUl, single bands of expected size were 
obtained (figure 3.3) confirming the specificity of the probe. From the PAC 
library screen six clones were found to hybridise to Dbxl. These were the 
following: 337-G15; 351-F09; 465-114; 514-A19; 582-G11; and 631-M19. They 
were purchased from the UK HGMP Resource Centre and further characterised.
3.2.2 PAC clone characterisation
To confirm that the genomic PAC clones contain the Dbxl gene, DNA was 
extracted, digested with EcoRl or Hindlll and analysed on Southern blots 
hybridised with the 900bp Dfo-specific cDNA probe mentioned above. All six 
clones contained the expected 16Kb EcoRI band and 1.6 Kb and 1.0Kb Hindlll 
bands corresponding to the Dbxl gene (figure 3.4).
In order to estimate the size of the DNA inserts in the PAC clones we digested 
the PAC DNA with Notl to release the entire insert. PFGE analysis of the digests 
revealed that the sizes of the PAC clone inserts ranged in size from around 
110Kb to 230Kb and contained up to 2 Notl sites (not including the sites in the 
vector) (figure 3.5).
The next step in characterisation of the PACs was to perform inverse PCR 
followed by sequencing of the PCR products and comparison of the sequences to 
the published mouse genomic databases (http://www.ensembl.org/) to identify 
the precise size and region of genomic DNA that each clone spanned. Inverse 
PCR was performed as outlined in Chapter 2 and the results of a typical round of 
inverse PCR are shown in figure 3.6. A blast comparison of the inverse PCR
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products to the Ensembl database showed that five out of the six PAC clones 
contained ‘asymmetrical’ inserts with the Dbxl gene located near one end on the 
clone (see figure 3.7). The sixth clone contained a more ‘symmetrical’ insert of 
236Kb in size which included 147Kb upstream and 84.5Kb downstream of the 
Dbxl gene. This was chosen as the most likely candidate to drive correct 
expression of Dbxl because it has a large insert with the Dbxl gene located 
relatively centrally. It would therefore be most likely to contain all the regulatory 
elements that control Dbxl expression. PAC 631-M l9 was used in all subsequent 
work for generation of Dbxl-ere transgenic mice.
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T7 J 3
pT3T7
Figure 3.2 Schematic diagram of IMAGE clone 426959 which 
contains the entire Dbxl open reading frame (ORF) and 3 ’ untranslated 
region (UTR) inserted between the EcoRl and Notl sites of the pT3T7 
vector. A 900bp BamYR -  Notl fragment was used as a probe to screen 
the genomic PAC library.
M EcoR1 HindiW
10kb
8kb
2.5kb
1.5kb
.04kb1kb 
0.8kb
Figure 3.3 Southern 
analysis of mouse genomic 
DNA digested with EcoRl 
and Hindlll and hybridised 
to a probe complementary to 
the 3’ UTR of Dbxl. The 
appearance of the expected 
bands at 16kb in the EcoRl 
digest and 1.6kb and 1.04kb 
in the Hindlll digest 
demonstrates that the probe 
is specific to this gene. M 
indicates the marker lane.
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Figure 3.4: Southern analysis of DNA from PAC clones digested with 
EcoRl (A) or Hindlll (B) and hybridised to a 900bp Dfo/-specific cDNA 
probe. The expected bands of 16kb in (A) and 1.6kb and 1.04kb in (B) are 
indicated.
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PAC Clone Insert 1 Insert 2 Insert 3 Total Size
337-G15 -110Kb - - -110Kb
351-F09 -30Kb -125Kb - -155Kb
465-114 -25Kb -160Kb - -185Kb
514-A19 -.130Kb - - -130Kb
582-G11 - 10Kb -135Kb - -145Kb
631-M19 -5Kb -85Kb -140Kb -230Kb
Figure 3.5: (A) PFGE analysis of DNA from the PAC clones digested with 
Notl. Note the presence of the 16.7Kb pPAC4 vector band (arrow). (B) Table 
listing the estimated sizes of the bands from the Notl digest and the estimated 
total sizes of the genomic inserts.
514-A19 337-G15
Hind III Hind III
Figure 3.6 Typical inverse PCR results. In this example two clones (524-A19 
and 337-G15) have been digested with one of three restriction enzymes (.Pstl, 
Sphl or Hindlll). The fragments were circularised by re-ligation, and then PCR 
was carried out using one of two primer combinations (F2R2 or F1R2). Specific 
fragments corresponding to clones of genomic sequence from the ends of a PAC 
insert are indicated by small shifts in band size between PCRs using the two 
primer combinations used. Good examples of specific bands are shown by the 
coloured asterisk pairs (White, shift from 1.5kb to 1.4kb; red, shift from 1.0Kb 
to 0.9Kb; green, shift from 1.3Kb to 1.2Kb). These bands would be band 
purified, TOPO® cloned and sequenced to determine what region of the genome 
they represent. Other bands represent non-specific PCR products.
3.2.3 Construction of the targeting vector
In order to manipulate the PAC by homologous recombination in bacteria, a 
targeting vector was constructed that would replace the D bxl coding sequence (4 
exons) with iCre (figure 3.8). This was based on a similar construct used by 
Pierani et. al. (Pierani et al., 2001) to express lacZ under control of Dbxl by a 
‘knock-in’ approach. Recombination in bacteria was mediated via a 547bp region 
of 5’ homology located immediately upstream of (and including) the ATG in 
exon I and a 566bp 3’ region of homology that includes sequences immediately 
downstream of the D bxl stop codon in exon 4. In order to ensure the correct 
transcriptional initiation of iCre, the link between the 5’ homology and iCre was 
designed to include the endogenous ATG and the proximal promoter sequences 
of the Dbxl gene. The construct relied on endogenous stop and polyadenylation 
signals contained in the 3’ homology region. Positive selection for recombinant 
PAC clones was mediated via a chloramphenicol resistance cassette inserted in 
the targeting vector. This could be removed prior to the pronuclear injection of 
recombinant PACs into mouse ova.
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Not\ Chromosome 7 Not\ 3 ’
Hrmt1l3 Htatip2
S b h  
Dbx 1 Neuron na vigator 2 
isoform L (predicted)
100Kb 337-G15
-----------------------  351-F09
190Kb--------------------------------------- 465-114
130Kb---------------------------- 514-A19
150Kb _____
-------------------------------  582-G11
236Kb ' 631-M19
Figure 3.7 Diagram showing the chromosomal region around the D bxl locus including any Notl sites present plus other 
genes, predicted or known, found close to Dbxl (grey boxes). The relative positions of the genomic inserts in each PAC 
clone are shown along with their length as predicted by the genomic mouse sequence found at http://www.ensembl.org/ .
A. PAC 631 -M19
B. The Dbxl gene
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C. Linear targeting vector pDbxlTV
DbxIGenFi 0.5kb probe
Figure 3.8 (A) PAC 631-M19 showing the extent of upstream (5’) and downstream (3’) sequences, the location of the 
D bxl locus and the positions of the Notl restriction sites. (B) Schematic of the dbxl locus showing the intron-exon 
structure. (C) The pDbxlTV targeting vector used in homologous recombination showing the two regions of homology 
(grey boxes), the iCre gene and the jr t  flanked chloramphenicol cassette (Cm1). The position of the PCR primers 
DbxIGenFi and DbxlGenRl used for mouse genotyping as well as the location of the 0.5kb 3’ UTR probe used in these 
studies are shown.
Construction of the targeting vector is shown in figure 3.9. Initially, the 5’ 
homology region was amplified by PCR from the PAC DNA, adding Pad  and 
Ncol to the flanks (forward primer, 5’-TTA ATT AAC TAG TCT CAG CAG 
GAG GCC GCA G-3\ reverse primer, 5’-CCA TGG TTA GAG CGG GTC 
TGG CAG TAG CTC-3’). This PCR product was isolated and cloned directly 
into pCRII-TOPO® (Invitrogen) to make pD5Hom. The pBPacAsc vector was 
constructed by modifying the multiple cloning site (MCS) of pBluesscript to add 
Pad  and A sd  restriction sites. pBPacAsc was a gift from N. Kessaris and 
M.Grist. The iCre gene was isolated as two fragments in plasmids pPI14 and 
pPI17 which contained the 5’ and 3’ sections of iCre respectively. These 
fragments had been amplified by PCR from the original iCre gene and TOPO® 
cloned separately in order to allow cloning of the 5’ end using Ncol. The pPI14 
and pPI17 plasmids were a gift from N.Kessaris and P. Iannarelli. The 3’ 
homology of Dbxl was amplified by PCR from PAC DNA, adding A sd  and 
HindlU sites at either end (forward primer, 5’-AAG CTT AGG AGC CCC TCC 
AGC GGC TCT GGG-3’, reverse primer, 5’-GGC GCG CCG CTT GAT AGT 
GCT TTC CCC TTA GAC C-3’). The PCR product was purified and directly 
cloned into pCRII-TOPO® to make pD3Hom. pBCm contains the 
chloramphenicol cassette flanked by fr t  sites. This was a gift from M. Fruttiger. 
All PCR products were fully sequenced and all cloning steps were verified by 
restriction enzyme analysis. Once completed, the insert from the targeting vector 
was excised with P ad  and A sd  and used for homologous recombination.
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Figure 3.9 (A) Construction of the 
Dbxl targeting vector. The first step 
in construction was a quadruple 
ligation step combining the 547bp 
Dbxl 5' homology from pD5Hom, 
the 5’ 326bp of iCre from pPI14 and 
the 3’ 773bp of iCre from pPI17 
within a modified pBluescript vector 
called pBPacAsc to make pPrdl.
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Figure 3.9 (B) Construction 
of the Dbxl targeting vector 
(contd.). The Dbxl 3’ 
homology was cloned from 
pD3Hom into pPrdl to 
create pPrd2. A 
chloramphenicol resistance 
cassette flanked by two frt 
sites was then excised from 
'  Awn 2016 pBCm, blunted, and ligated 
Paci 2236 into pPrd2 via an EcoRV site 
Zr 234"9 which produces blunt ends.
This final step created the 
Dbxl targeting vector 
pDbxTV.
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3.2.4 PAC modification
PAC modification was carried out by homologous recombination in bacteria 
according to the method of Lee et. al (Lee et al., 2001) and as summarised in 
Chapter 2. Two rounds of recombination were carried out: firstly, sequences 
from the pPAC4 vector backbone that may interfere with expression of the 
transgene in mice were removed, and secondly, the coding region of Dbxl was 
replaced with that of iCre.
(a) pPAC4 (figure 3.10) contains an hCMV promoter and an SV40 poly A both of 
which may interfere with expression of the transgene. In addition a loxG site 
present in the vector may lead to undesirable recombination events in the 
presence of Cre. In order to remove these regions, homologous recombination 
was carried out in bacteria to replace an 850bp region from pPAC4 with an 
ampicillin selection cassette (figure 3.11). The targeting vector for this step was a 
gift from N. Kessaris and P.Iannarelli. Recombination was carried out according 
to the protocol outlined in Chapter 2 and resulting ampicillin resistant colonies 
were verified by Southern analysis as shown in figure 3.12. Seven out of eight 
colonies chosen had undergone correct recombination.
(b) To replace the coding region of Dbxl with that of iCre the purified targeting 
vector shown in figure 3.9 was used. Removal of the chloramphenicol resistance 
cassette from the recombined clones was carried out by transient induction of 
flpe in EL250 cells using arabinose according to Lee et al. (Lee et al., 2001). All 
modification steps were confirmed by Southern analysis as shown in figure 3.13.
3.2.5 Introduction of the recombined PAC 631-M19 into mouse ova.
The modified Dbxl PAC clone was linearised with Ascl and purified by PFGE as 
described in Chapter 2. DNA was quantified as shown in figure 3.14 and injected 
into fertilised mouse ova at a concentration of around lng/pl. All pronuclear 
injections were carried out by P. Iannarelli and U. Dennehy as described in 
section 2.1.7.2
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Figure 3.10 The pPAC4 vector into which all the genomic PAC inserts are 
cloned between the two BamHl sites, thereby removing the intervening 2.7Kb 
(reproduced from http://bacpac.chori.org/images/vectors/ppac4.gif).
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Figure 3.11 Summary of the strategy for removing sequences from the pPAC4 
vector backbone before introduction into transgenic mice. Upper: sequences 
removed from the pPAC4 vector. Lower: the targeting vector used.
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Figure 3.12 Southern analysis of DNA from PAC 631-M19 
following recombination to remove sequences from the 
pPAC4 vector backbone. The DNA was digested with Pstl. 
The probe used was complementary to the 5’ homology 
sequence used in the targeting vector. A 3kb band 
corresponding to unrecombined PAC is seen (white arrow). 
After recombination this shifts to 11 kb (black arrow). 7 of 
the PAC clones had recombined correctly. Clone 2 showed 
plasmid contamination (red arrow)
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Figure 3.13 Southern analysis of DNA from PAC 631-M19 
following recombination to replace the coding regions of Dbxl with 
that of iCre. DNA was digested with BglII. The blot was hybridised 
with probe complementary to the Dbxl 3’ homology from the 
targeting vector. The Unrecombined lane contains unmodified PAC 
DNA. The un ‘flped’ lane shows a clone that has been recombined 
with the iCre targeting vector but still contains the chloramphenicol 
resistance cassette. The fully recombined clones (1-6) have all been 
further modified by Flpe to remove the ^ -flanked  chloramphenicol 
cassette.
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Figure 3.14 Quantification of purified linear 
PAC DNA for microinjection. After 
purification, aliquots of 1, 3 and 5 pi of the 
DNA solution were run by PFGE along with 
5 pi of a standard (Std) preparation of PAC 
DNA that had been used in previous injections 
and had been found to produce transgenic 
animals. The DNA was diluted accordingly 
before injection.
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3.2.6 Screening litters for the presence of the DbxliCre transgene 
Pups derived from pronuclear injections were screened by PCR for the presence 
of the transgene and confirmed by Southern analysis of genomic DNA from tail 
biopsies. The PCR designed to amplify the DbxliCre transgene used a forward 
primer specific to the iCre gene (DbxIGenFi), and a reverse primer specific for 
the Dbxl 3’ homology (DbxlGenRl) as shown in figure 3.8. The sequences are 
shown in table 2.1. Figure 3.15 shows the genotyping for one of the litters. The 
presence of the transgene in mouse 3/3 was confirmed by Southern analysis of 
genomic DNA digested with Bglll and hybridised with the 3’ homology probe. 
The results are shown in figure 3.16.
In total 11 pregnancies were obtained by transfer of ova injected with DbxliCre. 
These pregnancies resulted in 58 animals being bom. 3 of these animals were 
found to contain the transgene. These animals were designated 3/3, 5/3 and 9/3 
and were used to generate three lines of DbxliCre transgenic animals.
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Figure 3.15 Mouse 
genotyping by PCR. Mouse 
3/3 showed the presence of a 
specific band at 700bp 
indicating the presence of the 
transgene. Diluted PAC DNA 
was used as a positive control 
(+ve). Wild type mouse 
genomic DNA (-ve) and water 
(H2O) were used as negative 
controls.
Mouse 
3/1 3/2 3/3 3/4
Controls 
+v -ve H20
Figure 3.16 Genotyping 
putative transgenic founder 
mice by Southern analysis. 
Genomic DNA from tails was 
digested with Bglll. The blot 
was hybridised to a probe 
specific for the D bxl 3’ 
homology region used in the 
targeting vector. The expected 
5250bp wild type band can be 
seen in all the samples. The 
2546bp transgenic band is 
only seen in sample 3/3.
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3.2.7 Assessing the expression and function of the transgene
The expression and function of the transgene was assessed in animals derived 
from founder 3/3 by in situ hybridisation and immunohistochemistry. Figure 3.17 
shows expression of Dbxl and iCre in serial sections from a DbxliCre embryo at 
El 1.5. The pattern of expression for the two genes is virtually identical 
indicating that iCre expression mimics that of Dbxl. At no point was iCre 
expression found to differ in pattern from that of endogenous Dbxl.
DbxliCre animals crossed to the Rosa26-GFP Cre reporter mouse were 
examined for expression of GFP. Figure 3.18 shows the limits of GFP expression 
at E10.5. GFP is activated in a domain broader than the region expressing Dbxl 
at E10.5. The width is reminiscent of the Dbx2 expressing domain and reflects 
the initial broad expression of Dbxl in four neuroepithelial domains (Pierani et 
al., 2001). Ventrally, the limit of this domain corresponds to the dorsal limit of 
Nkx6.1 expression and therefore the pl/p2 boundary (Briscoe et al., 2000). 
Dorsally there is slight overlap between the expression domain of GFP and those 
of Mashl and Pax7 which correspond to the dP5/6 and dP6/pO domain 
boundaries respectively (Caspary and Anderson, 2003;Gowan et al., 2001;Helms 
and Johnson, 2003). This indicates that the dorsal boundary of GFP activation is 
the dP4/dP5 boundary. Thus GFP activation occurs across the domains in which 
Dbxl and 2 are expressed, i.e. pi, pO, dP6 and dP5 (see also fig. 3.1). 
Importantly, as will be discussed later on, the domain of GFP activation is 
located away from the region of Olig2 expression which marks the pMN domain 
and the region of generation of motor neurons and oligodendrocytes in the spinal 
cord (Lu et al., 2000;Zhou et al., 2000).
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Dbx1 iCre
Figure 3.17 In situ hybridisation on serial 
sections from an E l 1.5 DbxliCre embryo. The 
expression of the transgene iCre is found in the 
same pattern as the endogenous Dbxl indicating 
that regulation of transgene expression is 
occurring as expected. Scale bar: 100pm
Figure 3.18 Defining the 
limits of GFP expression in 
DbxliCre x Rosa26-GFP 
offspring. (A-I) Serial 10pm 
sections through an E l0.5 
spinal cord subjected to in 
situ hybridisation with 
various probes (A, B, D, E 
and H, probes indicated) and 
immunohistochemistry for 
GFP or PAX7 (C, F ,G and 
I) (G) Double labelling for 
GFP (green) and PAX7 
(red). Brackets (A-C) 
indicate the approximate 
limits of the GFP expression 
domain. Horizontal lines 
indicate the ventral (D-F) or 
dorsal (H and I) limits of 
GFP expression. The ventral 
limit corresponds
approximately to the p2/pl 
boundary and the dorsal 
limit to the dp4/dp5 
boundary. Scale bar: 50pm.
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Figure 3.19 Defining the early neuronal progeny derived form the Dbx domain 
at E l2.5. (A) Cells expressing GFP migrate laterally (1), ventro-laterally (2) and 
ventrally (3) from the Dbx domain. (B-F) Double immunolabelling for (B) GFP 
(green) and ISL1/2 (red); (C) GFP and LIM3; (D) GFP and LBX1; (E) GFP and 
EVX1; (F) GFP and LIM 2. Scale bar: 100pm.
3.2.8 Defining the neuronal progeny of the 4Dbx domain’
To confirm that expression of the transgene is restricted to four neuroepithelial 
domains we examined neuronal populations generated from the 'Dbx domain’. 
As seen in figure 3.19 (A), GFP labelled cells migrate ventrally and laterally 
from the Dbx domain. Commissural axons labelled with GFP can also be seen in 
the developing white matter. Co-labelling with markers of post-mitotic neurons 
shows that Dbx precursors give rise to a subset of LBX1 -positive neurons which 
are known to derive from dP4, dP5 and dP6 (Muller et al., 2002). There is also 
colocalisation of GFP with the pO-derived EVX1-expressing neurons (Moran- 
Rivard et al., 2001). Extensive colocalisation is observed with LIM2 which is 
known to be expressed in a wide range of post-mitotic neurons (Tsuchida et al., 
1994). On the other hand there is no colocalisation with ISL1/2 which normally 
labels neurons derived from the pMN or dP3 (Tsuchida et al., 1994). Neither is 
there any colocalisation of GFP with LIM3 which normally labels p2- and pMN- 
derived neurons (Tsuchida et al., 1994). All these results agree with data from
99
previous studies, further demonstrating that the domain of GFP activation is 
restricted to the pi, pO, dP6 and dP5 domains of the VZ
Figure 3.20 Analysis of the contribution of the Dbx domain to the postnatal 
neuronal population. (A) Double immunohistochemistry for NEUN (red) and 
GFP (green) in the cervical spinal cord. The approximate positions of the first 
five laminae (I-V) of the dorsal horn are indicated. (B) Confocal microscopy 
image of the area boxed in (A). Scale bar: 300pm.
Analysis of the neuronal progeny of the Dbx domain using NEUN expression 
(Mullen et al., 1992) at later stages of development (figure 3.20) showed that 
roughly 10% of neurons in the spinal cord at postnatal day 10 (P10) are derived 
from the Dbx domain. Of that population, roughly 75% reside in the area of the 
medial ventral horn highlighted in the boxed region of figure 3.20. Rare Dbx- 
derived neurons are found scattered in the regions of lamina III (and possibly 
lamina II) of the dorsal horn. This is consistent with previous results indicating 
that intemeurons derived from dP5 and dP6 around E12 can migrate up to the 
superficial laminae o f the dorsal horn where they are involved in nociception 
(pain sensing) and temperature sensing (Caspary and Anderson, 2003). In 
addition dP5 and dP6 are known to contribute neurons to the deep dorsal horn 
(laminae IV and V) and the medial ventral horn (Caspary and Anderson, 2003), 
regions that pO and pi also contribute to (Moran-Rivard et al., 2001;Sapir et al., 
2004;Saueressig et al., 1999).
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3.2.9 A proportion of radial glial cells are derived from the Dbx domain
At E9.5 just before the first neurons begin to emerge from the Dbx- 
neuroepithelium, cells expressing GFP in DbxliCre x R26RGFP embryos appear 
to co-express the radial glial cell marker RC2 (Misson et al., 1988), suggesting 
that radial glial cells reside at the top of the Dbx lineage tree. Figure 3.21 shows 
the presence of GFP-labelled radial glial fibres at E10.5 (A-C). By E12.5 single 
GFP-expressing processes can be seen to extend from the ventricular zone to the 
pial surface (Fig. 3.21 D-I), as described by Camillo Golgi in 1885 (for review 
see Bentivoglio and Mazzarello, (1999)). From E16 onwards, RC2 labelled cells 
with GFP-expressing cell bodies appear to move their cell body towards the 
white matter directly opposite the Dbx domain in the ventricular zone (Fig. 3.21 
J-O). This apparent movement of cell bodies coincided with a general 
fragmentation and reduction in the levels of visible RC2 labelled fibres. 
Coexpression of RC2 and GFP continued up to around the time of birth when 
RC2 was down-regulated. Colocalisation of GFP with the radial glial marker 
GLAST (Shibata et al., 1997) was also visible until E l5.5 (data not shown) after 
which, staining in radial fibres was gradually lost.
Figure 3.21 (below). A population of radial glial cells are found to coexpress 
RC2 and GFP. (A-C) At E l0.5, GFP (green) expressing fibres are found across 
the width of the neuroepithelium (indicated by arrows in A). There are many 
RC2 (red) expressing radial glial fibres in the neural tube (B) some of which are 
also GFP labelled (C, arrows). (D,E) At E l2.5 long fine processes labelled with 
GFP extend from the ventricular zone to the pial surface (arrows, E is a 
magnification of the box in D). RC2 labelling at E l2.5 is seen extensively in 
radial glial processes (F, magnified in G). Some radial glial processes extending 
from the Dbx domain are double labelled for GFP and RC2 (H, magnified in I). 
GFP-expressing radial glial cell bodies appear near the pial surface at E l6.5 (J- 
L) and E l8.5 (M-O). Scale bars: in A and D, 100pm: in J, 50pm.
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Figure 3.22 (above). Astrocyte populations derived from the Dbx domain. (A) 
Typical fibrous astrocytes expressing GFAP (red) and GFP (green) appear in the 
lateral funiculus at PO (arrows), the same age at which RC2 staining is lost (see 
figure 3.18). (B) At P I2, a subpopulation of fibrous astrocytes in the lateral 
funiculus strongly expresses GFP and GFAP (arrows). (C) D&c-derived 
astrocytes expressing SlOOp (red) are found at PI in the medial grey matter 
(arrows). (D) By PI2, S 100P-expressing GFP positive astrocytes have adopted a 
typical protoplasmic astrocyte morphology, with a small SlOOp positive cell 
body and an extensively branched network of GFP-positive processes (arrows). 
(E) The Dbx-derived protoplasmic astrocytes (arrows) can be found interspersed 
amongst the NEUN positive neurons of the grey matter. (F) Some of the 
protoplasmic astrocytes found in the grey matter around the central canal weakly 
express GFAP (arrows). E and F are counterstained with Hoescht (blue). Scale 
bars: in A and B, 100pm: in C, 15pm.
3.2.10 Differentiated astrocytic cells derived from the Dbx domain
At the end of neurogenesis radial glial cells are thought to retract their process 
towards the pial surface and transform into astrocytes (Edwards et al., 
1990;Hartfuss et al., 2001;Misson et al., 1988). To examine whether this was the 
case we looked at expression of the astrocytic marker GFAP (Debus et al., 1983) 
at around the time of birth which is when radial glial cells disappear. Expression 
of GFAP was observed in a population of Z)fo-derived cells located in the lateral 
funiculus directly opposing the Dbx domain of the neuroepithelium (figure 3.22). 
This up regulation began at PO just as RC2 was down regulated in a population 
of Dfa-derived cells located in the same region. It is therefore likely that at least 
some of the RC2 positive radial glia derived from the Dbx domain are trans- 
differentiating into astrocytes (Voigt, 1989).
Another widely used marker for astrocytes is SlOOp, the p sub-unit of a 
cytoplasmic calcium binding protein (Matus and Mughal, 1975). Colocalisation 
of GFP and SlOOp can be seen at PI in cell bodies found in the medial grey 
matter and ventral horn grey matter (fig 3.22C). GFP and SlOOp colocalisation is 
also seen at this age in some radially orientated fibres that have end feet 
contacting the pial surface in the lateral funiculus (not shown). These cells are 
identical in appearance to the GFAP- or RC2-positive cells found in this location 
at this age providing further evidence that the radial glial cells upregulate 
astrocytic markers as they down regulate radial glial markers. By P12 the vast 
majority of SlOOp positive cells lose their radial processes and instead appear as
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small cell bodies in grey and white matter. Those SlOOp positive cells that 
colocalise with GFP possess a unique morphology characterised by a relatively 
small S100P- and GFP-positive cell body surrounded by a dense network of 
GFP-only positive processes (fig 3.22D). Given the distinctive morphology of 
these cells they have been classified as ‘protoplasmic’ astrocytes as opposed to 
the more ‘fibrous’ astrocytes found in the lateral funiculus. They were found to 
be intimately associated with NEUN positive neurons in the grey matter (fig. 
3.22E). A small proportion of the protoplasmic astrocytes were found to express 
low levels of GFAP in their thicker processes. These were found only near to the 
ependymal cells surrounding the central canal (fig 3.22F). Note that none of the 
ependymal cells themselves expressed GFP suggesting that these are not derived 
from the Dbx domain. This is consistent with information indicating that 
ependymal cells are derived from more ventral regions (Fu et al., 2003). Both 
protoplasmic and fibrous astrocytes derived from the Dbx domain are found in 
the adult mouse as well, indicating that the contribution of the Dbx domain to 
this lineage is a permanent feature (data not shown).
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3.2.11 A population of oligodendrocytes is generated by the Dbx domain.
As mentioned earlier, the Dbx domain of the neuroepithelium is located several 
cell diameters away from the pMN domain, which is thought to be the source of 
oligodendrocytes in the spinal cord (Agius et al., 2004;Lu et al., 2002;0no et al., 
1995;Pringle and Richardson, 1993;Sun et al., 1998;Takebayashi et al., 
2002;Timsit et al., 1995;Warf et al., 1991;Yu et al., 1994;Zhou and Anderson,
2002). We were therefore surprised to find that in DbxliCre x R26GFP mice, a 
subpopulation of cells expressing the oligodendrocyte markers SOX 10 
(Kuhlbrodt et al., 1998) and OLIG2 (Lu et al., 2000) in spinal cords were also 
co-expressing GFP indicating that these cells are derived from the Dbx domain. 
Figure 3.23 shows that near the pial surface of the spinal cord at E l5.5, a 
population of D&c-derived cells that are radially orientated and have RC2- 
positive processes start to co-express the oligodendrocyte marker OLIG2 (figure 
3.23 A-D). At E l6.5, cells with a radial glial morphology, RC2-positive and 
GFP-positive processes and a SOX 10 or OLIG2-positive nucleus are seen in the 
same region. (Figure 3.23 E-L). Between E16.5 and E18.5, radially orientated 
GFP-positive cells expressing oligodendrocyte markers continue to appear near 
the pial surface (figure 3.23 M-P). However, RC2 labelling is lost during this 
time, which is consistent with results discussed earlier. In total during this period, 
around 20% of all the radially orientated GFP-positive cells co-express 
oligodendrocyte markers. Cells that express RC2 as well as GFP and 
oligodendrocyte markers are much more difficult to find, making up only around 
20% of the GFP/OLIG2+ or GFP/SOX10+ population. This suggests that the 
triple labelled cells represent a transitional cell type that exists only as radial glial 
cells differentiate into oligodendrocytes. Once differentiated, the Dbx derived 
oligodendrocytes show a radial orientation until the time of birth.
To further confirm the generation of oligodendrocytes from the Dbx domain and 
to investigate their distribution at later developmental stages, spinal cords were 
examined for the expression of GFP and oligodendroglial markers at P10. Cells 
that co-expressed GFP and SOX 10 were concentrated mainly in the white matter 
of the lateral funiculus. Scattered cells were also found in other areas of the cord 
(figure 3.24 A-B). They were confirmed as cells of the oligodendroglial lineage 
by their expression of PDGFRa (Pringle et al., 1992). At least some of them had
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attained a more mature phenotype as indicated by their labelling with CC1, a 
monoclonal antibody against adenomatosis polyposis coli (APC) which is 
expressed in mature oligodendrocytes (Bhat et al., 1996), their cell bodies 
appearing more rounded with multiple processes. Counts indicated that they 
make up around 3% of the oligodendrocyte population of the spinal cord at this 
age.
In the adult mouse we found that expression of GFP driven by the Rosa26 
promoter diminishes, presumably due to a decrease in promoter activity. This 
made it difficult to study the contribution of the £>&c-domain to the adult 
oligodendrocyte population. To overcome this problem, a different reporter 
mouse strain called the Z/EG reporter was crossed to the DbxliCre transgenic 
mice. This reporter uses the promoter from the pCAGG vector (Niwa et al., 
1991) which contains the CMV enhancer and the chicken p-actin promoter. We 
demonstrate that GFP-expressing SOXlO+ve cells are found in spinal cords of 
adult animals at least up to 69 days after birth (figure 3.25A.) This indicates that 
the oligodendrocytes derived from the Dbx-dom&m are not transient and do make 
a long term contribution to the oligodendrocyte population of the spinal cord.
Nkx2.2 is one of the markers known to be expressed in the oligodendrocyte 
lineage (Qi et al., 2001). Vallstedt et. al. recently reported the existence of a 
dorsally-derived oligodendrocyte population from progenitor domains dP3, dP4 
and dP5 (Vallstedt et al., 2005). They suggested that this population may be 
molecularly distinct from the pMN-derived population based on the lack of 
NKX2.2 expression. To investigate whether the -Dfor-derived oligodendrocytes 
are indeed molecularly distinct from the pMN-derived population, we looked for 
co-expression of GFP and NKX2.2 in the adult spinal cord. Figure 3.25B clearly 
shows that at least a subset of Z)fo-derived oligodendrocytes expresses NKX2.2. 
This is consistent with the idea that NKX2.2 is a marker that is expressed 
transiently in oligodendrocytes at a specific stage of their maturation (R.Taveira 
Marques, unpublished observations). It is therefore unlikely that these cells are 
molecularly distinct from the ventrally derived oligodendrocytes, at least in terms 
of NKX2.2 expression.
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Figure 3.23 Oligodendrocytes are generated from Z)fo:-derived radial glia. (A-D) 
Some radially orientated GFP-positive cells express the oligodendrocyte lineage 
markers OLIG2 (A, C) and SOXIO (B, D) at E16.5 (A, B) and E18.5 (C, D). (E-P) 
Cells expressing the radial glial cell marker RC2 and GFP can also express OLIG2 
at E15.5 (E-H) and E16.5 (I-L) or SOXIO at E16.5 (M-P). Scale bar; 50pm.
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Figure 3.24 Dbx derived oligodendrocytes in the postnatal spinal cord. (A) 
GFP (green) and SOXIO (red) double labelling of a P10 spinal cord. (B) 
Higher magnification confocal microscopy view of the area highlighted in 
(A) showing clear GFP expression in a subset of the SOXIO positive cell 
population. (C) GFP and PDGFRa double labelling at P10. (D) Double 
labelling with anti-GFP and the CC1 monoclonal antibody that recognises 
APC found in differentiated oligodendrocytes. Scale bar; 300pm.
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Figure 3.25 Oligodendrocytes in an adult (P69) DbxliCre x Z/EG animal. (A) 
Double labelling for GFP and SOXIO shows the presence of GFP+ SOX 10+ 
oligodendrocytes in the lateral funiculus of the spinal cord. (B) Double labelling 
for GFP and NKX2.2 shows colocalisation in a subset of the Dbx-derived 
oligodendrocytes in the lateral funiculus. Scale bar, 100pm.
3.2.12 Dbx derived oligodendrocytes develop independently of sonic 
hedgehog signalling
Specification of oligodendrocytes in the pMN domain of the ventral spinal cord 
is dependent on Shh signalling (Orentas et al., 1999;Poncet et al., 1996;Pringle et 
al., 1996). Recent work in our laboratory and others has implicated a role for 
FGF in inducing oligodendrocytes from embryonic spinal cord and cerebral 
cortex in vitro (Chandran et al., 2003;Kessaris et al., 2004). To determine signals 
responsible for inducing oligodendrocytes from the D&c-expressing cells we 
dissociated spinal cord cells from DbxliCre x R26RGFP mice at E l2.5 and 
cultured in the presence of the inhibitor of Shh signalling cyclopamine (Cooper 
et al., 1998;Incardona et al., 1998) or the FGFR inhibitor PD173074 (Incardona 
et al., 1998). In the absence of inhibitors, GFP-expressing oligodendrocytes were 
generated within 5 days (as assessed by expression of SOXIO, see figure 3.26 A, 
E). This compares well with the in vivo timescale for Z)fo;-derived 
oligodendrocyte production. In addition, the proportion of Dfo-derived 
oligodendrocytes found as a percentage of the total number of oligodendrocytes 
is similar to the in vivo results. Incubation with the Shh inhibitor cyclopamine 
had no significant effect on the proportion of GFP-expressing oligodendrocytes 
(Fig. 3.26 B, E) whereas the FGF inhibitor PD174073 alone or together with
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cyclopamine led to an almost complete abolishment of Dfoc-derived 
oligodendrocytes in the cultures (Fig 3.26 C-E). This suggests that Shh is not 
required for oligodendrocyte generation from Dbx-expressing precursors in vitro 
and FGF may provide an alternative inducing signal.
control dopamine
Control Cyclopamine PD173074 PD173074
+ Cyclopamine
PD 173074
+ cyclopamine
Figure 3.26 Dfoc-derived oligodendrocytes develop independently of Shh 
signalling. (A) Dissociated spinal cord cultures from DbxliCre x Rosa26-GFP 
embryos develop SOX10+ GFP+ OLPs within 5 days of culture. (B) Dbx- 
derived OLP development was not inhibited by cyclopamine but was inhibited 
by PD 173074 (C) or both inhibitors together (D). (E) The inhibition was 
quantified by sampling at least 1000 SOX 10+ cells per coverslip and counting 
how many of these expressed GFP. Similar data was obtained in two 
independent experiments.
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3.3 Discussion
Using Cre-loxP technology we have fate-mapped the Z)£x/-expressing domain of 
the mouse spinal cord and shown that it generates neurons, astrocytes and 
oligodendrocytes. Radial glia are first generated followed by VI and VO 
interneurons at E l0.5. At the time when down-regulation of radial glial markers 
begins (E l5.5) a population of Dfoc-derived cells shows transient coexpression of 
radial glial and oligodendroglial markers. This upregulation of oligodendroglial 
markers occurs three days after production of OLPs from the pMN domain 
(E12.5). Dfar-derived oligodendrocytes mainly populate the lateral funiculus, but 
can also be found scattered in other areas. Their specification in vitro is 
dependent on FGF signalling but independent of Shh. As radial glial markers are 
down-regulated astroglial markers are turned on. The Dbx-derived GFAP 
positive cells are concentrated in the lateral funiculus, but are also observed in 
the grey matter. A small population of Dbx-derived GFAP-positive cells was 
found in proximity to the ependymal cells lining the central canal. A second 
population o fDbx-derived astrocytic cells was found to express SlOOp and either 
very little or no GFAP. These cells were characterised by a small cell body 
surrounded by an extensively branched mass of processes. These were identified 
as protoplasmic astrocytes, as opposed to the GFAP positive fibrous astrocytes.
3.3.1 Oligodendrocytes are produced outside the pMN domain
It is widely accepted that the pMN domain of the neuroepithelium gives rise to a 
major population of spinal cord oligodendrocytes (Agius et al., 2004;Lu et al., 
2002;0no et al., 1995;Pringle and Richardson, 1993;Sun et al., 
1998;Takebayashi et al., 2002;Timsit et al., 1995;Warf et al., 1991 ;Yu et al., 
1994;Zhou and Anderson, 2002) and that induction of OLPs from the pMN 
domain requires Shh signalling (Orentas et al., 1999;Poncet et al., 1996;Pringle 
et al., 1996;Lu et al., 2002;Takebayashi et al., 2002;Zhou and Anderson, 2002). 
There has been some controversy though. Histological studies had suggested that 
oligodendrocytes could derive from radial glia and that given the ubiquitous 
nature of radial glia throughout the embryonic neuroepithelium, this implied that 
oligodendrogenesis might occur anywhere (Choi and Kim, 1985;Choi,
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1983;Hirano and Goldman, 1988). Studies using LacZ expressed under the 
transcriptional control of the myelin proteolipid protein gene suggested there 
might be dorsal sources of OLPs at least in the cervical spinal cord (Spassky et 
al., 1998). There were also controversial results from chick-quail chimeras that 
raised the possibility of dorsal OLP sources in birds (Cameron-Curry and Le 
Douarin, 1995;Pringle et al., 1998;Richardson et al., 1997). Dorsal 
oligodendrogenesis therefore remained a possibility, even though many had 
discounted it. Our results have gone a long way to settling the argument by 
demonstrating conclusively that oligodendrocytes are produced in regions other 
than the pMN domain in the spinal cord, but that during normal development 
these contribute a minor population compared to the pMN-derived 
oligodendrocytes.
Concurrent with publication of our data (Fogarty et al., 2005), two other papers 
were published that also reported the production of oligodendrocytes from 
regions distinct from the pMN domain (Cai et al., 2005;Vallstedt et al., 2005). 
Cai et al (Cai et al., 2005) examined Nkx6.1 and Nkx6.2 double mutants and 
found that normal expression of Olig2, the gene primarily responsible for OLP 
specification, was completely abolished at E10 and E l2.5 in the pMN domain. 
By E l4.5 though, OLIG2+ cells could be found in more dorsal regions of the 
cord, and by E l8.5 these dorsal OLIG2+ cells had migrated all over the cord, 
albeit in significantly lower numbers than OLPs in wild type cords. These dorsal 
OLIG2+ cells express other markers of the oligodendrocyte lineage such as 
SOXIO and PDGFRa at around E l8.5. The authors further claimed to have 
mapped the origin of the dorsal OLPs to the dI3-dI5 domains. They state 
however that no OLPs are generated from Dbx2- or -expressing 
neuroepithelium, which is surprising in light of our results. They further provide 
evidence that dorsal OLPs might be generated independently of Shh signalling. 
This conclusion was based on experiments using Shh knockout animals and in 
vitro studies using smo knockout ES cells and an anti-Shh antibody with spinal 
cord explant cultures. Due to the lethal nature of the Nkx6 double knockout 
phenotype, in vivo experiments were impossible after P0. Note that neither these 
data nor our own showing induction of D&c-derived oligodendrocytes by FGF in
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culture (see above) provide definitive proof that SHH or another hedgehog 
family member is not required in vivo.
Vallstedt et al (Vallstedt et al., 2005) provide similar evidence. They use explants 
of wild type dorsal spinal cord and Nkx6 mouse mutants to argue the presence of 
a dorsal source of OLPs. They further suggest that the dorsally derived OLPs are 
antigenically distinct from the ventrally derived ones in that the dorsal OLPs do 
not express Nkx2.2.
The above results mirror the results of our own studies showing a dorsal source 
of oligodendrocytes. There are however some discrepancies. We found 
expression of OLP markers from E l5.5, not E14.5 (Cai et al., 2005;Vallstedt et 
al., 2005), and we found SOXIO expression, from E16.5 onwards, not E18.5 
onwards. We demonstrate that cells of the Dbx gene lineage give rise to 
oligodendrocytes, while Cai et al state that neither Dbxl or Dbx2 expressing cells 
produce OLPs. There is also the issue of where these cells first appear. Both 
groups mentioned above find cells expressing OLP markers close to the 
ventricular zone where they coexpress markers of dorsal progenitors such as 
PAX7 and MASH1. We, on the other hand, find that the Dfo-derived OLPs first 
express OLP markers in the lateral margins of the grey matter, and more 
commonly the lateral fimiculus. Additional experiments in postnatal animals 
have allowed us to show that at least some Dfo-derived oligodendrocytes express 
Nkx2.2, contradicting the findings of Vallstedt et. al. that dorsal 
oligodendrocytes do not express Nkx2.2. We found no evidence that the dorsally 
derived oligodendrocytes represent a molecularly distinct population of 
oligodendrocytes. Further analysis of their function by electrophysiology will 
determine whether they represent a functionally distinct population.
There are various explanations for the discrepancies found between our results 
and the most likely is that Cai and Vallstedt have based their observations on 
knockout animals. Under normal conditions, dorsally-derived OLPs generated at 
E l5.5 compete with a pre-existing population of ventrally derived OLPs for 
growth factors (van Heyningen et al., 2001). This limits the amounts of growth 
factors available for dorsal OLPs and probably results in slower division, slower
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maturation and relatively little proliferation. This might explain why in the 
absence of the ventrally derived cells (e.g., in Nkx6 mutants), dorsally derived 
OLPs appear early (E14.5) and close to the ventricular zone. The fact that no 
Dbx-derived OLPs were seen (Cai et al., 2005) could be simply be due to a 
technical issue or the result of altered patterning of the neuroepithelium. The 
possibility that dorsal OLPs are antigenically distinct is unlikely. NKX2.2 
expression in oligodendrocytes is believed to occur later in development than the 
expression of other markers (R. Taveira-Marques, personal communication), 
quite possibly after E l8.5. Given that Nkx6 mutants die at birth, it is not 
surprising that dorsally derived OLPs did not show NKX2.2 expression 
(Vallstedt et al., 2005).
3.3.2 Dorsal oligodendrogenesis does not require Shh
Our in vitro data concerning the signalling involved in dorsal oligodendrogenesis 
are quite consistent with the other recent reports. Given the relative distance of 
the site of specification of dorsal OLPs from the source of Shh in the spinal cord, 
it makes sense that both ourselves and Cai et al (Cai et al., 2005) found that 
dorsal oligodendrogenesis might be independent of Shh signalling. Vallstedt et al 
(Vallstedt et al., 2005) show additionally that BMP signalling must be absent for 
oligodendrogenesis to occur in vitro in Nkx6 null cultures. This is consistent with 
our results showing that Dfo-derived OLPs are induced late in embryogenesis 
and in a lateral region, some distance from the roof plate, the source of BMP 
signalling. Work by Kessaris et al (Kessaris et al., 2004) and Chandran et al 
(Chandran et al., 2003) showed that FGF2 is able to induce oligodendrogenesis 
in neocortical cultures or from neurospheres derived from spinal cord. This led 
us to investigate whether FGF signalling was required for Dfo-derived 
oligodendrogenesis, and indeed we found that it was. Neither Cai et al or 
Vallstedt at al directly addressed the role of FGF signalling. Given this in vitro 
evidence for FGF signalling in oligodendrogenesis it is likely that it plays a role 
in vivo.
At this time although retinoids have been previously implicated in both induction 
(Staines et al., 1996;Tokumoto et al., 1999) and repression (Laeng et al., 
1994;Noll and Miller, 1994) of OLP differentiation, no one has addressed the
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possible role of retinoid signalling in dorsal oligodendrogenesis. The Dbx genes 
can be specified via a retinoid induced pathway (Pierani et al., 1999) which may 
also affect Dbx derived OLP specification. In addition, the site of Dfo-derived 
OLP specification is not far from the paraxial mesoderm, a source of retinoic 
acid in the embryo. Certainly paraxial mesoderm is closer than other major 
organising centres that secrete BMPs and Shh (the roof plate and floor plate 
respectively). It would therefore be interesting to study the effects of retinoids on 
the differentiation of these cells.
3.3.3 Oligodendrocytes differentiate directly from radial glia
D&t-derived radial glia cells can be found from E9.5 to the end of embryogenesis 
when the marker RC2 is down-regulated. Their cell bodies are initially located in 
the ventricular zone and their processes extend all the way to the pial surface. As 
the cord expands, radial glia translocate their nuclei towards the pial surface. At 
the time of this transition around E l5.5 we observed the upregulation of OLP 
markers in some radial glial cells. The production of OLPs from radial glia has 
been suggested previously (Choi and Kim, 1985;Choi, 1983;Hirano and 
Goldman, 1988) We now show that this occurs in the spinal cord in vivo. 
Admittedly the numbers of the OLP/radial glial cells were low, with only 20% or 
less of the radial glial cells formed within the D&c-domain expressing OLP 
markers. This is consistent with this cell type being transitory, only existing for a 
brief period before the radial glial phenotype is lost. Comparison with 
oligodendrogenesis in the pMN domain highlights an apparent difference 
between the modes of oligodendrogenesis, with pMN-derived OLPs being 
specified in the ventricular zone and Dfa-derived OLPs only appearing well 
outside the VZ. It is not known whether this represents a fundamental difference 
in the way that specification is occurring, or whether it is merely a question of 
timing. It would be interesting to see if the transitory radial glia/OLP cell can be 
found in the pMN domain.
It appears that the Dbx derived OLPs migrate less than their pMN derived 
counterparts, since they concentrate in the lateral funiculus rather than spreading 
through the cord. It can reasonably be argued, however, that given their late 
appearance, they enter an environment that is already highly populated with
116
OLPs and so they receive less migration-stimulating signals. It is of course 
possible that differing behaviours of the two populations reflect the fact that they 
represent different types of oligodendrocyte and therefore have different roles. 
Further work is required to investigate this.
3.3.4 The Dbx-domain gives rise to two distinct astrocyte populations
In addition to neurons and oligodendrocytes, the Dbx domain gives rise to at least 
two populations of antigenically and morphologically distinct astrocytes. One of 
these, the fibrous astrocyte, strongly expresses the astrocytic marker GFAP 
(Debus et al., 1983). These cells are concentrated in the white matter at the 
lateral funiculus in the same area as most of the Dbx derived oligodendrocytes. In 
fact, they are located in exactly the same positions as the pial ends of the radial 
glial processes. Given their appearance just as radial glial markers in this region 
are down regulated, it is very likely that they differentiate directly from radial 
glial cells. This would certainly be consistent with previous reports (Goldman, 
2001;Schmechel and Rakic, 1979;Voigt, 1989). We cannot be certain which 
domain is responsible for producing these astrocytes because we are labelling 4 
separate domains. It is not unlikely, however, that radial glia from all 4 domains 
give rise to fibrous astrocytes. Further Cre mouse lines will need to be created to 
refine the origins of these, and indeed all the cell types derived from Dbx 
progenitors.
The second astrocytic cell derived from the Dbx domain has a small spherical 
cell body which can be labelled with SlOOp and is surrounded by a dense 
network of fine processes. These cells are located throughout the grey matter of 
the cord, frequently associated with motomeurons and/or intemeurons. 
Expression of GFAP in cells with this morphology was rare, and any expression 
seen was at much lower levels than in the fibrous astrocytes of the white matter.
We also show that none of the ependymal cells that surround the central canal of 
the postnatal spinal cord express GFP and are therefore not derived from Dbx 
progenitors. This agrees with previous work showing that the ependymal cells 
are derived from the more ventral Nkx6. /-expressing neuroepithelium (Fu et al.,
2003). Ependymal cells are likely to represent a supportive niche for adult stem
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cells in the spinal cord (Fu et al., 2003) It is striking that Z)foc-derived astrocytes 
can always be found in close association with the ependymal cells (see Fig 
3.20F). The adult stem cells themselves are thought to correspond to 
subependymal cells (Doetsch et al., 1999). Perhaps the DZ>x-derived 
subependymal astrocytes correspond to a subset of adult neural stem cells, but 
this remains to be determined.
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Chapter 4
Msx3 transgenesis
4.1 Introduction to Msx3
Msx3 was identified as a mouse homeobox gene related to MsxJ and Msx2, all of 
which contain homeodomain sequences similar to the Drosophila msh (muscle 
segment homeobox) gene (Holland, 1991;Shimeld et al., 1996;Wang et al., 
1996). Msx3 is located on chromosome 7 and consists of two exons. The highly 
conserved homeobox sequence is 98% identical to the M sxl homeobox and is 
located in exon 2 (Wang et al., 1996). Msx3 expression is restricted to the dorsal 
third of the neural tube and starts at around E8. Expression is found only in the 
spinal cord and hindbrain regions and is largely excluded from the roof plate 
(Shimeld et al., 1996). Expression ceases around E l4.5.
In the neural tube, the Msx gene family appears to be involved in dorsal neural 
tube patterning by mediating the effects of BMP signalling from the roof plate 
(Davidson, 1995;Timmer et al., 2002). Initially, M sxl expression is probably 
induced by BMPs (Lee et al., 2000;Liu et al., 2004;Suzuki et al., 1997) and M sxl 
is subsequently thought to be involved in repressing the adoption of a neuronal 
cells fate by repressing the expression of pro-neurogenic genes such as M ashl 
and Mathl. Indeed unpublished results discussed in Liu et al., (2004) suggest that 
MSX1 regulates Mashl and M athl by binding their enhancer regions and 
repressing their expression. Msx3 expression begins later in development, and is 
probably also induced by BMP signalling. It is thought that MSX3 represses 
M sxl expression therefore de-repressing M athl and Mashl expression and 
allowing these pro-neurogenic genes to specify the production of the dorsal 
interneuron sub-types (Liu et al., 2004). This model is incomplete however and
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will require modification to take into account various other factors, for example 
the existence of long and short isoforms of Msx3 (Wang et al., 1996) and the 
possibility of an antagonistic interaction between the two (Matsui et al., 2004). 
These studies will be greatly aided by the production of the Msx3 knockout 
mouse.
Cells that express Msx3 have been shown to give rise to various intemeuron 
subtypes in the dorsal spinal cord and overexpression of Msx3 leads to the 
specification of dorsal interneuron subtypes at the expense of more ventral ones 
(Liu et al., 2004). Whether or not Msx3 expression occurs in glial precursors is 
not clear and certainly there is no information regarding a role for Msx3 in glial 
specification. It seems likely however that at least some of the regions of the 
dorsal neural tube where Msx3 expression occurs will give rise to glial cells, 
particularly astrocytes. Questions also remain over the possibility of dorsal 
sources of oligodendrocytes, especially in light of the results discussed in 
Chapter 3. To fully characterise the glial cell types that arise from the dorsal 
neural tube, we used Cre-loxP technology to permanently label the Msx3 lineage. 
We show that the Msxi-expressing dorsal neural tube gives rise to different 
populations of astrocytes and contributes significantly to the oligodendrocyte 
population of the spinal cord, particularly in the dorsal white matter tracts.
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4.2 Results
4.2.1 PAC clone screening
To identify a genomic PAC containing the Msx3 gene we screened the Mouse 
PAC (RPC 121) library with a cDNA probe specific for Msx3. The probe used 
was a 662bp fragment BglII -  Notl fragment from IMAGE clone 468340 
spanning the 3’ UTR plus a small portion of the 3’-most coding sequence of 
Msx3 (figure 4.1). When used as a probe on a Southern blot of mouse genomic 
DNA digested with EcoRl or Hindlll, bands of expected size were obtained 
(figure 4.2) confirming the specificity of the probe. From the PAC library screen, 
two clones were found to hybridise to Msx3. These were 402-G09 and 572-F04. 
They were purchased from the UK HGMP Resource Centre and further 
characterised.
4.2.2 PAC clone characterisation
To confirm that the PAC clones contained the Msx3 gene, DNA was prepared 
from them and digested with EcoRl. The digests were analysed on Southern blots 
hybridised with the Msx3 specific probe in order to verify the presence of the 
Msx3 gene in the PAC insert. Both clones contained the gene of interest (figure 
4.3). In order to determine the size of the genomic insert each PAC clone carried, 
the PAC DNA was digested with Notl to release the insert. Digested PAC DNA 
was analysed by PFGE which indicated that PAC 402-G09 contained an insert of 
around 125kb and PAC 572-F04 contained an insert of around 173kb (figure 4.4)
Inverse PCR was then performed followed by sequencing of the PCR products 
and comparison of the sequences to the published mouse genome 
(www.ensembl.orgl in order to determine the precise length and region of 
genomic DNA that each clone contained. Blast comparison of the sequence 
obtained for PAC 402-G09 indicated that it contained a 135kb insert with a 64Kb 
region upstream (5’) of Msx3 and a downstream region of 68Kb. The Ensembl 
sequence of this genomic region contains a single Notl site located around 42Kb 
from the 3’ end of the sequence (figure 4.5).
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Figure 4.1 Schematic diagram of IMAGE clone 468340 which 
contains the entire Msx3 open reading frame (ORF) and 3 ’ untranslated 
region (UTR) inserted between the EcoRI and Notl sites of the pT3T7 
vector. A 662bp BglII -  Notl fragment was used as a probe to screen 
the genomic PAC library.
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Figure 4.2 Southern 
analysis of mouse genomic 
DNA digested with Hinctlll 
and EcoRI and hybridised to 
a probe complementary to 
the 3’ ORF and 3’ UTR of 
Msx3. The appearance of the 
expected bands at 17.5kb 
and 12.5kb (arrows) for the 
Hindlll and EcoRI digests 
respectively demonstrates 
that the probe is specific to 
this gene. M indicates the 
marker lane.
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Figure 4.3 Southern blot of PAC DNA digested with 
EcoK\ and hybridised to the Msx3 probe. The 
expected 12.5Kb band can be seen indicating these 
PACs contain the Msxrigene.
194Kb
145Kb
97Kb
48.5Kb
23.1Kb
9.4Kb
6.6Kb
PAC Insert I Insert 2 Total Insert Size
402-G09 35Kb -90Kb -125Kb
572-F04 ~38Kb ~135Kb ~173Kb
Figure 4.4 (A) PFGE analysis of PAC DNA digested with 
Noll reveals that each clone contains two inserts plus the 
16Kb PAC vector band (B) Table showing estimations of 
the size of each fragment and the calculated total insert 
size.
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Figure 4.5 Schematic diagram summarising the results from the inverse PCR analysis of the PAC clone containing the 
Msx3 gene. The top schematic shows a 200Kb portion of chromosome 7 centred on the Msx3 locus including II sites 
plus other genes found close to Msx3 (grey boxes). The relative position of the genomic insert in PAC 402-G09 is 
shown below that. The schematic is to scale with 1cm = 10Kb.
Unfortunately, repeated cloning and sequencing of the inverse PCR fragments 
attained from PAC 572-F04 failed to yield fragments that correspond to genomic 
sequences around Msx3. One PAC end appears to be located 22Kb upstream of 
Msx3. Sequencing of fragments supposedly located at the other end of the PAC 
insert gave a variety of conflicting results. Some of these were undoubtedly due 
to contamination with other DNA fragments that were being manipulated in the 
laboratory. However we repeatedly obtained results locating the PAC insert end 
to a region of chromosome 2, which was surprising given that Msx3 is located on 
chromosome 7. Other results repeatedly placed the PAC end further upstream, 
around 165kb from the Msx3 gene. Assuming that the Ensembl genomic 
sequence is correct, this would indicate that PAC 572-F04 contains an insert that 
does not include the Msx3 locus, a result contradicted by our Southern blot data. 
Note however that the hybridisation of the Msx3 probe to digests of PAC 572- 
F04 was far weaker than the hybridisation to PAC 402-G09 (figure 4.3). This 
could indicate that this PAC contains a gene that is similar to Msx3. An 
alternative explanation is that a recombination event has occurred during or after 
the cloning of this PAC insert, creating a stretch of DNA that is organised in a 
different way to the endogenous genomic DNA around the Msx3 locus. PAC 
402-G09 however was a very suitable target for homologous recombination.
4.2.3 Construction of the targeting vector
In order to manipulate PAC 402-G09 in bacteria by homologous recombination, 
a targeting vector was designed that would insert iCre into exon 1 ofMsxi fusing 
the Msx3 ATG to iCre as illustrated in figure 4.6. This was mediated via a 477bp 
region of homology located immediately upstream of and including the Msx3 
ATG and a 570bp region of homology located immediately downstream of the 
Msx3 ATG. The 3’ end of the 5’ homology was modified slightly, adding a 
cytosine and an adenine residue immediately upstream (5’) of the Msx3’s ATG. 
This resulted in the creation of a Kozak sequence and an Ncol site incorporating 
the ATG. This Ncol site could then be used to fuse the 5’ homology to the ATG 
of iCre via the Ncol site found at the 5’ end of the 5’ iCre vector pPI14. An 
SV40 pA signal was inserted immediately 3’ of the iCre gene to ensure correct 
termination of transcription and post-transcriptional modification. Positive 
selection for recombinant PAC clones was mediated via a chloramphenicol
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resistance cassette. This was removed prior to the pronuclear injection of 
recombinant PACs into mouse ova.
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Figure 4.6 (A) Diagram showing the structure of theM sxi locus including the Spe I sites. Black boxes indicate exons, white boxes 
indicate untranslated regions. The hashed region indicates the portion of the 3’ UTR contained in IMAGE clone 468340. (B) The 
targeting vector used to insert the iCre gene, along with a chloramphenicol resistance cassette (Cm1) flanked by fr t sites (black 
triangles), intoM sxi. Also indicated is the 0.5Kb probe used in these studies. Grey boxes indicate regions of homology. (C) The 
MsxS locus after correct homologous recombination.
The strategy for construction of the targeting vector is summarised in figure 4.7. 
The SV40 pA signal was PCR amplified from pEGFP-F (Clontech) adding Pstl 
and SadI sites to the 5’ end and an Spe I site to the 3’ end (Forward primer, 5’- 
CTG CAG CCG CGG GAT CAT AAT CAG CCA TAC CAC-3’, reverse 
primer, 5’-GGA CTA GTT TAA GAT ACA TTG ATG AGT TTG G-3’). This 
was TOPO cloned directly into the pCRH-TOPO® (Invitrogen) to make 
pMSV40pA. The 3 ’ homology region was PCR amplified adding a Pad  site to 
the 3’ end and a Notl site to the 5’ end (forward primer, 5’-GCG GCC GCA 
CAT TCG ACA TGA ACG CGG C03\ reverse primer, 5’-TTA ATT AAG 
GGG TGC AGG AGC GTG AGC GAC CC-3’). This PCR product was TOPO 
cloned to create pM3’Hom. The 5’ homology region was PCR amplified adding 
an A sd  site to the 5’ end and modifying the 3’ end to include a Kozak sequence 
and an Ncol site (forward primer, 5’GGC GCG CCA CTG TGC CAG CAA 
AGA ACT GAT G-3’, reverse primer, 5’-GTC GAC CAT GGT TGG GAT 
GGC GGG TGC GGG GCT AG-3’). This was TOPO cloned to create 
pM5’Hom. The pSL1180 vector was obtained from GE Healthcare. The origins 
of the other plasmids are described in Chapter 3. All PCR steps were fully 
sequenced and cloning steps were verified by restriction enzyme analysis. Once 
completed the targeting vector was linearised with A sd  and P ad  and used for 
homologous recombination.
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4.2.4 Homologous recombination of PAC 402-G09
Homologous recombination was carried out in a bacterial system according to 
the method of Lee et. al (Lee et al., 2001) and as summarised in Chapter 2. As 
with the DbxJ transgenesis (see Chapter 3) two rounds of recombination were 
carried out:
(a) Sequences from the pPAC4 vector that might interfere with expression of the 
transgene in mice were replaced with an ampicillin resistance cassette (figure 
3.11). This was carried out as detailed in section 3.2.4. The resulting ampicillin 
resistant colonies were verified by Southern analysis as shown in figure 4.8. 
Colony 1 was picked for further manipulation.
(b) The iCre gene was inserted into the Msx3 gene locus via homologous 
recombination using the targeting vector described in section 4.2.3 and according 
to the method outlined in section 3.2.4. Agarose gel electrophoresis analysis of 
chloramphenicol resistant clones indicated that 2 of the 11 clones picked 
contained plasmid DNA (figure 4.9). Uncontaminated clones #1 and #7 were 
chosen and the chloramphenicol resistance cassette removed by transient 
induction of FLPe by arabinose treatment of EL250 cells according to the 
method of Lee et al (Lee et al., 2001). Southern analysis indicated all clones 
tested had undergone successful recombination (figure 4.10).
4.2.5 Introduction of recombined PAC 402-G09 into moue ova
Large quantities of recombinant PAC DNA were produced by PAC maxiprep. 
This DNA was then linearised with Ascl (see section 3.2.5 and figure 4.11). 
Purified linear DNA at around lng/pl was then injected into fertilised mouse 
eggs by P. Iannarelli and U. Dennehy.
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Figure 4.8 Southern blot of Pstl digested PAC clones after recombination 
with the ampicillin targeting vector to remove unwanted regions of the 
pPAC4 vector sequence. A and B represent unrecombined control clones. 
Numbers 1 to 11 indicate successfully recombined clones that have lost the 
normal band at 3Kb and have only a recombined band at 11Kb. The probe 
used was specific to the 5’ homology region of the ampicillin targeting 
vector (see figure 3.9 for details).
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Figure 4.9 Agarose gel electrophoresis of PAC clone minipreps 
digested with Spe I to check for plasmid DNA contamination. 
Clones 2 and 4 are contaminated with plasmid DNA as 
indicated by bands smaller than lOkb. The rest of the clones 
appear to contain only PAC DNA (>10Kb in size).
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Figure 4.10 Southern blot of Spel digested PAC DNA hybridised with a probe 
specific to the 3’ homology region of the Msx3iCre targeting vector. Wild-type 
(unrecombined) PAC DNA shows a band at 6kb. Recombined PAC DNA before 
the removal of the chloramphenicol cassette (un’flped’) gives a band at 1.7kb due 
to the introduction of an Spe I site by the targeting vector construct. After 
recombination and removal of the chloramphenicol cassette the band seen is 
reduced in size again to around 0.4kb. All clones gave the expected bands. A 
secondary band is seen in all samples at >10Kb. The region covered by the 3’ 
homology section used to make the probe is bisected in two by an Spe I site. 
Therefore the >10kb band found in all lanes is thought to be due to the probe 
hybridising to a 17Kb fragment that includes the 3’-most 150bp of the 3’ 
homology region.
3|jl 5[jl Std
194Kb
145Kb
97Kb
48 5Kb 
23.1Kb
Figure 4.11 PFGE of purified ^el-digested 
recombinant PAC 402-G09 (3 pi and 5 pi) run 
alongside a standard, previously injected PAC 
preparation for comparison.
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Figure 4.12 Results of the first genotyping PCR for the 
Msx3iCre founder mice indicating that animal 1/1 contains the 
transgene. The positive controls used were dilutions of 
transgenic PAC DNA in wild type genomic DNA. The negative 
control was wild type genomic DNA.
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4.2.6 Screening founder litters for the presence of the Msx3iCre transgene 
Screening of founder litters was carried out using PCR to detect the presence of 
the transgenic DNA in extracts from mouse tail biopsies. The PCR designed to 
amplify the Msx3iCre transgene used DbxGenFl as the forward primer specific 
to the iCre gene (see section 3.2.6). The reverse primer, Msx3GenR2, was 
specific for a region of genomic DNA located immediately 3’ of the end of the 
Msx3iCre 3’ homology. (For primer sequences see table 2.1.). Figure 4.12 shows 
the results from the PCR genotyping of the first litter of putative founders, 
indicating that founder 1/1 contains the Msx3iCre transgene.
In total 8 pregnancies were obtained from transfer of injected ova. These resulted 
in 33 pups being bom of which 8 were found to contain the transgene. One of 
these founders died shortly after birth, while another failed to transmit the 
transgene to its offspring. A third founder was unable to produce live offspring 
although pups appeared normal up to late developmental stages. Of the 
remaining 5 founders, two were studied in greater detail (1/1 and 3/2) and were 
found to produce identical patterns of iCre and GFP expression. The work 
discussed below was carried out using the line derived from 1/1.
4.2.7 Assessing the expression and function of the transgene
Characterisation of the expression of the transgene was carried out by in situ 
hybridisation analysis on serial sections for both Msx3 and iCre mRNA. Figure 
4.13 shows that both of these genes are expressed in the same dorsal domains at 
El 1.5 indicating that the transgenic iCre expression is regulated in the same way 
as that of the endogenous Msx3 gene. Serial sections were further analysed for 
Dbxl expression in order to define the ventral limits of the Msx3/iCre expression 
domain. The results suggest that the D&c/-expressing domain lies immediately 
ventral to the Msxi/z'Cre-expressing domain. As Dbxl is expressed in the dP6 
and pO domains at El 1.5, this indicates that Msx3 expression has its ventral limit 
at the dP5/dP6 domain boundary.
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Figure 4.13 In situ hybridisations for Msx3, iCre and Dbxl on serial sections of an 
Msx3iCre mouse at E l 1.5. The sections indicate that transgenic iCre expression is 
occurring in the same pattern as Msx3 expression as would be expected. Its 
location is also found to be immediately dorsal to the Dbxl expressing domain 
indicating that Msx3 and therefore iCre expression have their ventral limits at the 
dP5/dP6 boundary at this age. Scale bar, 100pm.
Pax7/GFP
Figure 4.14 Sections from El 1.5 Msx3iCre.Rosa26GFP crossed embryos 
showing the limits of the GFP-expressing domain. (A) MASH1 expression in the 
spinal cord seen using the anti-MASHl antibody (red). (B) The same section 
was also treated with anti-GFP antibody (green) and the overlay shows that the 
ventral limit of GFP expression is that same as that for MASH1. (C) PAX7 
expression. (D) PAX7 (red) and GFP (green) expression overlay showing that 
PAX7 expression extends slightly more ventrally than GFP in the Msx3iCre 
transgenic. Scale bar, 100pm.
Mash1/GFPMashl
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MsxSiCre mice were crossed to the Rosa26:GFP reporter mice in order to assess 
activation of GFP expression. Figure 4.14 shows sections of El 1.5 spinal cord 
stained for MASH1 and GFP or PAX7 and GFP. The MASH1/GFP double 
staining indicates that the ventral boundary of GFP expression coincides 
precisely with the ventral boundary of MASHI expression. Given that the ventral 
limit of Mashl expression in the dorsal spinal cord is the dP5/dP6 boundary 
(Caspary and Anderson, 2003;Gowan et al., 2001;Helms and Johnson, 2003) this 
would agree with in situ hybridisation data (figure 4.13). The PAX7/GFP double 
staining is also consistent with this. The PAX7-expressing domain extends 
slightly more ventrally than that of the GFP-expressing domain. This GFP- 
negative PAX7-positive domain presumably corresponds to the PAX7- 
expressing dP6 domain (Caspary and Anderson, 2003;Helms and Johnson, 
2003).
4.2.8 The neuronal progeny of the Msx3 domain
Previous work on the dorsal spinal cord neuroepithelium and its progeny has 
focused on the production of intemeuron subtypes. We therefore examined the 
neuronal progeny of the Msx3 domain in order to further investigate if GFP was 
being expressed in predicted neuronal cell types. Figure 4.15 (A) and (B) show 
that many of the GFP-expressing cells express the postmitotic neuronal marker 
LIM2 at E l3.5 (Tsuchida et al., 1994) indicating that Msxi-derived neurons are 
labelled with GFP. LBX1 is a marker of intemeurons derived from the dP4, dP5 
and dP6 domains (Muller et al., 2002) and figure 4.15 (C) and (D) indicate that 
some of these neurons also express GFP. Cells that express LBX1 but do not 
express GFP presumably derive from the dP6 domain. Figure 4.15 (E) and (F) 
shows that no GFP expression is found in neurons expressing LIM3, which 
marks cells derived from the pMN and p2 domains (Tsuchida et al., 1994). Use 
of an antibody that labels cells expressing Islet 1 and 2 proteins (Pan-Islet) 
indicates a large ventral Pan-Islet positive population that do not derive from the 
Msxi-domain (Figure 4.15 (G) and (H)). These cells are motomeurons derived 
from the pMN domain. However, a subpopulation of Pan-Islet-expressing cells is 
known to derive from the dP3 domain (Muller et al., 2002;0zaki and Snider, 
1997; Shiga and Oppenheim, 1999) and these can be seen showing positive 
labelling for both GFP and Pan-Islet in the dorsal spinal cord.
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Figure 4.15 The neuronal progeny of the Msx3 domain at E13.5. (A) LIM2 
expression is seen throughout the cord in postmitotic neurons (B) a large number 
of which are derived from the Msx3 domain and express GFP. (C) LBX1 
expressing neurons from the dP4, dP5 and dP6 domains also express GFP (D).
(E) LIM3 positive neurons from the p2 and pMN domains do not coexpress GFP
(F). Pan-Islet positive neurons in the ventral horns do not express GFP while a 
subset derived from the dP3 domain do (H). Scale bar in A, E, F, G and H, 
100pm, in C and D, 200pm.
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A limited analysis of the contribution of the Msx3 domain to the neuronal 
population was carried out using spinal cords from P10 animals (n=3). Sections 
of spinal cord were stained for GFP and the neuronal marker NEUN. To give a 
percentage contribution of the Msx3 domain to the total neuronal population the 
numbers of NEUN positive and GFP/NEUN double positive cells were counted 
per section. The number of double positive cells was then expressed as a 
percentage of the total number of NEUN positive cells in each section. To 
quantify the contribution to the dorsal and ventral neuronal populations 
separately, the spinal cord sections were divided into dorsal and ventral halves 
using a line drawn through the centre of the central canal of the cord. The results 
are shown in figure 4.16. Around 50% of the neurons in the spinal cord are 
produced by the Msxri-domain. The majority of these reside in the dorsal horn 
where the percentage contribution is much higher. Some of the ventrally located 
neurons are also dorsally-derived indicating migration of Msx3 derived neurons 
in ventral directions. Additionally not all the dorsal horn neurons are derived 
from the Msx3 domain indicating migration of neurons from more ventral 
regions to the dorsal horn. These results agrees with previous results (Caspary 
and Anderson, 2003).
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Figure 4.16 The contribution of the Mwti domain to the neuronal population of 
the postnatal spinal cord. (A) Section through a P10 Msx3iCre:Rosa26GFP 
mouse stained for NEUN and GFP. The dashed line delineates the boundary 
between the dorsal and ventral spinal cord used for counting purposes. (B) Graph 
showing the percentage contribution of the Msx3 domain to the NEUN-positive 
cell population of different areas of the spinal cord. The number of NEUN and 
GFP double positive cells was expressed as a percentage of the total NEUN 
positive cell population. Scale bar in (A), 200pm.
4.2.9 Radial glial and astrocytic cells are generated from the Msx3 domain 
The first GFP-expressing Msxri-derived cells that can be identified are radial glia, 
which express RC2 at E10.5 (figure 4.17 A-C). These cells are found densely 
packed throughout the dorsal ventricular zone. By E13.5 (figure 4.17 D-F) the 
typical radial glial cell morphology can be seen, with processes radiating out 
from the ventricular zone to the pial surface. The dorsal spinal cord of embryonic 
Msx3iCre.R26R-GFP mice show intense labelling with GFP. This means that 
resolving individual GFP-positive cells is difficult. To counter this, images of 
embryonic Msx3iCre:R26R-GFP mice taken on a confocal microscope represent 
either very thin (<4pm thick) Z-stacks, or single optical sections. This ensures 
that all double labelling seen was occurring in a single cell and that no false- 
positive coexpression was perceived due to two cells sitting directly on top of 
each other in a section. There are stretches of RC2-expressing fibres that appear 
negative for GFP. We do not know whether this is due to these fibres being 
derived from GFP-negative dorsal progenitors, or if it is a result of regions of 
Msxri-derived radial glia processes being GFP negative, in contrast to their cells 
bodies.
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Figure 4.17 Msxri-derived radial glia. (A) GFP and Hoescht, (B) RC2 and (C) 
overlay, indicating densely packed radial glial cells throughout the dorsal 
ventricular zone of an E l0.5 Msx3iCre:R26R-GFP embryo. (D-F) By E l3.5 the 
dorsal funiculus is forming with GFP+ radial glial fibres extending from the 
ventricular zone to the pia. The images are of single optical confocal sections 
ensuring optimal resolution of co-expressing cells. Scale bar, 50pm.
At P10 there are large numbers of Msx3-derived fibrous astrocytes in the dorsal 
spinal cord, particularly in the white matter regions (figure 4.18 A-C). Extensive 
GFP/GFAP coexpression is seen in the dorsal funiculus and lining the pial 
surface. GFP/GFAP coexpression is also seen in grey matter areas of the dorsal 
horns. These grey matter fibrous astrocytes appear smaller than their white 
matter counterparts, although this could actually be due to the high fluorescence 
intensity due to high GFAP expression in the white matter meaning smaller 
individual cells appear to merge, giving the impression of larger cells. The high 
GFAP signal and its distribution through the cell also makes quantification of the 
numbers of GFAP/GFP double positive cells very difficult. It is not unlikely 
however that all the GFAP-expressing cells found lining the pial surface of the 
dorsal spinal cord are derived from Msxi-expressing progenitors. This is 
consistent with a model of differentiation in which Msxi-derived radial glial cells
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radiate out from the Msx3 domain, translocate their cell bodies to the pial 
surface, and differentiate into GFAP-expressing astrocytes as seen previously 
with Z)Z>x-derived astrocytes (see Chapter 3). By P56, expression of GFP seen 
using the Rosa26R-GFP reporter is very low, so Msx3iCre animals were instead 
crossed to the Z/EG reporter strain (Novak et al., 2000) (figure 4.18 D-F, J-L). 
Using this reporter, GFAP/GFP double positive cells can still be found in the 
grey matter, although expression in the dorsal funiculus is almost completely 
undetectable. Grey matter fibrous astrocytes can be seen expressing high GFAP 
levels (figure 4.18 D-F, arrows) but cells with a more ‘bushy’ morphology and 
very low GFAP expression can also be seen (figure 4.18 D-F, arrowheads). 
These are likely to represent protoplasmic astrocytes. At P10, GFP-positive cells 
with the ‘bushy’ protoplasmic astrocyte morphology can be seen co-expressing 
SlOOp (figure 4.18 G-I, arrows). At P56, using the Z/EG reporter, these 
protoplasmic astrocytes are very obvious (figure 4.18 J-L) and the dense network 
of processes that contain high levels of GFP make up the majority of visible 
GFP-expressing cells in the dorsal horn (figure 4.18 J). The abundance of GFP- 
expressing cells with this morphology, most of which co-express SlOOp, 
indicates that the Msx3 domain gives rise to large numbers of protoplasmic 
astrocytes. The GFP-expressing protoplasmic astrocytes are restricted to the 
dorsal horn indicating limited migration and cells with this morphology never co­
express markers of neurons (NEUN) or oligodendrocytes (SOXIO), confirming 
their identity as astrocytes. Additionally it appears that the CAGG promoter of 
the Z/EG reporter mouse is preferentially active in this cell type. In other cell 
types such as neurons, GFP staining is much lower or non-existent (results not 
shown).
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Figure 4.18 Astrocytes derived from the MsxS domain. (A-C) At P10, GFP- 
expressing fibrous astrocytes, identified via GFAP positive processes, can be seen 
in the dorsal funiculus, grey matter and lining the pia. (D-F) By P56 GFAP 
expression is diminished. GFP-expressing cells are still found expressing GFAP at 
either high (arrows) or low (arrowheads) levels. (G-I) Msxi-derived astrocytes in 
the dorsal horn coexpress SlOOp and GFP. The ‘bushy’ morphology of some 
indicates they are protoplasmic astrocytes (arrow) (J) MsxJ-derived protoplasmic 
astrocytes in the dorsal horn at P56. (K, L) Magnification of area highlighted in (J) 
showing typical S100p/GFP-expressing protoplasmic astrocyte ‘bushy’ 
morphology (arrows). Scale bar, 50pm.
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Quantification of the contribution of the Msxi-domain to the spinal cord 
astrocyte population is not possible by GFAP staining due to problems with 
resolving individual cells as discussed above. Using SlOOp staining however 
indicates that at P10, Mari-derived astrocytes comprise around 55% of the total 
SI OOP-positive population in the dorsal spinal cord and around 2% in the ventral 
spinal cord indicating very limited dorso-ventral migration of the dorsal astrocyte 
population. The overall contribution to the S 100P-positive population is around 
30%. When this same quantification is done using the Z/EG reporter mouse at 
P56, 66% of the S 100P-expressing cells within the dorsal horn also express GFP. 
No GFP-expressing SI OOP-positive cells are found outside of the dorsal horn. 
These figures indicate that the Msxri-domain generates the majority of the 
dorsally located astrocytic cells in the spinal cord. These results are almost 
certainly an underestimate of the total astrocyte contribution of the Msxi- 
domain. Firstly, the demarcation of the dorsal spinal cord by drawing a 
horizontal line through the central canal as shown in figure 4.16 (A) leads to the 
inclusion of dorsal regions that are not Msxri-derived. The GFP-negative SlOOp- 
expressing cells in this region therefore affect the quantification by reducing the 
apparent contribution of the Msxi-domain to the ‘dorsal’ astrocyte population. In 
addition, many cells that appear to be protoplasmic astrocytes by morphology 
alone do not appear to express SlOOp. This may be due to low expression levels 
or the fact that the S 100P-expressing cell body is outside the plane of the section. 
Alternatively these cells may represent a different astrocytic cell type. As we 
cannot be certain these cells are astrocytes however, we must exclude them from 
our quantification. SlOOp has been reported to be expressed in subpopulations of 
neurons and oligodendrocytes (Hachem et al., 2005;Kimelberg, 2004). However 
we do not feel that this expression in non-astrocytic cells affects our results. The 
magnitude of this SlOOp expression in non-astrocytic cells has not been 
documented and therefore could be insignificant with respect to our results. In 
addition no SIOOp-positive cells with neuronal or oligodendroglial morphologies 
were observed in the Msx3iCre spinal cord.
4.2.10 Production of oligodendrocytes from the Msx3 domain
The Msx3 domain includes all dorsal spinal cord progenitor cells from the roof
plate to the dP5 domain. The Msx3iCre mouse therefore allows us to determine
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the contribution of the dorsal neuroepithelium to the oligodendrocyte population 
of the spinal cord.
Msx3iCre:R26R-GFP mouse spinal cords examined up to E l4.5 show no GFP- 
expressing oligodendroglial cells (results not shown). Msxri-derived cells 
expressing OLP markers first appear at E l5.5 in the dorsal white matter and also 
in the dorso-lateral grey matter. These cells express the early oligodendroglial 
markers PDGFRa and OLIG2 (Figure 4.19, A-D). At this age no SOXIO/GFP 
double positive cells are found. By E l6.5, SOXIO/GFP double positive cells are 
seen in the dorsal spinal cord. Triple labelling with SOX 10, GFP and the radial 
glial marker RC2 showed that at least a sub-population of these dorsally-derived 
OLPs appear to differentiate from radial glial cells (figure 4.19, E to L) as shown 
previously with the Dfor-derived OLPs (see Chapter 3). Whether or not all Msx3- 
derived oligodendrocytes differentiate directly from radial glial is hard to 
ascertain given the transient nature of the RC2/SOX10/GFP triple labelled cells. 
It is likely that this is a major mode of dorsal OLP specification however as these 
triple labelled cells can be found with relative ease as compared with the Dbx- 
derived radial glial OLP discussed in Chapter 3. This indicates they exist in 
greater numbers and is thus consistent with this form of specification occurring 
throughout the MsxJ-domain.
Figure 4.19 (below) Oligodendrogenesis in the Msx3iCre:Rosa26GFP mouse 
spinal cord. (A) and (B) E15.5 spinal cord stained for GFP (green) and PDGFRa 
(red) showing the appearance of oligodendrocyte precursors derived from the 
Msx3 domain in the lateral white matter (arrow, A) and the dorso-lateral grey 
matter (arrows, B). (C) and (D) Oligodendrocyte precursors expressing GFP and 
OLIG2 (red) at E l5.5 in the dorso-lateral white matter (arrows). (E) to (H) and 
(I) to (L) A sub-population of oligodendrocytes appear to be differentiating from 
RC2 positive radial glia at E l6.5 as shown by RC2 (blue) SOX 10 (red) and GFP 
triple labelling in the dorso-lateral white matter (arrowheads, E to L). Scale bar, 
50pm.
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In order to determine the overall contribution of dorsal oligodendrogenesis to the 
oligodendrocyte population of the spinal cord, spinal cords from P10, P33 and 
P80 mice were stained for GFP and SOX 10 and the proportion of Msxi-derived 
oligodendrocytes was determined at each age.. Figure 4.20 shows sample 
sections from spinal cords at these three ages plus the percentage contributions. 
At P10, the Msxi-domain contributes significantly to the oligodendrocyte 
population. As a whole, around 13% of the spinal cord oligodendrocytes are 
derived from the dorsal region. However, taking the dorsal horn in isolation (not 
including dorsal white matter), this contribution increases to around 20%. Even 
more significantly, the contribution of the Msxi-domain to the major white 
matter tract of the dorsal spinal cord, the dorsal funiculus, is at least 50%. By P33 
this has increased further, although the overall spinal cord contribution remains 
around the same. By adult stages (P80) the concentration of Msx3-derived 
oligodendrocytes in the dorsal funiculus appears to have decreased, while the 
contribution to the other areas of the spinal cord remains relatively stable. Note 
that oligodendrocytes are the only Msx:5-derived cell type found scattered 
throughout the spinal cord in adult animals (P56, results not shown). This is 
consistent with the highly motile nature of OLPs.
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Figure 4.20 The contribution of the Msx3 domain to the oligodendrocyte 
population of the spinal cord. Sample sections from P10 (A, whole cord), P33 
(B, dorsal funiculus), and P80 (C, whole cord) showing the presence of GFP+ 
SOX10+ oligodendrocytes concentrated in the dorsal spinal cord. (D) The 
number of GFP+ SOX10+ cells at each age is expressed as a percentage of the 
total number of SOX10+ cells to give the percentage contribution of the Msx3 
domain to the oligodendrocyte population. The figures for the dorsal funiculus 
and the dorsal spinal cord are given separately to illustrate the concentration of 
Msxri-derived oligodendrocytes in the dorsal regions of the spinal cord. The 
dorsal spinal cord figures do not include the oligodendrocytes of the dorsal 
funiculus. Scale bars in A and C, 200pm, in B, 100pm. N=3.
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4.3 Discussion
We have fate mapped the neural progeny of the Msxi-expressing domain of the 
spinal cord using Cre-loxP technology and have shown that it generates neurons, 
astrocytes and oligodendrocytes. Radial glia are the first cell type to be identified 
followed by dorsal interneurons at E10.5. At E l5.5, just as the down-regulation 
of radial glial markers begins, a transient population of cells expressing radial 
glial and oligodendrocyte markers can be found that derive from the Msx3- 
expressing domain. These cells give rise to a minor but significant dorsally 
derived population of oligodendrocytes, around 10-15% of the total spinal cord 
oligodendrocyte population. In the dorsal funiculus, their relative contribution is 
greater than 50% of the total oligodendrocyte population. In addition, the Msx3- 
expressing dorsal neural tube gives rise to possibly three distinct astrocyte 
populations. The majority, if not all, of the white matter fibrous astrocytes in the 
dorsal half of the spinal cord are derived from the Msx3-expressing domain. A 
population of grey matter fibrous astrocytes are also Msxi-derived, along with a 
population of protoplasmic astrocytes. Quantification of the astrocyte population, 
using S100P expression to define astrocytes, indicates that at least 30% of spinal 
cord astrocytes derive from the dorsal neuroepithelium. In the dorsal half of the 
spinal cord alone this figure rises to over 50%.
4.3.1 Oligodendrocyte generation in the dorsal neural tube
The majority of oligodendrocytes in the spinal cord are derived from the pMN 
domain as discussed in Chapter 1 and Chapter 3. However, results using the 
DbxliCre transgenic mouse discussed in Chapter 3 have shown that a 
subpopulation of oligodendrocytes derive from the Z)6x-expressing domain in the 
medial spinal cord neuroepithelium (Fogarty et al., 2005). In addition, genetic 
ablation of the pMN domain using Nkx6.J and Nkx6.2 knockout mice has 
indicated that the dorsal neuroepithelium has the capacity to produce significant 
numbers of oligodendrocytes in the absence of normal ventral 
oligodendrogenesis (Cai et al., 2005;Vallstedt et al., 2005). We have therefore 
used the Msx3iCre transgenic mouse to follow the specification of 
oligodendrocytic cells from the dorsal neuroepithelium.
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The high numbers of MsxJ-derived oligodendrocytes found particularly in the 
dorsal funiculus indicate that dorsal oligodendrogenesis is a significant 
phenomenon that normally occurs in spinal cord development. It begins around 
E l5.5, well after pMN domain oligodendrogenesis has started and occurs, at least 
in part, by differentiation of radial glial cells into OLPs. In this way it is identical 
to the Dfoc-derived oligodendrocyte generation (Fogarty et al., 2005). The Msx3- 
and Dfo-expressing domains do share a small region of overlap, the dP5 domain, 
raising the possibility that we are describing the same population of dP5-derived 
OLPs in both transgenic animals. This is not the case, however. The relative 
numbers of oligodendrocytes derived from the MsxS domain are around five-fold 
higher than those from the Dfo-domain (15% vs. 3%). The cells also populate 
different areas, with the Msxi-derived oligodendrocytes concentrated dorsally, 
particularly in the dorsal funiculus, as opposed to the lateral funiculus, the area in 
which most D&c-derived oligodendrocytes are located. The greater abundance of 
Msxi-derived oligodendrocytes indicates that greater numbers of progenitors are 
contributing to the GFP-expressing oligodendrocyte population in the Msx3iCre 
mouse than in the DbxliCre mouse.
Postnatally, the contribution of the Msxi-domain to dorsal oligodendrocytes is 
high, perhaps even increasing during the first postnatal month. A decline in the 
numbers of Msx:3-derived oligodendrocytes is seen after this time, particularly in 
the dorsal funiculus. This could be due to ‘dilution’ of the Msx3-derived 
population. Given that the pMN domain produces higher numbers of OLPs 
initially, it is likely that a greater proportion of pMN-derived OLPs persist in the 
postnatal spinal cord as compared to dorsally-derived OLPs. OLPs in the adult 
are known to provide new oligodendrocytes in the rodent CNS (Dawson et al., 
2003). The pMN-derived OLPs could therefore make a greater relative 
contribution to production of oligodendrocytes in the adult, explaining the 
relative decrease in the contribution of the dorsal neuroepithelium to the 
oligodendrocyte population seen in older animals. However this ‘dilution’ of the 
Msxi-derived oligodendrocyte population remains to be proven and is 
undermined by the observation that the numbers of SOX 10-positive cells counted 
in spinal cord sections of P80 animals appear around 20% lower than in P33
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animals. This contradicts the finding that oligodendrocyte numbers increase as 
was found in the rat CNS (Dawson et al., 2003) and suggests instead that there 
may be problems with immunohistochemistry in older animals, making counts at 
these ages less accurate.
Immunohistochemical staining of P80 tissue is of poor quality compared with 
that of younger tissue. For example by P33 and older, GFP staining is vastly 
reduced in intensity. It is therefore possible that the apparent decrease in the 
numbers of GFP-positive oligodendrocytes is a result of down-regulation of the 
activity of the Rosa26 promoter, thus reducing GFP expression. To try and avoid 
this we crossed Msx3iCre mice to the Z/EG reporter strain which uses the C AGG 
promoter to drive GFP expression. However we still observe a decrease in the 
levels of GFP expression in the spinal cord particularly in the dorsal funiculus. 
The only exception was within the protoplasmic astrocyte population (see above) 
in which the CAGG promoter seems preferentially active. This down-regulation 
phenomenon may therefore be common among various promoters in different 
cell types within the spinal cord and for future work it will be important to 
identify promoters that do not exhibit this problem.
The Msx3-derived oligodendrocyte progenitors appear to be radial glial cells as 
was seen with Dbx-derived oligodendrocytes. Transient radial glial/OLP cells 
derived from the Msxi-domain are found throughout the dorso-lateral regions of 
the spinal cord. The relative ease with which these cells can be found, especially 
at E l5.5, demonstrates that they are much more abundant than the equivalent 
cells derived from the Dfa-domain. As the Msx3 domain covers a wider area of 
the neuroepithelium, this is consistent with OLP production being widespread 
throughout dorsal progenitor domains and not limited to a small region of the 
Msxi-domain. It cannot be ruled out that a limited region of the Msxri-domain is 
giving rise to all these cells, or that a small domain of the dorsal neuroepithelium 
is particularly oligodendrogenic. This possibility is undermined by the fact that 
Cai et al. (Cai et al., 2005) found dorsally derived OLPs co-expressing markers 
of the dP3-dP5 domains {Pax7 and Mashl), indicating that these three domains 
give rise to dorsal oligodendrocytes. This is consistent with our results indicating 
a broad region of dorsal oligodendrogenesis. Their results do not rule out the
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possibility that dPl and dP2 also have oligodendrogenic capacity. It would be 
interesting therefore to know if markers of the dPl and dP2 domains such as 
Mathl and Ngnl/2 can be found to be expressed in early dorsal OLPs. 
Alternatively, fate mapping to follow the progeny of the dorsal-most domains 
using similar strategies to those described here would help to clarify the 
situation.
The signals that control the specification of Msxi-derived oligodendrocytes have 
not been investigated. The process is likely to be independent of SHH signalling 
given the distance from the source of SHH, the floor plate. Independence from 
SHH signalling has already been suggested for the D&c-derived oligodendrocytes 
(Fogarty et al., 2005) and was also demonstrated with ES cells derived from Smo 
knockout mice and Shh knockout mouse spinal cords (Cai et al., 2005). Msx3- 
derived OLP specification probably requires the evasion of BMP signalling This 
was indicated previously by results showing an increased production of 
oligodendrocytes by dorsal explants when exposed to BMP antagonists (Mekki- 
Dauriac et al., 2002;Vallstedt et al., 2005). It is also possible that FGF signalling 
plays a role given the probable requirement for FGF signalling in Dfo-derived 
OLP specification (Fogarty et al., 2005) and for induction of Olig gene 
expression in dorsal progenitor cells (Vallstedt et al., 2005).
A model can now be proposed for dorsal, and indeed non-pMN ventral 
oligodendrogenesis. It is likely that subsets of progenitor cells located throughout 
the neuroepithelium retain the ability to differentiate into OLPs after 
neurogenesis has ceased (post-El2.5). At least some of these neuroepithelial 
progenitors are radial glia that differentiate into oligodendrocytes at the end of 
embryogenesis, when the oligodendrocyte-inhibiting effects of BMPs and other 
signals are lost. Perhaps these persisting radial glia correspond to the glial- 
restricted precursors (GRPs) described and studied by others (eg. Liu and Rao, 
(2004) and others). Dorsally, oligodendrocyte differentiation could be permitted 
due to a combination of spinal cord expansion increasing the relative distance 
from the roof plate and possibly down-regulation of BMP signals. 
Oligodendrocyte specification in the dorsal spinal cord may also require 
inductive signals such as FGFs. By the time dorsal oligodendrogenesis begins
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there are large numbers of pMN-derived OLPs throughout the spinal cord. This 
means competition for factors such as PDGF, known to be required for 
oligodendrocyte development, is high. This competition will limit the degree to 
which non-pMN derived OLPs are able to migrate and proliferate, indicated by 
previous results showing mitogens to be a limiting factor in OLP proliferation 
(van Heyningen et al., 2001). In regions where the numbers of progenitors 
permissive to OLP specification are relatively high (as compared to the numbers 
pMN-derived OLPs) dorsal OLP specification is able to make a greater overall 
contribution to the oligodendrocyte population, hence the greater numbers of 
dorsally derived OLPs found in regions such as the dorsal funiculus. Therefore, 
entry into the oligodendrocyte lineage can be viewed as a possibility for 
progenitors located throughout the neuroepithelium, but one that is only 
permitted once anti-oligodendrogenic signals are lost. This idea that the entire 
neuroepithelium can give rise to oligodendrocytes is not a new one (Choi and 
Kim, 1985;Hirano and Goldman, 1988) although to our knowledge this is the 
first time it has been demonstrated directly via Oe-mediated lineage tracing. The 
MsxSiCre mouse provides a valuable tool for continuing investigation into the 
control of this phenomenon.
4.3.2 Astrocyte generation in the dorsal neural tube
The Msx3 domain is initially composed of radial glial cells. Previous work has 
indicated that radial glial cells differentiate directly into astrocytes towards the 
end of embryogenesis (Goldman, 2001;Schmechel and Rakic, 1979;Voigt, 1989) 
and indeed our own work with the DbxliCre mouse seems to imply that Dbx- 
derived radial glia differentiate into fibrous astrocytes at the end of 
embryogenesis (see Chapter 3, and Fogarty et al., (2005)). The data from the 
Msx3iCre mouse are consistent with radial glia from the Msx3 domain 
differentiating into the white matter fibrous astrocytes that line the pial surface of 
the dorsal half of the spinal cord. These astrocytes could well be located in the 
same areas lining the pia that were previously contacted by the end feet of their 
radial glial precursors. This scheme suggests that each domain of the 
neuroepithelium is responsible for the production of white matter fibrous 
astrocytes that will line the segment of the pial surface directly opposing the 
domain. This is speculative however and although appealing in its simplicity,
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direct differentiation is almost impossible to demonstrate with the Msx3iCre 
mouse due to the density of GFP staining found when the dorsal spinal cord is 
immunohistochemically labelled. The lack of ventrally located Msx3-derived 
fibrous astrocytes suggests they indeed differentiate directly from the Msx3- 
derived radial glia that project only to the dorsal sections of the pial surface. 
Another two transgenic mice generated within the Richardson Lab further 
support the idea that each neuroepithelial domain produces its own population of 
fibrous astrocytes. When a mouse expressing Cre under the control of the Olig2 
promoter is crossed to a Cre reporter mouse it appears to label fibrous GFAP- 
positive white matter astrocytes that come to lie at the ventral pial surface (N. 
Callard and N. Kessaris, unpublished). A similar ventrally located fibrous 
astrocyte population also derives from the Nkx2.2-expressing p3 domain (R. 
Taveira-Marques, personal communication). These results, in conjunction with 
my own findings indicate that each neuroepithelial domain is responsible for 
producing a unique section of the white matter fibrous astrocyte population.
Two more types of astrocyte that derive from the Msxi-domain can be 
distinguished. Firstly, GFAP-expressing astrocytes can be seen in the grey 
matter. It is unknown whether or not these differ significantly from their 
counterparts located in the white matter. Certainly many are associated with 
blood vessels that penetrate the grey matter and could thus be considered to play 
a role in forming the blood-brain barrier in the same way that the white matter 
astrocytes presumably do at the pial surface. A subpopulation of GFAP-positive 
astrocytes is also seen in some spinal cord sections associated with the 
ependymal cells that surround the central canal.
A second population of grey matter astrocytes appears to correspond to the 
protoplasmic astrocyte sub-type. These can be identified by their ‘bushy’ 
network of GFP-positive processes surrounding a relatively small, often SI000- 
positive cell body. Unfortunately, due to the extensive overall GFP 
immunoreactivity found in the dorsal half of Msx3iCre:R26R-GFP spinal cords, 
they are very hard to distinguish on the basis of their morphology. Isolated 
examples can be seen in regions of low GFP immunoreactivity, typically slightly 
ventrally to the strongly GFP-positive dorsal horn. We therefore cannot yet rule
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out the possibility that these cells are solely derived from the dP5 domain and 
actually represent the same population of protoplasmic astrocytes found to derive 
from the Z)&x>domain (see Chapter 3).
In conclusion, the MsxJ-domain has clearly been shown to give rise to astrocytes 
of various types. Due to the broadness of the domain that is labelled however, 
very little detail can be seen in terms of dorsal astrocyte specification. The 
Msx3iCre mouse does provide a useful tool for investigating glial cell 
specification however. Firstly it provides a means for in vitro investigation into 
the specification of cell types derived from the dorsal neuroepithelium. Previous 
cell culture and explant work has always been prone to the criticism that 
contamination with ventral neuroepithelial cells could have affected any results 
ascribed to dorsal progenitors. Perhaps more importantly, the Msx3iCre mouse 
provides the ability to specifically disrupt genes only in cells of the dorsal neural 
tube. This is possible via the Cre-mediated excision of /oxP-flanked target genes. 
In combination with a variety of transgenic mice carrying ‘floxed’ genes, we can 
therefore start to clarify various aspects of dorsal spinal cord development. The 
Msx3iCre mouse also expresses Cre in neural crest derivatives due to the 
expression of Msx3 in the presumptive neural crest prior to neural tube closure 
(results not shown). Although beyond the scope of this study, the Msx3iCre 
mouse may therefore also provide a valuable tool for investigating development 
of neural crest derived tissues.
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Chapter 5
Emxl transgenesis
5.1 Introduction to Emxl
Emxl was identified as a HD transcription factor that shares high sequence 
similarity within the homeobox domain to the Drosophila empty spiracles (ems) 
gene. It is located on chromosome 6 in the mouse and is encoded by three exons 
spanning over 16kb. Emxl is expressed in the dorsal telencephalon from E9.5 
(Simeone et al., 1992) and continues to be expressed throughout all cortical 
layers in both proliferating and differentiated neurons, into adulthood. In the 
developing cortex, Emxl is expressed in a high caudomedial to low rostrolateral 
gradient (Gulisano et al., 1996). In the olfactory bulb it is expressed in all 
proliferating cells during development and postnatally at low levels in mitral 
cells. It is also expressed in the hippocampus and outside the CNS in the 
branchial pouches, apical ectodermal ridges of developing limbs and in the 
developing kidney (Briata et al., 1996).
Knockout of Emxl sometimes (Guo et al., 2000) results in the failure of the 
formation of the corpus callosum and disorganisation of fibre formation 
(fasciculation) in the corpus callosum and anterior commisure. It can also affect 
organisation of the cortical layers and reduce the size of the hippocampus 
(Yoshida et al., 1997). These effects can be quite subtle though and studies have 
indicated that knockout of Emxl is partially compensated for by the expression 
of the related HD gene Emx2. Emx2 expression begins a little earlier than Emxl 
around E8 and it is expressed in the cortex in a domain that includes the Emxl- 
expresing region but that also extends beyond it. The idea that Emx2 
compensates for Emxl in the Emxl knockout is supported by the increased
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severity of the cortical phenotype seen with Emxl/2 double knockouts. Early in 
development of the cortex, Emxl/2 double knockouts show loss of the medial 
pallium which is the invagination at the dorsal midline of the cortical plate which 
gives rise to the cortical hem and archipallial structures such as the hippocampus. 
This loss alters the formation of the cortical roof, which becomes abnormally 
expanded. It is thought then that Emxl and 2 work in cooperation to specify the 
cortical hem and the boundary between the archipallium and the roof of the 
cortex (Shinozaki et al., 2004). The cortical hem is a major source of Cajal- 
Retzius cells (Takiguchi-Hayashi et al., 2004) and therefore it follows that these 
cells are not specified in the Emxl/2 double mutants (Bishop et al., 
2003;Shinozaki et al., 2002). In addition, subplate neurons are not specified, 
indicating roles for the Emx genes in specification in the ventricular zone. 
Normal migration and function of Cajal-Retzius cells and subplate neurons is 
thought to be required for correct lamination of the cortex, in part through reelin 
signalling mediated by Cajal-Retzius cells (Mallamaci et al., 2000a;Shinozaki et 
al., 2002). It is therefore unsurprising that double knockout animals show severe 
disruption in cortical lamination. The mutants also show major reductions in 
cortical thickness and surface area. This cortical hypotrophy is not due to 
increased cell death or decreased numbers of proliferating cortical progenitors, 
but may be partly affected by a change in progenitor cell cycle length (Bishop et 
al., 2003). Reduction in cortical size is also partly due to the inhibition of 
migration of intemeurons from the ventral telencephalon into the cortex 
(Shinozaki et al., 2002). It may be that a normal laminar structure in the cortex is 
required for correct migration of interneurons. Additionally it has been proposed 
that intemeurons follow the fibre tracts of thalamocortical axonal projections. 
Subplate neurons are known to guide the efferent projections of cortical axons to 
the internal capsule (McConnell et al., 1989). They are also required for the 
correct guidance of afferent axons from the thalamus into the cortex (Molnar et 
al., 1998). These roles are thus consistent with the loss of subplate neurons in the 
Emxl/2 knockouts causing extensive dismption of the thalamocortical 
projections (Bishop et al., 2003). If interneurons cannot migrate correctly when 
these fibres are disrupted it follows that they will not be able to migrate in the 
Emxl/2 double mutant mice. The dismption of fibres projecting from the 
thalamus will also directly affect the size of the cortex which will be diminished
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by the amount of space normally taken up by these fibres. Disruption of 
thalamocortical projections may also have secondary effects on laminar 
organisation, thus contributing to the perturbed cortical laminar organisation 
(Bishop et al., 2003).
It appears then that the major cortical phenotypes seen in the Emxl/2 double 
mutant mice can be traced, at least partly, to the aberrant specification of cortical 
cells such as the subplate neurons and Cajal-Retzius cells. Besides specifying 
these cells however, does Emxl also play a role in arealisation of the neocortex? 
It is known that Emxl and Pax6 are expressed in opposing caudomedial to 
rostrolateral gradients, with Emx2 expressed in relatively greater levels in the 
caudomedial direction, and Pax6 expressed more in the rostrolateral direction 
(Bishop et al., 2002). These gradients play opposing roles in patterning the 
rostro-caudal arealisation of neurons of the neocortex. They help to define, in a 
neocortically autonomous manner (i.e. before thalamocortical fibres appear), the 
development of regions of neocortical neuron specialisation, such as in the 
visual, sensory and motor cortical areas (Bishop et al., 2000;Mallamaci et al., 
2000b). It is reasonable to assume that given its similarity to Emx2, Emxl may 
play an analogous role. Examination of Emxl mutants however, in combination 
with other patterning gene mutants, disproves this theory. They indicate rather 
that Emxl does not have a role in arealisation of neocortical neurons (Bishop et 
al., 2002;Muzio and Mallamaci, 2003). Therefore its only patterning function 
identified so far appears to be in specifying the medial pallium during early 
corticogenesis (Shinozaki et al., 2004).
The mechanisms by which the Emx genes are induced, and also their downstream 
targets remain unclear. Ablation of WNT signalling before the onset of 
neurogenesis leads to the down-regulation of a variety of dorsally expressed 
genes including Emxl and 2 (Backman et al., 2005). In addition analysis of the 
Emx2 enhancer indicates its expression is regulated by WNT and BMP signalling 
(Theil et al., 2002). It is therefore likely that both Emxl and 2 are regulated by 
WNT signalling. However, the expression of the Emx genes precedes those of the 
Wnt family making them unlikely inducers of Emx expression. Gli2 mutants 
exhibit loss of Emxl expression and show large reductions in Emx2 expression
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indicating GliS plays a role in Emx gene regulation (Tole et al., 2000). In 
addition the Gli3 mutants display many similar phenotypes to the Emxl/2 double 
knockouts (Grove et al., 1998). The results are confused however, by the effects 
that Gli3 disruption has on the transcription of other genes that might more 
directly influence Emxl and 2. In addition the incomplete abolishment of Emxl 
expression indicates other factors are involved in regulating its expression. 
Therefore more work is required here. Knowledge of the downstream targets of 
the Emx genes is limited. Alterations in the expression profiles of various genes 
occur in the Emxl/2 mutants, including changes in Fgf8, Writs, BMP6, noggin, 
Lhx5, Msxl, Otx2 and others (Shinozaki et al., 2004). However, which of these 
genes, if any, are the direct targets of the Emx genes is unknown.
The origins of oligodendrocytes in the forebrain remain unclear, with evidence 
for both dorsal and ventral sources meaning that controversy still surrounds the 
subject. As part of a wider investigation into oligodendrocyte origins in the 
forebrain, we are using the restricted expression profile of Emxl to enable us to 
fate map the cells derived from the dorsal telencephalon using PAC transgenesis 
and Cre-loxP technology. We have created two separate transgenic mice 
expressing two different types of Cre in the same pattern as Emxl. The first uses 
the codon-improved Cre recombinase gene, iCre (Shimshek et al., 2002) that was 
used in the studies described in Chapters 3 and 4. The second uses an inducible 
form of Cre called CreER12 that requires the presence of a ligand to activate its 
recombination activity by utilising a property of steroid receptors. The ligand 
binding domain (LBD) of the steroid receptors is responsible for inactivating the 
functions of the receptor in the absence of bound steroid. This is because the 
LBD causes the receptor to associate with a cytoplasmic protein complex 
containing Heat-shock protein 90 (Hsp90) when no steroid is bound, preventing 
its’ movement into the cell nucleus. Fusion of the LBD to various cellular 
proteins has thus been shown to be a method for regulating the function of those 
proteins (Picard, 1994). These chimeric proteins require binding of a ligand to 
their LBD to allow the chimeric protein to dissociate from Hsp90 and carry out 
its normal function. Fusion of the LBD from the oestrogen receptor to the Cre 
recombinase gene for example generates a chimeric recombinase the activity of 
which requires the presence of oestrogen or a synthetic oestrogen ligand such as
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tamoxifen (Metzger et al., 1995). In order to be useful in transgenic mice, which 
normally produce endogenous oestrogen, the LBD of the oestrogen receptor was 
mutated so that it is not bound by endogenous oestrogen and instead is only 
activated by the synthetic ligand tamoxifen (Feil et al., 1997). This CreER72 gene 
therefore provides a means for inducing Oe-mediated recombination in a 
temporally specific way. It was decided this could be a useful tool to investigate 
various aspects of forebrain development.
This chapter will describe the creation of the EmxliCre and EmxJCreER72 mice. 
Using these mice we show that the £>wx7-expressing neuroepithelium of the 
dorsal telencephalon is a major source of cortical oligodendrocytes, as well as of 
neurons and astrocytes. These results and others will be discussed in relation to 
the overall picture of forebrain oligodendrogenesis. Results found using the 
EmxliCre mouse to mediate ablation of specific cell populations and targeted 
gene knockout will also be discussed both in relation to forebrain 
oligodendrogenesis and in terms of wider applications for the transgenic lines 
generated.
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5.2 Results
5.2.1 PAC clone screening
To identify a PAC clone containing the Emxl gene, we screened a mouse PAC 
library (RPC 121) with a cDNA probe specific for Emxl. The probe used was a 
280bp Notl-Xhol fragment from IMAGE clone #3168456 that represents part of 
Emx Vs V  UTR (see figure 5.1). When used as a probe on southern blots of 
BamHl or EcoRl digested mouse genomic DNA, single bands of the expected 
sizes were seen demonstrating the specificity of the probe (figure 5.2). Screening 
the PAC library indicated that 5 PAC clones contained the Emxl gene; 357-D14; 
366-L20; 441-P20; 442-P20 and 628-J4. These were ordered from UK HGMP 
Resource Centre.
5.2.2 PAC clone characterisation
To confirm the presence of the Emxl in the genomic PAC clones, the PAC DNA 
was extracted, digested with EcoRl or BamHl and analysed on Southern blots 
hybridised with the 280bp Emxl-specific cDNA probe (figure 5.3). 4 of the 5 
clones contained the expected 7.5kb BamHl and 7.0kb EcoRl bands. However 
PAC 628-J4 gives bands of the wrong sizes on agarose gels indicating some sort 
of recombination or deletion event has occurred.
In order to estimate the size of the DNA inserts in the PAC clones, the PAC 
DNA was digested with Not! to release the entire insert. PFGE analysis of the 
resulting fragments allows estimation of the clone insert sizes (figure 5.4).
Further characterisation of the PAC clones was carried out using inverse PCR 
followed by sequencing of the PCR products. These sequences were then blasted 
against the published mouse genome found at www.ensembl.org. The results 
obtained allowed us to identify the precise size and regions of genomic DNA that 
each clone spanned (see figure 5.5). 4 of the 5 PAC clones yielded interpretable 
results but we were only able to obtain inverse PCR sequence for the 3’ end of 
PAC clone 628-J4. Of the remaining 4 clones, PAC 357-D14 had the most 
symmetrical insert and also the largest insert with extensive regions flanking
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Emxl both upstream and downstream of the gene (around 75 and 105kb 
respectively). These were most likely to contain all of the regulatory elements 
required to drive correct Emxl expression. PAC 357-D14 was therefore chosen 
for all further manipulation in order to generate Emxl-ext transgenic mice.
Xho\E c o R l
Emxl ORF Noty  UTR
870bp
T7 T 3
pT3T7
Figure 5.1 Schematic diagram of IMAGE clone 3168456 which 
contains the most of the Em xl open reading frame (ORF) and 3’ 
untranslated region (UTR) inserted between the EcoRl and Notl sites of 
the pT3T7 vector. A 280bp Xhol -  Notl fragment was used as a probe 
to screen the genomic PAC library.
10kb
8kb
2.5kb
Figure 5.2 Southern 
analysis of mouse genomic 
DNA digested with BamHl 
and EcoRl and hybridised to 
a probe complementary to 
the 3’ UTR of Emxl. 
Expected bands of around 
7.5kb and 7kb for each 
digest demonstrate that the 
probe is specific for Emxl.
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Figure 5.3 Southern analysis of DNA from PAC clones digested with 
BamHl or EcoRl and hybridised to a 280bp E/wx7-specific probe. The 
expected positive bands at 7.5kb (BamHl) or 7kb (EcoRl) are indicated. 
PAC 628 J4 does not give the expected fragment sizes.
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194K b-
145K b-
9 7 K b -
48 .5K b-
23 .1K b-
9 .4 K b -
6 .6 K b -
4 .4 K b -
16.7Kb
vector
PAC Clone Fragment 1 Fragment 2 Total Size
357-D14 ~105Kb ~75Kb ~180Kb
366-L20 ~95kb ~ 40Kb ~135Kb
441-P20 ~150Kb - ~150Kb
442-P20 ~150Kb - ~150Kb
628-J4 ~95Kb ~110Kb -200Kb
Figure 5.4 (A) PFGE analysis of DNA from the PAC clones digested 
with Notl. (B) Table listing the approximate sizes of the fragments 
obtained from the Notl PAC clone digestion, plus the calculated total 
insert sizes.
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Figure 5.5 Diagram showing the chromosomal region around the Em xl locus including any Notl and Swal sites present, plus other 
genes found close to Emxl. The relative positions of the genomic inserts in each PAC clone are shown along with their length as 
predicted by the genomic mouse sequence found at http://www.ensembl.org
5.2.3 Construction of the EmxliCre targeting vector
The EmxliCre targeting vector was designed to introduce iCre (Shimshek et al., 
2002) into exon 1 of the Emxl gene according to the strategy summarised in 
figure 5.6. To ensure correct transcriptional initiation the targeting construct uses 
an endogenous Notl site immediately upstream of the Emxl ATG to fuse the iCre 
gene to the Emxl upstream sequences. This was mediated by PCR amplifying the 
5’ end of iCre from pPI14 and modifying its 5’ end to include the 15bp 
immediately upstream of the Emxl ATG. In this way iCre could be directly 
joined to the 5’ homology region via the Notl site and the endogenous translation 
initiation site could be recreated. An SV40 poly-adenylation (pA) signal was 
added at the 3’ end of the iCre gene to ensure proper transcriptional processing 
of the transgene. Positive selection for recombinant PAC clones was mediated 
via a chloramphenicol resistance cassette. This could be removed prior to the 
pronuclear injection of recombinant PACs into mouse eggs by virtue of its 
flanking^/ sites.
The construction of the EmxliCre targeting vector is summarised in figure 5.7. 
The 405bp 3’ homology was PCR amplified from PAC clone 357-D14 adding 
Hindlll and Ascl sites to the 5’ and 3’ ends respectively (forward primer 5’-CCC 
AAG CTT CTA AGC GGG GTT TCA CCA TAG AG-3’, reverse 5’-GGC GCG 
CCG CGG TGG CCA AAG AAG CGA TTC CG-3’). This PCR product was 
isolated and cloned directly into pCRII-TOPO® (Invitrogen) to make pE3Hom. 
The 3’ homology region was then subcloned via Ascl and Hindlll into the 
modified pBluescript vector pBPacAsc to make pEPrdl. An frt site-flanked 
chloramphenicol resistance cassette was isolated from pBCm (M. Fruttiger) 
using M/mI and Notl, blunted, then blunt ligated into the EcoRN site of pEPrdl to 
make pEPrd2. The 329bp 5’ homology region was PCR amplified from PAC 
clone 357-D14 and modified by adding Pacl to the 5’ end (forward primer 5’- 
TTA ATT AAT CCA GGA GGA CCG CTG AAG CG-3’, reverse 5’-CGT CGC 
GGC CGC CGA AGC GGA GTG AGG-3’). After cloning into pCRII-TOPO® to 
make pE5’Hom the 5’ homology was subcloned into pEPrd2 via Pacl and Notl 
to make pEPrd3. The 5’-most 335bp of iCre were PCR amplified from pPI14 
(gift, P. Iannarelli) modifying the 5’ end to add the 15bp upstream of the Emxl 
ATG (forward primer 5’-GCG GCC GCG ACC ATG GTG CCC AAG AAG
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AAG AGG AA-3’, reverse primer 5’- GGC CAG ATC TCC TGT GCA GCA 
TGT TGA GC-3’). This was cloned into pCRII-TOPO® to make p5’iCre. The 5’ 
of iCre was then isolated from p5’iCre with Notl and BgtH and combined with 
the 3’ iCre BgUl and SpeI fragment from pPI17 and the Notl and Spel digested 
pEPrd3 in a three-way ligation to make pEPrd4. An SV40 pA signal was PCR 
amplified from pEGFP-F (Clontech) adding Spe I to the 5’ end and BamHl to the 
3’ end (forward primer, 5’-ACT AGT GAT CAT AAT CAG CCA TAC CAC-3’, 
reverse primer, 5’-GGA TCC TTA AGA TAC ATT GAT GAG TTT GG-3’). 
This was cloned into pCRII-TOPO® to make pSV40pA. The pA fragment was 
isolated by digestion with Spe I and BamHl and then ligated into the Spell BamHl 
digested pEPrd4 to make the final EmxliCre targeting vector pEiCRETV. PCR 
products were fully sequenced and cloning steps were verified by restriction 
enzyme analysis. Once completed, the insert from the targeting vector was 
excised with Pacl and Ascl and used in homologous recombination.
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Figure 5.6 (A) Diagram showing the structure of the Em xl locus including the endogenous Notl site and the Sacl sites. Black boxes 
indicate exons, white boxes indicate untranslated regions. (B) The targeting vector used to insert the iCre gene, along with a 
chloramphenicol resistance cassette (Cm1)  flanked by Jrt sites, into exon 1 of Emxl. Also indicated are the BglII site and the 405bp probe 
used in these studies. Grey boxes indicate regions of homology. (C) The Em xl locus after correct homologous recombination.
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5.2.4 Homologous Recombination of PAC 357-D14 with the EmxliCre 
targeting vector.
PAC modification with the EmxliCre targeting vector was carried out in a 
bacterial system as previously described (Lee et al, 2001) and according to the 
protocol outlined in Chapter 2. As the pPAC4 vector backbone sequences were 
to be removed prior to injection (see Section 5.2.5) it was unnecessary to remove 
the unwanted sequences of pPAC4 via homologous recombination with the 
ampicillin resistance cassette (see Section 3.2.4). Homologous recombination 
with the EmxliCre targeting vector was carried out and colonies were checked 
for plasmid contamination. Colonies were then arabinose treated to induce FLPe 
expression and remove the chloramphenicol resistance cassette (using clones #5 
and #6). The resulting clones were checked for the correct recombination events 
via Sacl and Bglll digestion and Southern analysis. The blots were hybridised 
with a probe constructed from the 3’ homology region of the targeting vector. 
Figure 5.8 shows that all colonies picked had undergone the correct 
recombination event.
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Figure 5.8 Southern analysis of PAC 357-D14 following recombination to insert 
the iCre gene into exon 1 of Emxl. DNA was digested with BglII and Sad  and 
hybridised to a 3’ homology-specific probe. Unrecombined wild-type PAC clone 
DNA is shown with a band at 1.6kb. Recombined PAC clones all show a band 
shift to 1.8kb corresponding to the predicted size for the Emxl locus once 
recombination with the EmxliCre targeting vector and chloramphenicol 
resistance cassette excision has occurred. Non-specific bands are indicated by 
red arrows.
5.2.5 Introduction of PAC 357-D14 recombined with EmxliCre into mouse 
ova
Modified EmxliCre PAC DNA was linearised with A sd  and Swal. The PAC 
357-D14 insert contains two Swa\ sites located 55 and 60Kb downstream of the 
Emxl gene (see figure 5.5). Digestion with A sd  and Swal therefore excises a 
130Kb fragment containing all of the sequence upstream of Emxl (75kb) and 
around 55kb downstream of Emxl (see figure 5.9). It was felt that removal of the 
3’-most 50kb of PAC sequence plus the vector backbone sequence would 
probably not affect the control of the transgene’s expression, but would prevent 
any problems caused by inclusion of pPAC4 sequences in the transgenic 
animals’ genomes. After digestion the DNA was purified and quantified (Figure
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5.9) and injected into mouse eggs at around lng/pl by P. Iannarelli and U. 
Dennehy.
1pl 3pl
194Kb
145Kb
97Kb
48.5Kb
23.1Kb
Figure 5.9 Quantification of 
purified linear PAC DNA for 
microinjection. After
purification, aliquots of 1, 3 
and 5 pi of the DNA solution 
were run by PFGE along with 
5 pi of a standard (Std) 
preparation of PAC DNA that 
had been used in a previous 
injection and had been found 
to produce transgenic animals. 
The DNA was diluted 
accordingly before injection
5.2.6 Screening litters for the presence of the EmxliCre transgene 
Pups derived from pronuclear injections were screened by PCR using primers 
specific to the iCre gene that was introduced into the Emxl locus (for primer 
sequences see table 2.1). Figure 5.10 shows a typical genotyping PCR result 
indicating that mice 46/1 and 47/5 contain the transgene. Further confirmation of 
the presence of the EmxliCre transgene by Southern blot proved impossible due 
to technical difficulties but the iCre PCR has been used very successfully in our 
hands for genotyping other transgenic animals that also contain the iCre gene, 
such as DbxliCre and Gsh2iCre. It was therefore felt that the results from PCR 
alone could be relied upon.
In total 30 litters were obtained from injection of mouse eggs with the EmxliCre 
PAC construct and implantation into pseudopregnant mothers. These pregnancies 
yielded 145 pups of which 4 were found to contain the transgene.
174
0
0
45 Litter 46 Litter 47
6 1 2 3 1 2 3 4 5 6 7
Figure 5.10 Mouse genotyping by PCR for the EmxliCre transgene. 
Mice 46/1 and 47/5 show the presence of a specific band at lkb 
indicating presence of the transgene.
5.2.7 Assessing the expression and function of the EmxliCre transgene 
To determine whether or not the transgene was expressed, in situ hybridisation 
was carried out to compare the expression profiles of Emxl and iCre. Figure 5.11 
(A-C) shows serial sections from the telencephalon of an El 1.5 EmxliCre x 
Rosa26 GFP embryo. Sections were probed for either Emxl or iCre RNA, or 
assessed for the presence of the GFP reporter protein via immunohistochemistry. 
As can be seen the expression of the iCre transgene faithfully reproduces the 
expression pattern of Emxl. Interestingly iCre shows a punctuate expression 
pattern as compared to Emxl. This indicates an altered subcellular localisation of 
the transgenic RNA, presumably with a bias towards the peri-nuclear region 
although this has not been confirmed. Labelling with anti-GFP antibody shows 
that the reporter protein is produced in all the E’/wxy-expressing cells indicating 
that recombination is occurring correctly and efficiently. By E l6.5, the entire 
cortex is densely GFP-positive (figure 5.11 D) indicating that all cortically 
derived cells undergo recombination. By P0 and later (figure 5.11 E, F) the GFP- 
expressing axons of cortical projection neurons can be seen labelling white 
matter tracts in the striatum, including the anterior commisure. None of the 
founders examined showed any aberrant expression of the transgene and we used 
the line from mouse 25/1 for all further studies.
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Figure 5.11 Expression and function o f the EmxliCre gene. (A-C) Serial coronal 
sections of EmxliCre x Rosa26GFP forebrain from E l 1.5 show that expression of 
Em xl (A) closely resembles that of iCre (B). The transgene is also functional as 
immunohistochemical analysis of GFP expression shows that cells expressing iCre 
have activated expression of GFP (C). Early migrating cortical cells can be seen 
moving ventrally (arrows). By E l6.5 the cortex is densely GFP-positive (D) 
indicating all cortically derived cells have undergone recombination. Postnatally 
(E, F) fibre tracts in the striatum become highly visible as they contain the GFP- 
expressing axons of cortical neurons (arrowheads). Scale bar (A, B, C, D, E) 
500pm, (F), 900pm.
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5.2.8 Oligodendrocytes are generated from the dorsal telencephalon 
neuroepithelium
The primary aim of generating the EmxliCre mouse was to enable us to 
investigate the specification of oligodendrocytes from a dorsal telencephalic 
source. Previous reports had suggested that the ventral telencephalon is the 
source of forebrain oligodendrocytes (Fuccillo et al., 2004;Spassky et al., 
2001;Tekki-Kessaris et al., 2001)). Other recent work however has indicated that 
the dorsal telencephalic ventricular zone can also act as a source of 
oligodendrocytes (Gorski et al., 2002). We therefore crossed the EmxliCre 
mouse to the Rosa26R-GFP reporter line and examined the offspring for 
expression of oligodendrocyte markers and GFP. Prior to E l6.5 no coexpression 
of GFP and oligodendrocyte markers was observed. Extensive expression of 
PDGFRa was seen in GFP-negative cells though. These appeared to originate 
from the ventral telencephalon and migrate towards the cortex consistent with the 
idea that the ventral telencephalon is a source of OLPs. At E l6.5 however, GFP- 
expressing PDGFRa-positive OLPs began to appear near the dorsal SVZ (figure 
5.12 A-C). By P0, the number of GFP/ PDGFRa co-expressing cells in the cortex 
had increased substantially (figure 5.12 D-F, H). This OLP specification appears 
to be concentrated around the cortical SVZ implying that this is the region in 
which the cells responsible reside. In support of this the regions in closest 
proximity to the dorsal SVZ, the motor cortex and external capsule, show the 
greatest numbers of dorsally-derived OLPs at P0 (figure 5.12 H). This indicates 
that these areas are populated first as cells migrate from their regions of 
specification. Regions further away such as the corpus callosum and lateral 
cortex probably receive migrating dorsal OLPs later, hence the lower numbers 
found there at earlier times. Dorsally-derived OLPs are never seen in ventral 
areas such as the anterior commisure, even though the axons of cortical 
projection neurons traverse this tract (figure 5.11).
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Figure 5.12 OLPs are specified by the cortical ventricular zone. (A-C) At E l6.5, 
GFP-positive PDFGRa-positive OLPs (arrows) are found near the dorsal 
ventricular zone along with the GFP-negative PDFGRa-positive OLPs derived 
from more ventral sources (arrowheads). (D-F) By PO, there are significant 
numbers of GFP/ PDFGRa co-expressing OLPs in the cortex (arrows) along with 
more ventrally derived OLPs (arrowheads). (G) Diagram of the brain indicating 
the regions in which cortical progenitor contribution to the OLP population was 
quantified. (H) Quantification of the cortical progenitor contribution to the OLP 
population in various forebrain regions at E16.5 and PO. Scale bars, (A-C) 20pm, 
(D-F), 40pm.
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PDGFRa is down-regulated as OLPs differentiate into maturing 
oligodendrocytes (Hall et al., 1996). PDGFRa is therefore unsuitable as a marker 
to study the contribution of the Emxl -expressing ventricular zone to the postnatal 
oligodendrocyte population. SOX 10 expression on the other hand persists in the 
mature oligodendrocyte (Stolt et al., 2002). We therefore used SOXIO expression 
to examine the dorsal oligodendrocyte population after birth (figure 5.13). We 
focused much of our attention on regions of the forebrain at the same rostro- 
caudal level at which the anterior commisure traverses the midline. This was to 
prevent any rostro-caudal variation confusing our results. Thus at this level we 
examine grey matter regions both dorsally (the motor cortex) and ventrally (the 
pre-optic area and septum). We also looked at the cortical region that contains 
the secondary somatosensory cortex, granular insular cortex and dysgranular 
insular cortex. For simplicity this region is referred to as lateral cortex. We 
examined white matter tracts in the dorsal (corpus callosum, external capsule) 
ventral (anterior commisure) and ventro-lateral (lateral olfactory tract) forebrain. 
In order to examine any possible rostro-caudal variation, we also looked at more 
anterior regions such as the orbital cortex, olfactory bulb and forceps minor 
corpus callosum, and more posterior structures such as the fimbria and dorsal 
hippocampal commisure.
Postnatally, GFP/SOXIO double positive oligodendroglial cells can be seen in all 
regions of the cortex, both in grey and white matter. In the grey matter of the 
motor cortex, £>wx/-derived oligodendrocytes actually make up the majority of 
the oligodendrocyte population at P10 and P30. In the more anterior orbital 
cortex the contribution is around 50% at these ages. In more lateral cortical 
regions the contribution is lower than this presumably due to the proximity of 
this area to ventral sources (figure 5.13 A-D, I). £7wx/-derived oligodendrocytes 
in the white matter show a similar cortical distribution with contribution of 
around 50% in the corpus callosum and external capsule (figure 5.13 E-H, J). 
Both anterior white matter (forceps minor corpus callosum) and posterior white 
matter (dorsal hippocampal commisure) again show significant contribution from 
the cortical oligodendrocyte source. The more posterior fimbria perhaps shows 
the greatest deviation from this with a significant delay in the appearance of
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larger numbers o f Emxl-fov'wedi oligodendrocytes. Even here though, almost 
40% of the oligodendrocyte population is cortically derived at P30.
Grey matter White matter
Figure 5.13 The contribution of the £m:/-expressing neuroepithelium to the 
cortical oligodendrocyte population. (A-H) Example sections of the brain regions 
analysed for GFP (green) and SoxlO (red) expression at P10; (A), Motor cortex, 
MC, (B), Lateral cortex, LC, (C) Orbital cortex, OC, (D) Olfactory bulb, OB, (E) 
corpus callosum, cc, (F), external capsule, ec, (G) dorsal hippocampal commisure, 
dhc. (H) fimbria, fi. In addition the forceps minor corpus callosum (fmi) was 
examined (I) Quantification of the E m xl-derived oligodendrocyte contribution to 
the total oligodendrocyte population in selected grey matter regions. (J) 
Quantification of the same contribution to white matter regions. Scale bar, 60pm.
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There is quite a different story in the ventral forebrain. Here, both in white or 
grey matter regions, no cortically derived oligodendrocytes appear; presumably 
the population here is entirely derived from ventral sources. The one possible 
exception to this is in the septum where a population of £>w:x;/-derived SOX 10- 
positive cells can be found by P80 (results not shown). The level of this 
contribution is highest in the very dorsal septum (-25%), decreasing rapidly in 
the more ventral regions. This indicates that cells from the cortex may actually be 
slowly migrating ventrally, possibly along axons tracts of cortical projection 
neurons. This contribution to the ventral population is extremely limited in area 
though.
An interesting feature of the quantification is that in most areas examined, the 
proportion of GFP positive oligodendrocytes seems to be reduced by P80 (figure 
5.13 I, J). This could be due to other sources of oligodendrocytes being active in 
the adult animal, thus producing more GFP-negative oligodendrocytes and 
essentially diluting the Emxl-derived oligodendrocyte population. Alternatively, 
this could be due to a down-regulation of the Rosa26 promoter as animals the 
animals mature. A similar phenomenon is seen with other transgenic animals 
used both in this study (see Chapter 4) and in others, indicating a general 
decrease in Rosa26 activity with age. It appears in the forebrain however that this 
down-regulation may be less severe, given the relatively high numbers of GFP- 
expressing cells that persist at P80. Use of other reporter lines will help clarify 
the situation. Two exceptions to this loss of GFP-expressing cells appear in the 
lateral cortex, and more strikingly in the olfactory bulb. Olfactory bulb 
oligodendrocytes appear to become predominantly more Emxl-dev'wed over 
time. This suggests that -derived progenitors provide an ongoing source of 
new olfactory bulb oligodendrocytes throughout life. This could be misleading 
however as the olfactory bulb itself expresses Emxl (Briata et al., 1996) and is 
thought to endogenously produce its own oligodendrocytes (Spassky et al., 
2001). Thus it is likely that the increase in contribution from Emxl-expressing 
progenitors over time reflects a gradual dilution of non-olfactory bulb-generated 
oligodendrocytes by oligodendrocytes from an endogenous olfactory bulb 
source. The work described here with respect to olfactory bulb development and 
maintenance is limited, however, and further studies are required.
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One criticism of the work described above is that it is possible that 
oligodendrocyte progenitors derived from ventral sources might migrate into 
cortical regions and activate Emxl expression in response to their arrival in the 
£>wx7-expressing cortical field. A way of controlling for this possibility is by 
using an inducible form of Cre recombinase that requires the drug tamoxifen to 
enable it to mediate recombination. If Cre is activated transiently by tamoxifen 
only in a time period before any ventral progenitors have migrated into the dorsal 
telencephalon, then only endogenous 7£/wx7-expressing cortical cells will undergo 
recombination. Previous studies have indicated that tamoxifen-induced Cre 
activation as assessed by nuclear localisation of Cre is reduced to insignificant 
levels 48 hours after a single dose (Hayashi and McMahon, 2002). The creation 
of the EmxiCreER72 mouse described below allowed these experiments to be 
carried out.
5.2.9 Construction of the EmxlCreERT2 targeting vector
The strategy for targeting Emxl with CreER72 (Feil et al., 1997) is very similar to 
that used for iCre and is summarised in figure 5.14. The targeting construct again 
takes advantage of the endogenous Notl site immediately upstream of the Emxl 
ATG to fuse the CreER72 gene to the Emxl upstream sequences. To enable this, 
the 5’ end of the CreER72 gene was PCR amplified separately from the rest of the 
gene and modified to add 16bp found upstream of the Emxl ATG, which 
includes a Notl site. CreER72 can be directly joined to the 5’ homology region via 
the Notl site recreating the endogenous translation initiation site. The 3 ’ end of 
the CreER72 gene cassette contains a stop signal and poly-adenylation signal to 
enable the correct termination of transgene transcription. Positive selection for 
recombinant PAC clones was again mediated via a chloramphenicol resistance 
cassette which could be removed prior to pronuclear injection of recombinant 
PACs into mouse ova by virtue of its flanking^/ sites.
The construction of the EmxiCreER72 targeting vector is summarised in figure 
5.15. The strategy uses the previously constructed plasmid pEPrd3 (figure 5.7), 
however CreER72 was introduced instead of iCre. To achieve this the 5’-most 
366bp of CreER72 including an endogenous BamHl site were PCR amplified
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Figure 5.14 (A) Diagram of the Emxl locus including the endogenous Notl site and the Sacl sites immediately flanking exon 1. 
Black boxes indicate exons white boxes indicate untranslated regions. (B) The targeting vector that was used to insert the CreER72 
gene, along with a chloramphenicol resistance cassette (Cm1) flanked by fr t  sites, into exon 1 of Emxl. Grey boxes indicate regions 
of homology. Desired recombination events were screened for by digesting DNA with Sacl and carrying out Southern blots. A 
405bp region of the 3’ homology was used to probe the Southern blots. (C) The correctly targeted Emxl locus prior to Cmr 
excision.
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from the pCre-ERT2 plasmid (Feil et. al. 1997) and modified by adding Notl to 
the 5’ end (forward primer 5’-TTC GGC GGC CGC GAC CAT GTC CAA TTT 
ACT GAC CGT A-3\ reverse 5’-GGA TCC ACT AGT AAC GGC CGC C-3’). 
The resulting amplicon was cloned into pCRII-TOPO® to make p5’CreER. The 
5’ CreER12 fragment was then inserted into pEPrd3 via Notl and Bamlll to make 
pEPrd5’CreER. The 3’ end of CreER72 was isolated by digesting pCreERT2 with 
Sail and blunting, and then subsequently digesting again with Bamlll to release 
the desired fragment. This fragment was cloned into pEPrd5’CreER via the 
BamlU site and a blunted Pstl site to form the final vector, pECreERTV. PCR 
products were fully sequenced and cloning steps were verified by restriction 
enzyme analysis. The linear targeting construct was isolated for use in 
homologous recombination via its flanking Pacl and A sd  sites.
5.2.10 Homologous Recombination of PAC 357-D14 with the EmxlCreERT2 
targeting vector.
PAC modification was carried out in a bacterial system as previously described 
(Lee et al., 2001) and according to the protocol outlined in Chapter 2. Firstly 
undesired regions of the pPAC4 vector were removed using the ampicillin 
targeting vector as described in section 3.2.4. All colonies analysed were found 
to have correctly undergone recombination as shown by Southern blot (results 
not shown). 2 of these colonies were recombined with the linear EmxiCreERf2 
targeting vector. Chloramphenicol resistant colonies were picked after this 
recombination and were arabinose treated to remove the chloramphenicol 
resistance cassette. DNA from recombined colonies was digested with Sad, and 
analysed by Southern blot using a radioactive probe constructed from the 3’ 
homology region of the targeting vector. All the colonies checked showed correct 
recombination and chloramphenicol excision (figure 5.16).
5.2.11 Introduction of PAC 357-D14 recombined with EmxlCreERT2 into 
mouse ova
The EmxiCreER72 targeted PAC 357-D14 was linearised, purified and injected 
into mouse eggs in exactly the same way as the EmxliCre targeted PAC. Figure 
5.17 shows a typical DNA preparation.
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5.2.12 Screening litters for the presence of the Emxl-CreERT2 transgene 
Pups derived from the injection of the Emxl-CreER12 transgene were screened 
by PCR and Southern blot. The PCR primers used were specific to the 3’ end of 
the CreER72 gene (forward primer) and to a genomic DNA sequence 
immediately 3’ of the end of the 3’ homology (reverse primer, for sequences see 
table 2.1). Results from an Emxl-CreER72 PCR genotyping reaction are shown in 
figure 5.18 where mouse 10/1 shows the presence of the transgene. The 
transgenic status of putative founder animals was confirmed by carrying out 
Southern analysis of Sacl digested genomic DNA and hybridising with a 3’ 
homology probe (figure 5.19)
In total, 20 pregnancies were obtained from injection of the Emxl-CreER72 PAC 
construct. These pregnancies yielded 102 pups of which 4 were found to contain 
the transgene.
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Figure 5.16 Southern analyses of Sacl digests of 
recombined and unrecombined PAC clones probed with the 
Em xl 3’ homology. Wild type unrecombined PAC shows a 
band at 1600bp. After homologous recombination, the Sacl 
fragment is increased to 2400bp in length. Removal of the 
^/-flanked chloramphenicol cassette by Flpe causes the Sacl 
fragment to shift to 1 lOObp. A non-specific band is found in 
all clones at 3000bp (red arrow)
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Figure 5.17 PFGE 
EmxiCreERT2 targeted 
PAC 357-D14
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Swal and purified. 1 pi, 
3 pi and 5 pi of the 
DNA were run in 
order to check the 
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and also to quantify.
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Figure 5.18 Mouse genotyping by PCR for the 
EmxiCreER72 transgene. Mouse 10/1 shows 
the presence o f a specific band at 650bp 
indicating that it contains the transgene. Water 
was used as a negative control.
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Figure 5.19 Genotyping putative founder mice by Southern analysis. 
Genomic DNA from tails was digested with Sacl, and hybridised to a 
radioactive probe to the Emxl 3’ homology region. 10/1 and 15/1 are both 
transgenic animals, showing the transgenic band at llOObp (compare with 
figure 5.12) and the 1600bp wild type band. 10/8 is a wild type animal as it 
contains only the wild type band. The non-specific 3kb band is still present 
in all these samples (red arrow).
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5.2.13 Assessing the expression and function of the EmxlCreERT2 transgene
T2Animals found to contain the EmxiCreER transgene were analysed using in 
situ hybridisation for Emxl and CreER expression. Figure 5.20 shows that
rp*y
CreER and Emxl are expressed in the same pattern in the dorsal telencephalon 
of E l2.5 embryonic brains. In order to assess the function of the transgene, 
animals were crossed to Rosa26GFP reporter animals. CreER function was 
activated in pregnant mothers at E9.5 by gavage of animals with lOOp.1 of a 
solution of 4mg tamoxifen in com oil. E9.5 is well before OLPs from ventral 
sources start to enter the cortex around E l6. Therefore at E9.5 only endogenous 
progenitors in the dorsal telencephalon will express CreER . Examination of 
GFP expression at P10 indicates that induction of GFP expression occurred in a 
small minority of the CreER -expressing cells (figure 5.21). GFP-expressing 
cells derived from these progenitors include oligodendrocytes (figure 5.21 A-B) 
astrocytes (figure 5.21 C-D) and neurons (not shown). Therefore Emxl- 
expressing endogenous cortical progenitors are proven to give rise to 
oligodendrocytes. Note however that most cortical cells are not GFP labelled 
indicating that the efficiency of CreER -induced recombination is low.
T2Figure 5.20 In situ hybridisation showing expression of the EmxiCreER 
transgene at E l2.5. (A) Em xl expression can be seen in the cells lining the 
ventricles in the presumptive hippocampal cortex (h), the parahippocampal 
cortex (p) and the neocortex (n). (B) CreER72 expression can be seen in the same 
pattern as Emxl indicating the transgene is regulated in the same way as the 
endogenous gene. Scale bar; 500p,m.
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GFP/S0X1Q GFP/SOX10
GFP/S100P GFP/GFAP
Figure 5.21 Expression of GFP in P10 EmxiCreERT2 x Rosa26GFP induced 
with 4mg tamoxifen by gavage at E9.5. (A) Coronal section of the motor cortex 
of a P10 brain (see inset) stained for SOXIO and GFP. (B) Higher power 
confocal images showing SOXIO/GFP double positive oligodendrocytes 
(arrows), (C) SlOOp/GFP double positive astrocytes (arrows), (D) GFAP/GFP 
double positive astrocytes (arrows). Scale bars, lOOum.
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5.2.14 Induction of GFP expression by tamoxifen in the EmxlCreERT2 
mouse is inefficient
CreER72 expression occurs as expected in most or all E l2.5 cortical precursors 
(figure 5.20). After tamoxifen induction at E9.5, however, the number of cells 
induced to express GFP at P10 was only around 2% of the total cortical 
population (figure 5.21). Even taking into account the influx of cells from other 
areas of the forebrain, this still demonstrates inefficient induction of CreER17 
activity and GFP expression by tamoxifen. A variety of methods were therefore 
used to try and increase the efficiency of induction in embryos. These included 
intraperitoneal injection of the mother, feeding the mother tamoxifen-soaked 
food pellets, direct injection of tamoxifen into embryos during in utero surgery 
(R. Taveira-Marques, personal communication) and intra-oral gavage. A variety 
of carriers were used for tamoxifen introduction, including ethanol and com oil. 
In addition, 4-hydroxytamoxifen, a metabolite of tamoxifen that exhibits a more 
potent oestrogen agonist/antagonist activity (Kupfer et al., 1994), was used. The 
maximum reproducible induction was achieved using 4mg of tamoxifen 
dissolved in 100pi of com oil and introduced by intraoral gavage at E9.5 (figure 
5.21). Increasing tamoxifen levels beyond this increased the risk of foetuses 
aborting and reduced the sizes of litters. This is consistent with previous findings 
that tamoxifen can interfere with blood vessel development in the placental bed 
and can cause retardation of foetal growth and increase foetal death (Sadek and 
Bell, 1996). The 4mg of tamoxifen that was routinely used for induction usually 
prevented mothers from giving birth naturally meaning pups had to be delivered 
by Caesarean section and fostered. This is again consistent with previous reports 
indicating that tamoxifen interference with normal oestrogen activity can dismpt 
the onset of labour (Downing et al., 1981). This poor induction of CREER72 
protein activity is also seen with other CreER12 strains in our laboratory when 
crossed with the Rosa26GFP reporter line (e.g. the Nkx2.2CreERn  line, R. 
Taveira-Marques, personal communication). Induction by tamoxifen did show a 
dose-dependant response in our limited investigation. A 50% reduction in the 
level of tamoxifen administered (2mg) results in an approximately 25% reduction 
in the number of GFP+ cells, consistent with previous reports (Hayashi and 
McMahon, 2002)
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5.2.15 GFP expression is induced in various cell types in the dorsal cortex of 
the EmxlCreERT2 mouse
The results obtained using the EmxiCreER72 mouse indicate that the relatively 
few cells that do express GFP show a wide distribution throughout the cortex and 
exhibit a wide variety of morphologies (figure 5.21). They include astrocytes 
expressing both GFAP and/or S100P, oligodendrocytes expressing SOX 10, and 
neurons (not shown). Quantification of the relative numbers of the cell types seen 
indicates that 20 ± 5% of GFP-expressing cells are oligodendrocytes (SOX 10 
positive), 20 ± 5% of GFP-expressing cells are astrocytic (SIOOp-positive) and 
50 ± 5% of GFP-expressing cells are neuronal (NEUN-positive) when tamoxifen 
is administered at E9.5. The cells appear to be arranged in columns radiating out 
from the sub-ventricular zone (SVZ). This columnar organisation is well 
illustrated in figure 5.21 B and D where the SVZ is located to the bottom right of 
the images and cells appear to be arranged in columns radiating towards the top 
left, the direction of the pial surface. Often, clusters of cells are found that appear 
to consist of one cell type. Clusters of GFP-expressing oligodendrocytes, neurons 
or astrocytes occur in various regions, for example the astrocyte cluster shown in 
figure 5.21 C. This phenomenon suggests that the labelled cell clusters are 
actually derived from a single recombination event in one lineage-restricted 
precursor cell that is dedicated to the production of a single neuronal or glial cell 
type. Such lineage restricted precursors that produce homogenous cell clusters in 
the cortex have been demonstrated previously (Reid et al., 1995;Reid and Walsh, 
2002;Zerlin et al., 2004).
Induction was also carried out at different time points during development. 
Induction with 4mg of tamoxifen at El 5.5 resulted in at least a 10-fold reduction 
in the overall numbers of cells found to express GFP at P 10 as compared with 
induction at E9.5. This could indicate that fewer Emxl-expressing cells are 
mitotically active at E l5.5 or that the levels of CreERn  expression are 
diminished. Interestingly the relative numbers of neurons to glia appear similar, 
with for example around 26% of the GFP-expressing cells being 
oligodendrocytes following induction at E l5.5 compared to around 20% at E9.5. 
This indicates that £>wx7-expresing oligodendrocyte precursors are still present at
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E l5.5, consistent with the finding from the EmxliCre mouse that at E l6.5, 
cortical progenitors are just starting to produce OLPs. Induction at PO and later 
gives very low numbers of GFP positive cells at P10. Neonates cannot be 
gavaged and so tamoxifen is introduced by intraperitoneal or intragastric 
injection. Both methods fail to produce useful levels of induction. Those 
extremely rare cells that are seen however do still include a proportion of 
oligodendrocytes. Since glial cells do not express Emxl (Gulisano et al., 1996) 
this result suggests that the GFP-labelled oligodendrocytes are derived from 
persisting SVZ precursors and not by division of existing glia. Induction in the 
adult using 4mg tamoxifen introduced by gavage every 48 hours for 6 days failed 
to induce significant recombination. These results indicate that the levels of 
recombination that can be achieved diminish rapidly up until early postnatal ages 
and then disappear altogether. This could represent a down-regulation of the 
transgene, or perhaps an endogenous lowering of Emxl expression, although this 
is unlikely given reports that Emxl expression persists in cortical neurons into 
adulthood (Gulisano et al., 1996).
Further ways of increasing the efficiency of CreER72 induction have not been 
investigated at this point, and may indeed be futile with this particular transgenic. 
The EmxiCreER72 mouse does however provide a useful tool for investigating 
the embryonic timing of specification of cortical cell types and it is also useful 
for study of cell morphology. Individual cells are hard to visualise in the 
EmxliCre mouse due to the generally high levels of surrounding GFP 
expression. This makes cell outlines difficult or impossible to resolve. The 
inducible form of Cre allows us to avoid this issue. Precisely because so few 
cells are labelled they stand out clearly as figure 5.21 shows and their 
morphology and development are easier to study.
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5.3 Discussion
Using the EmxliCre mouse we have shown that the dorsal telencephalon is a 
major source of cortical oligodendrocytes. Progenitors from this region begin to 
produce OLPs on, or just before E l6.5 as shown by the appearance of 
GFP/PDGFRa double positive OLPs in the EmxliCre x Rosa26R-GFP offspring. 
The number of £mx/-derived OLPs increases dramatically between E l6.5 and 
birth so that by PO they constitute almost 50% of the OLP population in the 
motor cortex and external capsule. Production of oligodendroglial cells by 
dorsally-derived progenitors is also demonstrated by the appearance of SOX 10- 
expressing cells that label with GFP. These cells already exist in relatively high 
proportions in some cortical regions at PO. After birth many areas show a 
dramatic increase in the numbers of GFP/SOXIO double-positive cells so that by 
P10, up to 60% of the oligodendrocyte populations of areas such as the motor 
cortex and corpus callosum appear to derive from dorsally-specified progenitors. 
This level of contribution is maintained, and in some cases increased, over at 
least the first five weeks of life. Using the EmxiCreER?2 mouse to induce Cre- 
mediated recombination around E9.5 indicates that production of GFP- 
expressing oligodendrocytes occurs from progenitors that were located in the 
dorsal telencephalon well before any immigration of cells from ventral sources. 
This demonstrates that production of oligodendrocytes occurs from endogenous 
progenitors from the dorsal telencephalon and that the production of dorsally- 
derived oligodendrocytes observed in the EmxliCre mouse is not an ‘artefact’ 
caused by ventrally-derived progenitors up-regulating Emxl, and therefore iCre, 
as they enter the cortex.
5.3.1 The EmxliCre mouse forms part of a larger study into forebrain 
oligodendrogenesis
The EmxliCre mouse was created primarily to help examine the developmental 
origins of oligodendrocytes in the forebrain. It therefore forms part of a larger 
study that uses two additional transgenic mouse lines that exhibit Cre expression 
in other areas of the forebrain. The first of these is the Nkx2.1iCre line which was 
created by means of PAC transgenesis using a strategy similar to that used to
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make the EmxliCre mouse (figure 5.22 A, B). This mouse expresses iCre in the 
same pattern as the HD transcription factor Nkx2.1, that is in ventral forebrain 
regions including the septum, pre-optic area and medial ganglionic eminence 
(MGE) (figure 5.22 C-E). The second additional transgenic used was the 
Gsh2iCre mouse again created via PAC transgenesis (figure 5.22 A, B). This 
mouse expresses iCre in the same pattern as the Gsh2 gene in the forebrain, in 
the lateral ganglionic eminence (LGE), caudal ganglionic eminence (CGE) and 
overlapping partially with Nkx2.1 expression in the MGE (figure 5.22 F-H). Both 
mouse lines were created by N. Kessaris and M. Grist in our laboratory.
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Figure 5.22 (A) Structures of the genomic PAC inserts used to create the 
Nkx2.1iCre and Gsh2iCre transgenic mice. (B) Diagram showing how the 
Nkx2.1 and Gsh2 loci were modified by insertion of iCre. (C) In situ 
hybridisation showing endogenous Nkx2.1 expression or (D) iCre expression in 
E l 1.5 telencephalon of an Nkx2.1iCre mouse. (E) GFP activation in Nkx2.1iCre 
x Rosa26R-GFP E l 1.5 telencephalon. (F) In situ hybridisation showing 
endogenous Gsh2 expression or (G) iCre expression in E l2.5 Gsh2iCre mouse 
telencephalon. (H) p-Galactosidase enzymatic labelling in Gsh2iCre x Rosa26R- 
LacZ E12.5 telencephalon. Scale bar, 400pm. Figure adapted from N. Kessaris.
In order to map the origins of oligodendrocytes in the forebrain, the EmxliCre, 
Nkx2.1iCre and Gsh2iCre transgenic lines were individually crossed to the 
Rosa26R-GFP line and the offspring examined at various stages for the presence 
of cells co-expressing GFP and oligodendrocyte markers. I was primarily 
concerned with the production and examination of the EmxliCre line as 
discussed above. The majority of the work on the Nkx2.1iCre and Gsh2iCre lines 
was carried out by N. Kessaris. However, I also analysed a small proportion of 
the data from these other two transgenic lines and in order to place the results
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from the EmxliCre mouse in context, I will discuss here the results from all three 
mice.
5.3.2 Forebrain oligodendrocytes are generated in three waves from ventral 
and then dorsal sources
Initially, Nkx2.JiCre xRosa26R-GFP offspring were examined for co-expression 
of GFP and PDGFRa. GFP/PDGFRa double positive OLPs were first seen in the 
ventral telencephalon at E11.5-E12.5 (figure 5.23 A, B). Until E14.5, the OLP 
population of the forebrain was overwhelmingly GFP-positive regardless of the 
location of the cells. In light of previous work implicating the MGE in early 
forebrain OLP generation (Fuccillo et al., 2004;Spassky et al., 2001;Tekki- 
Kessaris et al., 2001), this confirms the MGE as the sole initial source of OLPs in 
the early embryonic telencephalon. However, by E16.5, a population of 
PDGFRa-positive, GFP-negative OLPs could be found in the cortical 
intermediate zone of the Nkx2.1iCre mice (figure 5.23 C, D). The relative 
proportion of forebrain OLPs that were GFP/PDGFRa double positive began to 
diminish, indicating a second source of OLPs had appeared outside of the MGE.
To examine whether this second source of OLPs might correspond to the LGE 
and CGE, Gsh2iCre x Rosa26R-GFP offspring were examined for 
GFP/PDGFRa co-expression. Double labelled OLPs derived from Gsh2- 
expressing regions were found from around E l5.5. Given that Nkx2.1 and Gsh2 
share a region of overlapping expression in the MGE, it was necessary to 
demonstrate whether or not any OLPs labelled with GFP in the Gsh2 mice were 
derived from the same source as in the Nkx2.1 mice, or from a distinct source. 
The Nkx2.1iCre and Gsh2iCre animals were therefore crossed and the triple 
Nkx2.1iCre x Gsh2iCre x Rosa26R-GFP transgenic was examined for GFP/ 
PDGFRa co-expression. At E16.5, virtually all the OLPs in this triple transgenic 
are labelled with GFP indicating that the Gs/?2-expressing LGE and/or CGE 
represents a second source of OLPs (figure 5.23 E, F). Therefore at E16.5 the 
ventral telencephalon represents the origin of all OLPs in the forebrain, with 
OLPs originating firstly in the MGE, then in the LGE/CGE.
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This situation changes yet again by the time of birth. In the triple transgenic 
(Nkx2.1 x Gsh2 x Rosa26R-GFP) at P2, GFP-negative PDGFRa-positive OLPs 
are once again found, this time in the dorsal cortex (figure 5.23 G, H). As 
mentioned, previous reports had suggested that the cortex itself can give rise to 
OLPs (Gorski et al., 2002).
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Figure 5.23 Three waves of forebrain OLP generation. (A-B) The E l2.5 
telencephalon of an Nkx2.1 x Rosa26R-GFP, showing generation of PDGFRa- 
expressing (red) OLPs from the MGE, that also express GFP (green) (arrows in 
B). (C-D) By E l6.5 PDGFRa-positive GFP-negative (arrowheads, D) are 
shown which must derive from a source other then the MGE. (E-F) All 
PDGFRa-positive cells express GFP in the Nkx2.1iCre/Gsh2iCre/Rosa26R- 
GFP triple transgenic (arrows, F) indicating that all OLPs derive from the MGE 
and LGE/CGE at this age. (G-H) At P2 the presence of a third wave of OLP 
specification is shown by PDGFRa-positive GFP-negative OLPs that appear in 
the cortex (arrowhead, H). (I-J) This third wave is shown to derive from the 
Em xl-expressing cortex by GFP/ PDGFRa coexpression in the EmxliCre x 
Rosa26R-GFP animals (arrows, J). (K) Diagram illustrating the three 
successive waves of OLP generation from firstly the MGE (1), then the 
LGE/CGE (2) and finally from the cortex (3). Scale bars, (A, C, E, G, I) 
500pm, (B, D, F, H, J), 60pm. Adapted from N. Kessaris.
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These findings were therefore the motivation behind our investigations using the 
EmxIiCre transgenic as discussed above. Although cortically derived OLPs can 
first be found at E l6.5, their contribution to the overall OLP population in the 
cortex only becomes highly significant around the time of birth. This is 
illustrated by the fact that their existence in the Nkx2.1/Gsh2/Rosa26R-GFP 
mouse, as shown by an absence of GFP expression in OLPs, is only clearly 
demonstrated after birth (figure 5.23 G, H). Use of the EmxIiCre mouse directly 
demonstrates the significant contribution of cortically derived OLPs at P2 (figure 
5.23 I, J).
These results show that initially, all forebrain OLPs including those in the cortex, 
derive from the MGE. Subsequently the LGE/CGE also begins to contribute and 
by birth, the cortex starts to produce its own endogenous OLPs. Therefore 3 
waves of OLP generation can be identified in the forebrain (figure 5.23 K). 
Animals from all three lines were examined postnatally for SOXIO/GFP co­
expression to quantify the contribution of the three sources of oligodendrocytes 
to the total oligodendrocyte populations of various areas. Quantification was 
carried out in both grey and white matter from PO to P80 and the relative 
contributions of the three sources compared graphically (see figure 5.24). In both 
grey and white matter areas of the ventral forebrain, initial contribution to the 
oligodendrocyte population by Nkx2./-derived progenitors is very high (100% in 
the anterior commisure and pre-optic area, figure 5.24 B, E), but this decreases 
rapidly after birth, eventually becoming almost insignificant by P80 (only 15- 
20% in the anterior commisure and pre-optic area, figure 5.24 B, E). The Gsh2- 
derived progenitors on the other hand represent the major source of postnatal 
ventral oligodendrocytes. Even in areas where the Gsh2-derived progenitor 
contribution is initially less than that of the Nkx2. /-derived progenitors, such as 
the anterior commisure and pre-optic area (figure 5.24 B, E), Gsh2-derived 
oligodendrocytes soon predominate, contributing 55-100% of the 
oligodendrocyte population at P30 in the ventral areas studied (figure 5.24 B, E 
and F). The contribution of E'/wx/-derived progenitors to the ventral 
oligodendrocyte population is essentially nil at all ages.
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Figure 5.24 The origins of oligodendrocytes in the forebrain at various postnatal 
ages. The proportions of SOX 10-expressing cells that also express GFP were 
assessed in a variety of forebrain regions in the three transgenic lines, EmxIiCre 
(pink), Gsh2iCre (blue) and Nkx2.1iCre (green). (A) Diagram showing the 
locations of the forebrain regions in which the contribution of the various 
oligodendrocyte sources to the overall SOX 10-expressing cell population was 
assessed. (B) POA, pre-optic area. (C) LC, lateral cortex. (D) MC, motor cortex. 
(E) ac, anterior commisure. (F) lot, lateral olfactory tract. (G) ec, external 
capsule. (H) cc, corpus callosum.
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The more lateral (figure 5.24 C, G) and dorsal (figure 5.24 D and H) regions of 
the forebrain that constitute the cortex tell a different story. In dorsal and lateral 
forebrain we again see a striking loss of Nkx2.1 -derived oligodendrocytes after 
PO, and indeed before PO in the external capsule (figure 5.24 G). By P80 
therefore, and in some regions before this time, the Nkx2.1-derived 
oligodendrocyte population is completely abolished. On the other hand, Gsh2- 
derived oligodendrocytes represent a major proportion of the cortical 
oligodendrocyte population, particularly in lateral regions (figure 5.24 C, G), 
throughout the period examined. The most obvious difference in the cortical 
regions is the contribution of £/wjc7-derived oligodendrocytes. After P10, the 
motor cortex and corpus callosum in particular contain populations of 
oligodendrocytes derived from £mx7-positive precursors that are at least equal in 
size to the Gsh2-derived populations (figure 5.24 D, H).
By P80 it appears that at least a proportion of forebrain oligodendrocytes do not 
derive from any of the regions labelled, given that the sum of the GFP-expressing 
oligodendrocyte percentage contributions is significantly less than 100%. This 
could represent invasion of the forebrain by oligodendrocytes from more caudal 
regions, or could actually represent down-regulation of the Rosa26 promoter 
leading to loss of GFP expression in some cells as has been discussed previously.
Our demonstration of the existence of three separate oligodendrocyte lineages in 
the forebrain led to the question of whether or not these lineages are functionally 
distinct. Therefore an approach was devised in our laboratory to specifically 
ablate each oligodendrocyte lineage individually. This was mediated by placing 
the diphtheria toxin A fragment (DTA) (Palmiter et al., 1987) under the control 
of the oligodendrocyte specific Sox 10 promoter. DTA expression was further 
controlled by separating it from the Sox 10 promoter by /oxP-flanked stop signals. 
In this way DTA expression could be limited to oligodendrocyte cells derived 
from specific Oe-expressing progenitor populations, depending on which Cre 
transgenic (EmxIiCre, Nkx2.1iCre or Gsh2iCre) the SoxlO-DTA transgenic was 
crossed to. Surprisingly, it was found that deletion of any one of the three 
oligodendrocyte populations could be compensated for by oligodendrocytes 
produced from the other two sources. No phenotype was observed in the animals
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in which one oligodendrocyte population had been deleted by specific DTA 
expression. In addition, the numbers of oligodendrocytes found in forebrain 
regions that would usually contain oligodendrocytes derived from the deleted 
population were the same as in control animals. These findings therefore have 
important implications for the way we view forebrain oligodendrogenesis. These 
results are presented in full in a paper currently in press (Kessaris et al., 2005).
5.3.3 The implications of compensation between different regionally-derived 
oligodendrocyte populations.
Ablation of any of the three sources of oligodendrocytes appears to have no 
lasting effect on the numbers, or distribution, of OLPs or oligodendrocytes in the 
forebrain. At early time points there are occasional deviations in 
OLP/oligodendrocyte number and/or spatial distribution between control animals 
and those with ablated populations, but these differences are no longer significant 
by P10. Behavioural studies with the SoxlO-DTA crossed animals have not yet 
been done, but the animals all survive, appear normal and reproduce as expected. 
This implies that the three populations of oligodendrocytes are functionally 
equivalent and do not represent distinct forms of oligodendrocyte required for 
specialised roles in marked contrast to the numerous neuronal cell types that 
derive from these same progenitor populations. Alternatively each source could 
produce the same heterogeneous mix of OLPs, but there is no evidence for this.
The compensation for lack of one oligodendrocyte population by another is 
rapid, implying that normally the populations compete against each other for 
space and resources. When one population is removed, another can rapidly move 
into and populate the newly available territory. This competition is likely to 
reflect, at least in part, competition for limiting supplies of mitogens such as 
PDGF, (van Heyningen et al., 2001). We have shown that the dorsal spinal cord 
acts as a delayed, secondary source of oligodendrocytes in the same way as the 
Emxl-derived progenitors do in the forebrain (Fogarty et al., 2005). In addition, 
ablation of the pMN domain-derived oligodendrocyte population in Nkx6.1 and 
Nkx6.2 double knockout mice appears to be partially compensated for by the 
dorsal spinal cord oligodendrocyte source (Cai et al., 2005;Qi et al., 2001).
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Therefore the caudal and rostral CNS appear very similar in terms of the basic 
principles that underlie oligodendrocyte specification and development.
What is the point in multiple oligodendrocyte sources? They do not seem to be 
functionally distinct, ruling out the idea that each source provides a population of 
oligodendrocytes tailored to a particular role. The system also seems to be able to 
cope quite well with removal of one of the other sources, indicating all three are 
not essential for forebrain function. There are minor phenotypes involved with 
the ablation of an oligodendrocyte population however. First, there are minor 
variations in the timing and dispersal of oligodendrocytic cells at early time 
points, presumably due to a delay in the compensation of one source by another. 
It is testament to the plasticity of the CNS that it can cope so rapidly with a major 
loss of cells. Second, as the work using the SoxlO-DTA mouse is proceeding it 
appears that there may be slight differences in brain size between animals with 
ablated populations and wild type controls. The differences have yet to be 
quantified and confirmed but may indicate that delays in production of 
oligodendrocytes caused by ablation could have effects on the growth and 
survival of other neural cell types. This may indicate that the multiple 
oligodendrocyte sources represent a means of optimising the maturation and 
function of the developing brain. Oligodendrocytes are known to provide 
survival factors for neurons (Dai et al., 2003;Meyer-Franke et al., 1995;Wilkins 
et al., 2001) and so early disruption of oligodendrocyte-neuron interactions due 
to a delayed oligodendrocyte production in the ablation experiments may disturb 
forebrain development. The ability to produce as many oligodendrocytes as 
possible in a short time may therefore be important in order to support and 
sustain newly produced neurons in the forebrain. This leads to the idea that the 
acquisition of multiple sources of oligodendrocytes represents an adaptation to 
cope with the increases in brain size and neuron number that have occurred 
during mammalian evolution.
5.3.4 How are the different oligodendrocyte sources specified?
Oligodendrocyte specification in the ventral forebrain is almost certainly 
controlled by SHH signalling. The MGE expresses components of the SHH 
signalling pathway and disruption of SHH signalling prevents ventral forebrain
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progenitors from producing oligodendrocytes (Nery et al., 2001;Spassky et al., 
2001;Tekki-Kessaris et al., 2001). It is therefore very likely that the Nkx2.1- 
derived and probably the Gsh2-derived populations of oligodendrocytes are 
specified by the action of SHH secreted in the ventral forebrain. However, what 
signals control OLP specification in the cortex? One candidate is fibroblast 
growth factor (FGF) signalling which has been implicated in the generation of 
forebrain oligodendrocytes, at least from cortical progenitors in vitro (Hall, 
1999;Kessaris et al., 2004;Qian et al., 1997). There is evidence, based on binding 
affinities and expression studies, that FGF2 acts through FGFR1 in the forebrain 
(Ford-Perriss et al., 2001;Kessaris et al., 2004;0mitz et al., 1996). Therefore we 
have started to analyse the effects of region specific knockout of FGFR1 using a 
‘floxed’ FGFR1 mouse (Pirvola et al., 2002) to mediate specific FGFR1 
mutagenesis in the three oligodendrocyte lineages of the forebrain. The 
investigations are still ongoing but currently it appears that there is no 
discemable effect upon cortical oligodendrocyte generation when FGFR1 is 
deleted in the £mx/-expressing lineage. In EmxJiCre/Rosa26R- 
GFP/FGFRJhxP/loxP animals we have found around 73% (±5%) of the SOX10- 
expressing cells in the motor cortex are GFP-positive. This compares to 74% 
(±13%) of SOX 10-expressing cells in the motor cortex of EmxliCre/Rosa26R- 
GFP/FGFRlhxP/WT littermate control animals. This indicates that the contribution 
of the £>wx7-expressing progenitors to the cortical oligodendrocyte population is 
not affected by the absence of FGFR1. We know that FGFR1 excision occurs as 
expected because, intriguingly, EmxliCre/Rosa26R-GFP/FGFRlloxP/loxP animals 
lack a corpus callosum. This result is similar to that seen with hGFAP-Cre 
mediated excision of FGFR1 in the forebrain recently reported by Ohkubo et al 
(Ohkubo et al., 2004). These results indicate that FGFR1 plays a vital role in the 
formation of this major white matter tract in the forebrain. Determining what this 
role is however will require further investigation. Studies are ongoing as to 
whether an oligodendrocyte phenotype is seen with Gsh2iCre or Nkx2.1iCre 
mediated FGFR1 mutagenesis. The latest results indicate that in the pre-optic 
area of control animals, the Nxk2.1-derived SOX 10+ cells constitute around 72% 
(±3%) of the total population while in the mutants the contribution is around 
83% (±8%). This result probably indicates that FGFR1 disruption has no 
significant effect on oligodendrocyte specification by the Nkx2.7-expressing
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progenitors. This is hardly surprising given the likely role that SHH plays in this 
region.
It is possible that FGFR1 is involved in cortical oligodendrogenesis, but any 
effects that deletion of the gene may cause are compensated for by FGF 
signalling though other FGF receptors such as FGFR2 and/or FGFR3 both of 
which can mediate FGF2 signalling with high specificity (Ornitz et al., 1996) and 
are expressed in the developing forebrain (Belluardo et al., 1997;Reuss and 
Bohlen und, 2003) Investigating this question further will require Cre-mediated 
excision of perhaps all of these FGFR genes. The tools are now available to 
begin to pick apart the processes that are involved in forebrain oligodendrocyte 
specification and development.
5.3.5 Inducible Cre-mediated recombination
It has become obvious from our investigations into the use of the inducible 
CreER12 that the efficiency of induction of Cre function by tamoxifen or 4- 
hydroxytamoxifen is a highly inefficient process in the embryo, at least in our 
hands. Comparison of the GFP-expression in EmxliCre/Rosa26R-GFP forebrain 
and in EmxlCreERT2/Rosa26R-GFP forebrain shows that the maximum 
induction achieved by tamoxifen gives, at best, 50-fold fewer recombined cells 
than the constitutively active iCre. This means use of the EmxlCreER72 mouse is 
restricted to qualitative studies on £ ’/wx7-derived cell morphology,
The reasons for the inefficient induction of Cre activity in the EmxlCreER'T2 
mouse are not certain, but are probably related to the levels of CreER72 protein 
that are produced in £/wx7-expressing cells. Previous reports have indicated that 
tamoxifen can be used to efficiently induce recombination in embryos. Hayashi 
and McMahon (Hayashi and McMahon, 2002) placed CreER72 under the control 
of the pCAGG promoter and generated transgenic mice by pronuclear injection. 
They then crossed the resulting transgenic animals to the Rosa26R-LacZ reporter 
animals and assessed p-Gal activity after embryonic induction of recombination. 
Injection of 3 mg of tamoxifen into a pregnant female of 40g body weight at E8.5 
induced 95% of the cells of the embryonic telencephalon to express p-Gal by 48 
hours later. This highly efficient recombination provides proof of principle for
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the CreER72 system. However the CAGG promoter drives high levels of gene 
expression in many tissues (Niwa et al., 1991;Pratt et al., 2000), thus this
rpj
construct results in extremely high CreER expression. The level of CreER 
expression in the EmxlCreER72 mouse is much lower. Other examples of 
efficient induction of recombination in embryos using the CreER7 system are 
rare and also use known promoters that are likely to drive high levels of CreER7 
expression (Danielian et al., 1998;Gothert et al., 2004). It seems then that this 
inducible recombination system will have to be modified or improved upon 
before it will prove to be universally useful for functional studies in the embryo.
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Chapter 6
General Discussion
6.1 Summary of results
The aim of this work was to fate-map defined regions of the mouse neural tube 
neuroepithelium using PAC transgenesis and Crt-loxP technology, with 
particular emphasis on the origins of glial cells. Three genes were identified with 
expression patterns restricted to regions of the neural tube epithelium that were 
of interest. The first, Dbxl, is a homeodomain (HD) transcription factor 
expressed during embryogenesis in a small region of the spinal cord 
neuroepithelium located between the alar and basal plates. The second, Msx3, is 
another HD transcription factor expressed in the dorsal third of the developing 
spinal cord. Finally, Emxl is a HD transcription factor expressed in the dorsal 
telencephalon during embryogenesis in a region already known to be fated to 
become the cerebral cortex. Mouse PAC clones were identified that carry 
genomic DNA inserts containing one of the genes of interest, plus extensive 
flanking genomic regions likely to include all the genetic elements required for 
the normal expression of that gene. Suitable PAC inserts were then modified by 
inserting Cre recombinase into the locus of each of the genes of interest. This 
was done in such a way as to ensure that Cre was expressed in the same pattern 
as the gene of interest. Modified PAC inserts were introduced into the genomes 
of mice via injection of the modified PAC insert into the pronuclei of fertilised 
mouse ova. The resulting transgenic mice were then crossed to reporter mouse 
strains containing a reporter gene cassette that requires Cre-mediated 
recombination in order to permanently activate expression of a reporter gene. 
Thus the reporter gene becomes permanently activated in cells expressing Cre 
and in all their progeny. The offspring of these crosses only express reporter
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genes in cells that derive from neuroepithelial regions that also express one of the 
genes of interest. This allowed us to identify all the progeny derived from a 
particular neuroepithelial region, providing insights into the mechanisms and 
processes that underlie cell fate determination in that region.
Using the DbxliCre mouse we were able to demonstrate that the Dbxl- 
expressing neuroepithelium gives rise to neurons, oligodendrocytes and at least 
two distinct types of astrocytes. The Z)2>x7-expressing domain is initially 
comprised of RC2-positive radial glial cells. These give rise at first to several 
intemeuron sub-types from E l0.5 to E l2.5. After neurogenesis, Dbxl-derived 
radial glial cells begin to translocate their cell bodies from the neuroepithelium to 
the pial surface. As their cell bodies near the pia, the radial glial cells then 
undergo differentiation into oligodendrocytes or astrocytes. This therefore 
represents a novel source of spinal cord oligodendrocytes distinct from the well- 
established source in the pMN domain. In vitro specification of Dfo-derived 
oligodendrocytes appears to be SHH-independent, but does require signalling via 
FGF. It occurs late in embryo development, commencing around E l5.5, 3 days 
after production of OLPs from the pMN domain begins. D&xr-derived 
oligodendrocytes represent a relatively small contribution to the total spinal cord 
oligodendrocyte population (-3%) and they remain largely confined to the lateral 
funiculus, the region to which their radial glia precursors originally project to.
The MsxSiCre mouse exhibits Cre expression in a wide domain covering dPl to 
dP5 in the dorsal spinal cord neuroepithelium. This broad domain is initially 
comprised of radial glial cells that give rise to dorsal intemeurons. After 
neurogenesis, the region switches to gliogenesis producing oligodendrocytes 
from E l5.5. This occurs, at least in part, via direct differentiation from radial 
glial precursors. These oligodendrocytes populate all areas of the spinal cord but 
are concentrated in the dorsal horn and dorsal funiculus of the spinal cord. Cell 
counts indicate that the Msxi-expressing domain contributes around 13% of the 
total spinal cord oligodendrocyte population, but in the dorsal horn this 
proportion is increased to 20%, and in the dorsal funiculus it is around 50%. 
Therefore the dorsal spinal cord neuroepithelium represents a significant source 
of spinal oligodendrocytes. Although investigations into the mechanisms
208
governing dorsal spinal cord oligodendrocyte specification have not yet begun, it 
is likely that the process is SHH-independent given the region’s distance from 
the source of SHH in the ventral neuroepithelium. The Msx3 domain is also a 
significant source of at least two morphologically distinct populations of 
astrocytes. It appears to contribute virtually all of the fibrous astrocytes that line 
the dorsal pial surface. It is likely, given the results obtained with the DbxliCre 
mouse, that these astrocytes directly differentiate from radial glial precursors that 
radiate out from the dorsal neuroepithelium prior to birth. The Msxi-domain also 
contributes the majority of the protoplasmic astrocytes located in the dorsal horn 
grey matter.
The EmxIiCre and EmxlCreER72 mice have allowed us to demonstrate that the 
dorsal telencephalon neuroepithelium is a significant source of oligodendrocytes 
that populate cortical regions of the mouse forebrain. OLPs derived from Emxl- 
expressing progenitors can first be seen at E l6.5 near the dorsal SVZ and their 
numbers increase dramatically so that by birth they constitute over 45% of the 
PDGFRa-positive cells that are present in the motor cortex. By around 4 weeks 
of age, £m;7-derived oligodendrocytes constitute well over half the 
oligodendrocytes found in the motor cortex and corpus callosum. They also make 
significant contributions to more lateral cortical regions including both white and 
grey matter. An overall picture of oligodendrocyte specification in the forebrain 
has emerged in which OLPs first appear from the MGE at around E l2.5, from 
the LGE/CGE around E14.5, and from the cortical anlage around E16.5. 
Postnatally, the oligodendrocytes derived from the MGE are gradually replaced 
with those derived from the LGE and CGE, such that this second source of OLPs 
becomes the major contributor to oligodendrocytes in all areas of the forebrain. 
Oligodendrocytes derived from the cortical neuroepithelium still represent a 
significant minority of the cortical oligodendrocyte population however. 
Combining the EmxIiCre, Gsh2iCre and Nkx2. HCre mouse with a SoxlO-DTA 
mouse in order to specifically ablate the oligodendrocyte population from each 
source indicates that the oligodendrocytes produced from the MGE, LGE/CGE 
or cortex are functionally equivalent. Each source of OLPs is able to compensate 
for the removal of another source by producing extra OLPs to colonise areas of 
the forebrain deficient in oligodendrocytes due to the ablation. Another
209
application of the EmxIiCre mouse, to direct region specific mutagenesis of the 
Fgfrl gene indicates that this gene is not necessary for specification of 
oligodendrocytes from the cortical neuroepithelium.
6.2 Glial cell specification in the spinal cord
The pMN domain is the major source of oligodendrocytes in the spinal cord 
(Miller, 2002;Pringle and Richardson, 1993;Richardson et al., 2000;Rowitch, 
2004;Timsit et al., 1995;Warf et al., 1991). However, generation of 
oligodendrocytes from the rodent dorsal cervical spinal cord was also suggested 
by Spassky et. al. (Spassky et al., 1998), and was implied by findings from chick- 
quail chimera experiments (Cameron-Curry and Le Douarin, 1995). The work 
presented here using the DbxliCre and MsxSiCre mice, backed up by 
information from Nkx6.1 and Nkx6.2 double knockouts (Cai et al., 2005;Vallstedt 
et al., 2005), now confirms that the progenitor cells in at least dP3, dP4 and dP5, 
but possibly in all spinal neuroepithelial domains, represent a secondary source 
of oligodendrocytes distinct from the major source in the pMN. 
Oligodendrogenic capacity is therefore not only a feature of restricted and 
specialised domains, but is a property shared by precursor cells located 
throughout the neuroepithelium. This view is backed up by information from the 
forebrain using EmxIiCre, Gsh2iCre and Nkx2. liCre mice, which indicates that 
widespread oligodendrogenic capacity is a feature common throughout the CNS. 
The obvious question that leads on from this is what are the signal(s) that cause 
these precursors to differentiate into oligodendrocytes?
The current state of our knowledge of oligodendrocyte specification was 
discussed in Chapter 1 but can be briefly summarised as follows; in the pMN 
domain SHH is the primary signal involved in directly inducing oligodendrocyte 
generation. SHH probably acts via GLI proteins to cause expression of pro- 
oligodendrogenic transcription factors such as the Olig genes and Nkx2.2. These 
then act on downstream targets involved in the expression of genes specific to 
the oligodendrocyte lineage. However, SHH and Olig genes are also directly 
involved in motomeuron (MN) generation which precedes oligodendrocyte
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production. Therefore there must be other factors involved that regulate the 
switch between motomeuron and oligodendrocyte production. Determining the 
mechanisms that govern this switch will greatly enhance our knowledge of 
gliogenesis. Work from Stolt et. al. (Stolt et al., 2003) argues that the 
transcription factor Sox9 is vital in gliogenesis. Their model suggests that SHH- 
induced Olig gene expression confers pMN domain identity and initially induces 
motomeuron specification around E9. Sox9 expression begins around E10, but at 
low levels, becoming more strongly expressed by E11-E12. It is proposed 
therefore that coexpression of Sox9 and Olig2 is required to mediate the switch 
that sends precursors down an oligodendrocyte differentiation pathway after MN 
production. Sox9 expression actually occurs throughout the other neuroepithelial 
domains as well where it is thought to be involved in astrocyte specification. This 
means that Sox9 can actually be considered a general pro-glial gene. Perhaps 
then in the pMN domain, expression of the other pro-oligodendrogenic genes 
(Olig, Nkx2.2 etc.), plus Sox9 leads to oligodendrocyte specification, while Sox9 
expression without pro-oligodendrogenic gene expression leads to a more 
‘default’ astrocytic differentiation. It is unlikely that Sox9 is the sole glial 
determinant however, given that its disruption did not completely abolish 
oligodendrocyte development and oligodendrocyte numbers recover to near-wild 
type levels in the Sox9 disrupted animals, albeit with a significant delay. In 
addition Sox9 expression starts prior to gliogenesis in the spinal cord, indicating 
some sort of delay in its effects (Stolt et al., 2003). Other factors must be 
involved.
The role of Notch signalling in cell fate specification is undergoing intense 
investigation. It has appeared for a while that the Notch signalling pathway is 
involved in maintaining progenitor cells in an undifferentiated state and that 
escape from this maintenance is a prerequisite for cell differentiation. This is 
highly reminiscent of the situation in Drosophila where a process of lateral 
inhibition mediated by Notch signalling controls the segregation of neuronal and 
ectodermal fates. The vertebrate Notch pathway is highly complex however and 
it appears that various aspects of Notch signalling are likely to have multiple 
roles in glial cell specification (for review of Notch signalling in the mouse see 
Yoon and Gaiano, (2005)). Work in zebrafish has focussed attention on the role
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of Notch signalling in oligodendrocyte specification in the ventral neural tube. 
Here it appears that lowering the levels of Notch signalling encourages neural 
precursors to exit the cell cycle, initially as neurons, mediated by cyclin- 
dependant kinase (Cdk) inhibitors. This decreases the numbers of 
oligodendrocytes that are specified. Increasing Notch signalling promotes the 
maintenance of dividing precursors by inhibiting Cdk inhibitors thus inhibiting 
neuronal differentiation. This acts to increase oligodendrocyte numbers (Park et 
al., 2005;Park and Appel, 2003). Note however that Notch-mediated Cdki 
inhibition must also be evaded eventually in order for oligodendrocyte precursors 
to exit the cells cycle and differentiate. This means that the timing of Notch- 
controlled Cdki expression is vital.
A simple model can be proposed in which undifferentiated pMN precursors are 
initially maintained by Notch signalling. Early (E9-E11) evasion of Notch 
signalling allows neural precursors to differentiate into neurons, because pro­
neuronal genes are expressed at this time which is prior to the expression of Sox9 
reaching the levels required for OLP specification (see Stolt et al., (2003)). Later 
Notch evasion coincides with the expression of all the genes required for OLP 
specification allowing the production of proliferative OLPs. The controlling 
factors in this model are thus the timing of Notch signalling evasion, and the 
timing of the expression of pro-neuronal and pro-oligodendrocyte genes. How is 
this Notch signalling evasion mediated however? Whether or not a cell evades 
Notch signalling could simply be a stochastic event. Random inequalities in 
Notch ligand and receptor levels could become reinforced by lateral inhibition as 
shown in C. elegans and Drosophila thus leading to segregation of two cell 
lineages. There must however be other cues that allow a progenitor to evade the 
Notch-mediated undifferentiated state. Once Notch signalling segregates a 
neuronal and a non-neuronal (progenitor) pathway, what allows the progenitor, 
maintained by Notch-signalling in its undifferentiated state, to leave the cell 
cycle and become an oligodendrocyte? How is this cell cycle exit linked to Sox9 
expression and the control of other pro-oligodendrogenic genes? It is likely that 
the complex interplay of the various Notch ligands and receptors, plus their 
downstream targets, are involved in the fine control of these processes.
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Astrocyte specification adds another dimension to this problem. Unpublished 
results from our lab using an Olig2-iCre mouse indicate that the pMN domain 
also produces small numbers of astrocytic cells, both fibrous and protoplasmic. It 
could be argued then that these differentiate from precursors, likely to be radial 
glia, maintained in an undifferentiated state throughout neuronogenesis and 
oligodendrogenesis via Notch signalling. Astrocyte precursors only evade the 
Notch-mediated undifferentiated state after the expression of pro- 
oligodendrogenic genes has reduced. It can therefore be argued that multipotent 
precursors undergo Notch-mediated maintenance in an undifferentiated state as 
radial glia. Evasion of this maintenance occurs, via unknown mechanisms, in 
subsets of precursors at various times throughout CNS development, and the 
timing of this evasion will coincide with the expression of different sets of cell- 
specification genes. These particular genes will make it more likely that a 
particular developmental pathway is chosen at any time.
The results we have presented indicating specification of astrocytes and
oligodendrocytes from all areas of the neural tube must be addressed. Vallstedt 
et al indicated that evasion of BMP signalling was involved in dorsal 
oligodendrogenesis (Vallstedt et al., 2005). Notch-mediated maintenance of 
undifferentiated precursors occurring until after the removal of the anti-gliogenic 
effects of dorsal BMP (and WNT) signalling could therefore provide a pool of 
precursors able to differentiate into glia later in development. These precursors 
exist all along the dorso-ventral axis of the neural tube as radial glial progenitors, 
thus providing the ability to generate glia from all domains. One problem with 
this model however is that both astrocytes and oligodendrocytes appear to be 
produced from the same neuroepithelial regions. So what are the signals in the 
more dorsal regions that decide between astrocyte and oligodendrocyte
differentiation? Perhaps again it is the timing of differentiation that determines
which developmental pathway is taken, and different sets of pro-
oligodendrogenic or pro-astrocytic genes are expressed at different times. 
Alternatively both types of genes could be expressed concurrently, but in 
separate precursor populations. But what determines this segregation? Could a 
stochastic process of lateral inhibition operate here too, or are as yet unidentified 
factors involved? A major impediment to studying these questions is the lack of
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information regarding the genes involved in astrocyte specification. It might be 
that astrocyte differentiation is the default pathway that all precursors will take 
once Notch-mediated inhibition of differentiation is evaded. This is consistent 
with the observation of direct differentiation of radial glia into astrocytes at the 
end of embryogenesis -  in the absence of any other cues, the remaining radial 
glia become astroglial. Only the expression of genes promoting an alternative 
fate would prevent astrocyte specification in this scenario. This idea is fine, 
although it does not explain why some dorsal progenitors enter the non-default 
pathway of oligodendrocyte development. What is causing the expression of pro­
oligodendrocyte genes in a few precursors in the dorsal spinal cord? If another 
major signalling centre is not involved in this process, perhaps more local factors 
have to be considered.
It is possible that signals in the local microenvironment surrounding a precursor 
cell provide the cues that will determine which developmental pathway the 
precursor is primed to take. Investigating these has previously been difficult. 
However the Cre mice produced in this study and by others provide invaluable 
tools to explore these processes. The specific over-expression or knockout of 
candidate genes in small populations of precursors will enable us to study how 
small populations of cells behave in response to disruptions in their signalling 
pathways.
6.3 Glial cell specification in the forebrain
Our work in the forebrain has concentrated on the generation of oligodendrocytes 
and we have found that neuroepithelial precursors located throughout the dorso- 
ventral axis produce oligodendrocytes. This is highly reminiscent of the situation 
in the spinal cord and it is very tempting to draw direct parallels between these 
two CNS regions both conceptually, and in terms of the actually processes 
governing cell fate specification. The forebrain contains huge numbers of 
neurons and it follows that equally large numbers of glial cells are required to 
support neuronal development and function. It can therefore be argued that the 
gliogenic potential of precursors from all regions of the rostral neuroepithelium 
has become maximised in order to support the expanded neuronal populations
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that have developed during the evolution of the brain. Oligodendrogenesis in the 
ventral forebrain shows parallels with that described in the spinal cord, with SHH 
signalling involved in promoting the specification of OLPs from less restricted 
precursors. The control of dorsal oligodendrogenesis on the other hand is less 
well characterised and remains a puzzle because of a lack of evidence for SHH 
mediated signalling in the dorsal forebrain. We must therefore look for 
mechanisms that do operate in this region and that mimic the specification 
processes controlled by SHH in the ventral forebrain. Links between the 
intracellular signalling pathways controlled by SHH and FGF receptors (Kessaris 
et al., 2004) provide a glimpse into what these processes may be. It will be 
fascinating to use the power of Cre-loxP mediated genetic manipulation in order 
to tease out the details of the mechanisms involved.
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